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Abstract 
 
Sister-chromatid cohesion is a vital cellular process which involves the topological 
entrapment of sister-chromatids inside the ring of a protein complex called cohesin 
(Smc1, Smc3, Scc3 and Scc1). The early loss of cohesion can lead to chromosome 
mis-segregation, which in humans can cause the development of cancers. As a 
result, cells have evolved complex regulatory mechanisms to control cohesion 
throughout the cell cycle. Broadly, the cohesion cycle can be split into four stages 
loading, anti-establishment, establishment and release. The establishment of sister-
chromatid cohesion occurs during S-phase with the passage of the replication fork, 
which is due to the acetylation of Smc3 at K112 and K113 through the action of the 
acetyltransferase called Eco1. Apart from this acetyltransferase, a number of other 
non-essential establishment factors have been identified, which include Chl1, Ctf4 
and RFCCtf18. RFCCtf18 is a replication factor C (RFC) like complex formed of the 
seven subunits Ctf18, Rfc2-5, Dcc1 and Ctf8. Apart from sister-chromatid cohesion 
RFCCtf18 has also been shown to function in intra-S phase checkpoints. 
 
To further improve our understanding on the establishment of sister-chromatid 
cohesion the structures of the heterotrimer Ctf18C-Dcc1-Ctf8 was solved along with 
the acetyltransferase domain (ACT) of X. laevis Eco2 (xEco2) bound to two substrate 
peptides. The structure of Ctf18C-Dcc1-Ctf8 revealed that Dcc1 contained three 
tandem winged helix (WH) domains which could bind to both ssDNA and dsDNA. 
These WH domains were involved in recruiting RFCCtf18 to stalled replication forks. 
The structure of xEco2 ACT domain indicated that it had different binding 
mechanisms for both K112 and K113 substrates. To further investigate this, a mass 
spectrometry assay was employed to examine the relative rates of acetylation of 
K112 and K113. It was discovered that K112 acetylation occurs at a faster rate than 
the acetylation of K113. 
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Chapter 1. Introduction 
Complex organisms are made up of eukaryotic cells of a diameter ranging between 
10-30 µm. For growth, repair and reproduction cells are required to divide. Cell 
division requires genomic DNA to be copied after which, mitosis occurs. Daughter 
cells are made with an exact genomic copy of their parent’s DNA. This is an 
extremely challenging process not least because higher eukaryotes can have over 3 
billion base pairs of DNA, which have an estimated unfolded length of over one meter. 
Higher eukaryotes have made this process manageable by linking sister-chromatids 
together from replication until the onset of anaphase. 
 
The protein complex called cohesin is responsible for the linkage of sister-chromatids. 
Cohesin was identified, initially, in yeast cells by mutants that exhibited increased 
rates of chromosome mis-segregation (Michaelis et al., 1997; Guacci et al., 1997). 
Later, these proteins were shown to be required in Xenopus laevis (Losada et al., 
1998) and human cells (Sumara et al., 2000). The core cohesin complex is formed 
from two structural maintenance of chromosome (Smc) proteins, Smc1 and Smc3; a 
kleisin subunit, called sister-chromatid cohesion 1 (Scc1) and a protein called Scc3. 
This complex is totally conserved throughout evolution although higher eukaryotes 
have multiple versions of all four subunits. For instance, human cells have two copies 
of the Scc3 subunit called SA1 and SA2 (Losada et al., 2000). The nomenclature 
varies between organisms; for simplicity in this thesis the budding yeast naming will 
be used unless stated otherwise. However, a list of gene names for the cohesin core 
subunits and accessory subunits, in five different species, is presented below (Table 
1.1). 
 
The main role of cohesin is to provide cohesion between sister-chromatids; however, 
it has been discovered to have numerous other functions. For instance, during the 
repair of double strand breaks by homologous recombination, cohesin is required to 
provide a linkage between sister-chromatids (Sjögren and Nasmyth, 2001). Cohesin 
also has roles in transcription regulation (Horsfield et al., 2007) and the development 
of X. laevis (Dorsett and Merkenschlager, 2013). 
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Apart from the core complex, other cohesin ‘accessory’ subunits are required 
throughout the cell cycle for efficient sister-chromatid cohesion (discussed in detail 
below). These include the Scc2 and Scc4 complex, Wpl1, Pds5 and the 
acetyltransferase Eco1. Together these proteins work to coordinate cohesin on 
chromosomes in a dynamic process known as the ‘cohesion cycle’, which will be 
reviewed in detail below. Firstly, further structural information is presented on the 
core cohesin complex. 
 
 
Table 1.1. Gene Names for The Cohesin Subunits. 
 
1.1 The Core Cohesin Complex 
The core cohesin complex is made up of four proteins: Smc1, Smc3, Scc1 and Scc3 
(Michaelis et al., 1997). In this section, I will discuss information currently available 
on the structure of cohesin. I will start by reviewing Smc proteins and then describe, 
in more detail, the cohesin specific subunits. 
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1.1.1 Overall architecture of Smc proteins 
All genomes from bacteria to humans have been shown to contain at least one Smc 
complex (Hirano, 2006). These complexes have been revealed to be fundamental to 
chromosome biology, and structural insights have proved key in understanding their 
mechanistic function. There are six Smc genes encoded in higher eukaryotes, which 
form three heterodimers. The three complexes are made from Smc1 and 3, which 
form a complex called cohesin, and is required for chromosome segregation; Smc2 
and 4, which make a complex called condensin, and is involved in chromosome 
resolution at mitosis; and Smc5 and 6, which is currently unnamed, and functions in 
DNA repair pathways (Lehmann, 2005). 
 
Individual Smc proteins can be as long as 1300 residues, and have a domain 
organisation which is unique to this family of proteins (Figure 1.1A). The N-terminus 
and C-terminus interact to form a globular domain termed the ‘head’. Each head 
domain contains two nucleotide binding motifs, Walker A and B, which are separated 
by an antiparallel coiled-coil (Saitoh et al., 1994). Present between the two coiled-
coils is another globular domain, which is responsible for the dimerisation of the Smc 
proteins, which is called the ‘hinge’. A series of biochemical experiments revealed 
that by replacing the hinge of Smc3 with Smc1 you could form a homodimer with 
mutant and wild type Smc3 proteins. This suggested the hinge domain was 
responsible for the formation of the three different Smc complexes found in higher 
eukaryotes (Haering et al., 2002).The head domain of Smc proteins shows sequence 
similarities to a family of nucleotide binding proteins called the ATP-binding cassette 
(ABC) ATPases, which include Rad50; a double strand break (DSB) repair protein 
(Saitoh et al., 1994). 
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Figure 1.1. Structure of Smc Complexes. 
A) The secondary structure elements of all Smc heterodimers. B) The cohesin specific 
subunits. 
 
Electron microscopy (EM) analysis of MukB, a bacterial Smc protein, revealed that 
Smc proteins form an extended ‘V shape’ of ~50 nm, which can exist in vitro in an 
open or closed conformation (Melby et al., 1998). Analysis of vertebrate condensin 
and cohesin show different coiled-coil arrangements. Condensin coiled-coils are 
close together forming a ‘lollypop’ structure, while cohesin arms exist in an open ‘ring’ 
conformation (Anderson, 2002). To form a functional complex, the head domain of 
Smc complexes interact with other regulatory subunits (Figure 1). For instance, the 
head domain of condensin is formed from the additional kleisin subunit CAP-H, and 
two homologous huntingtin, elongation factor 3, A subunit and TOR (HEAT) repeat 
proteins called CAP-D2 and CAP-G. The Smc5 and Smc6 heterodimer binds to four 
subunits called Nse1, Nse2, Nse3 and Nse4 (Hirano, 2006). Recently, Nse1 and 
Nse3 have been shown to contain tandem winged helix (WH) domains (Palecek and 
Gruber, 2015). 
 
1.1.2 The head domain of cohesin 
The topological entrapment of DNA requires cohesin to form a tripartite ring (Gruber 
et al., 2003) made from two Smc subunits, Smc1 and Smc3, and the kleisin subunit 
Scc1 (Figure 1.1B). One molecule of Scc1 has been shown to bind to the Smc1 and 
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3 heterodimer (Haering et al., 2002). Scc1 is an elongated protein with highly 
conserved N- and C-terminal domains, and two conserved protease sites in the 
centre of the protein (see below). Scc1 completes the ring through binding to the 
nucleotide binding domains (NBD) of both Smc subunits; the N- and C-terminal 
regions of Scc1 bind to Smc3 and Smc1 respectively (Haering et al., 2002). The 
crystal structure of the head domain of Smc1 and Scc1 revealed that the C-terminal 
region of Scc1 forms a WH domain, which is able to bind to Smc1 (Haering et al., 
2004). WH domains usually function in DNA binding yet no interaction between the 
Scc1 C-terminal region and DNA could be observed (Haering et al., 2004). It was 
proposed that the N-terminal domain of Scc1 could interact with Smc3 in the same 
way as the Smc1-Scc1 complex. However, it took over a decade to disprove this 
hypothesis with the solving of the crystal structure of Smc3-Scc1N, which indicated 
that the N-terminal region of Scc1 forms two alpha helices. These helices bind to the 
coiled-coil close to the head domain of Smc3 forming a helical bundle (Gligoris et al., 
2014). 
 
The additional HEAT repeat containing protein Scc3 is also required to complete the 
core cohesin complex (Michaelis et al., 1997). Scc3 interacts predominantly with 
Scc1 in an equi-molar ratio, and only partially binds to the Smc subunits (Haering et 
al., 2002). The crystal structure of human Scc3 and Scc1 revealed a ‘dragon’ shaped 
structure of Scc3. Scc1 makes a large number of contacts with the surface of Scc3 
in an elongated fashion (Hara et al., 2014). A budding yeast homologue has also 
been solved, which predicts a similar binding mechanism between Scc3 and Scc1 
(Roig et al., 2014). Furthermore, two recent crystal structures showed that a HEAT 
repeat protein called Pds5 binds to the N-terminal region of Scc1 through a similar 
mechanism to the Scc3-Scc1 interaction. This suggests that the binding mechanism 
of HEAT repeat proteins to subunits of cohesin is conserved (Lee et al., 2016; Muir 
et al., 2016). 
 
1.1.3 The hinge domain of cohesin 
Before the crystallisation of the bacterial hinge domain it was unknown whether the 
coiled-coil domains of Smc complexes were intra- or intermolecular. Through 
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structural analysis of the coiled-coils leaving the hinge domain, and EM analysis of 
a single Smc subunit it was clearly shown that Smc proteins have intramolecular 
coiled-coils (Haering et al., 2002). The crystal structure of the hinge domain also 
showed a pseudo 2-fold symmetry in each subunit with a positively charged channel 
between the dimerisation domain. The structure showed no similarity with any known 
protein structures. In addition, a further crystal structure of an Smc1 and Smc3 hinge 
complex from vertebrates showed conservation with the bacterial structure, which 
suggested the dimerisation mechanism has been conserved throughout evolution 
(Kurze et al., 2010). Biochemical analysis of the hinge domain with a region close to 
the coiled-coil revealed it was able to bind to double stranded DNA (dsDNA); 
however, the hinge domain alone was unable to (Chiu et al., 2004). The above results, 
raised the possibility that the hinge domain was involved in either entry or exit of DNA 
from cohesin’s ring. 
 
1.2 The Cohesion Cycle 
The interplay between cohesin and chromatin is a dynamic process requiring many 
additional proteins, and is often referred to as the ‘cohesion cycle’. This cycle can 
broadly be split into four stages: loading, anti-establishment, establishment and 
release (Figure 1.2). Each stage is tightly controlled throughout the cell cycle and will 
be reviewed in detail below. The progress towards a complete understanding of 
cohesin and the cohesion cycle has been the work of decades of research including 
the labour of many laboratories. 
 
1.2.1 Cohesin loading 
For cohesin to carry out its dynamic function it needs to be present on chromatin. 
This process has in recent years been shown to be complicated requiring a separate 
protein complex formed from two proteins, Scc2 and Scc4 (Ciosk et al., 2000). This 
complex was first identified in budding yeast to be required for the loading of cohesin 
onto DNA in the G1 phase of the cell cycle (Ciosk et al., 2000). Later, Scc2 and 4 
were shown to be conserved in all higher organisms (Seitan et al., 2006). However, 
the bacterial cohesin equivalent does not contain a loader complex. Cohesin loading 
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is not just confined to G1 as studies in both budding yeast and human cells have 
shown that the presence of cohesin on chromatin is dynamic. For instance, Scc1 
produced after the G1 phase in budding yeast was found on chromatin (Ocampo-
Hafalla et al., 2007). In addition, the residence time of cohesin on chromatin in the 
G1 and G2 phase of the cell cycle was discovered to be ~25 minutes in HeLa cells 
(Gerlich et al., 2006). There appears, however, to be cohesin molecules with a much 
longer residence time. It was suggested that this population was responsible for the 
stable linkage between sister-chromatids (Gerlich et al., 2006).  
 
 
Figure 1.2. The Cohesion Cycle.  
During G1, cohesin is loaded onto DNA by the Scc2/4 complex. At this stage, cohesion 
is known not to be established due to the anti-establishment activity of Wapl and Pds5. 
During S-phase cohesion is established by the acetyltransferase Eco1. Finally, upon the 
onset of anaphase, cohesion between sister-chromatids is lost due to the action of 
separase, which cleaves Scc1. 
 
Analysis of Scc2 revealed it contained a C-terminal HEAT repeat domain (Neuwald 
and Hirano, 2000) with further structural studies indicating that the loader complex 
formed three separate domains. These globular regions were called the head, body 
and hook regions (Chao et al., 2015). Scc2 is also able to bind to dsDNA but not 
ssDNA (Murayama and Uhlmann, 2013). The hook is formed from the C-terminal 
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region of Scc2 and is sufficient to load cohesin onto circular DNA in vitro (Chao et 
al., 2015). This implicated Scc4 in a regulatory role for cohesin loading as it is thought 
to recruit Scc2 to specific chromatin locations (Bernard et al., 2006). Scc4 is a 
tetratricopeptide repeat (TPR) protein, which binds to an extended N-terminal 
peptide from Scc2, (Chao et al., 2015; Hinshaw et al., 2015) and has a conserved 
patch of residues on its surface required for the localisation of the loader complex 
(Hinshaw et al., 2015). 
 
The Scc2/4 complex will load cohesin onto DNA, in vitro, in a sequence independent 
manner (Murayama and Uhlmann, 2013). However, in cells cohesin is loaded at 
actively transcribed regions before it moves to intragenic areas (Lengronne et al., 
2004). This suggested that Scc4 has a role in locating the complex to specific 
chromatin location through interactions with a protein partner, as it has a redundant 
role in the loading reaction (Chao et al., 2015). This has been supported with 
evidence that the loader co-localises with both the mediator complex (Kagey et al., 
2010) and the RSC complex (Lopez-Serra et al., 2014). In addition, Scc4 is thought 
to interact directly with the pre-replication complex via the Cdc7-Dbf4 subunits 
(Takahashi et al., 2008). It is possible that Scc4 interacts with a variety of chromatin 
bound complexes; however, further work needs to be conducted to clarify the above 
results. 
 
Two studies carried out by Frank Uhlmann and co-workers have improved our 
understanding of the loading mechanism of cohesin by Scc2/4 (Murayama and 
Uhlmann, 2015; 2013). Using recombinant proteins, they managed to reconstitute 
the loading reaction in vitro, and provided evidence that cohesin topologically entraps 
DNA. They also showed that ATP hydrolysis was required for the loading reaction, 
which they suggested caused dissociation of the Smc head domains. Furthermore, 
their results indicated that DNA enters cohesin through an ‘entry’ gate, which is 
located between the Smc3-Scc1 interface. 
1.2.2  Anti-establishment 
Analysis of cohesin loaded onto chromatin has shown that it is not stably associated 
in the G1 phase of the cell cycle (Gerlich et al., 2006). At this stage cohesion is known 
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not to be established, and ‘anti-establishment’ is occurring due to the action of two 
proteins called precocious dissociation of sisters protein 5 (Pds5) and wings apart 
like protein (Wapl) (Hartman et al., 2000; Vernì et al., 2000). Pds5 and Wapl form a 
stable sub-complex in vitro, which is able to bind to cohesin (Murayama and Uhlmann, 
2015). Co-operative binding to cohesin is required for the interaction as Pds5 or Wapl 
alone could not bind independently of the other subunit (Murayama and Uhlmann, 
2015). Pds5 is an essential gene as Wapl is dispensable in budding yeast (Hartman 
et al., 2000). This suggests Pds5 has a role outside its function in anti-establishment. 
 
Wapl was first identified in Drosophila melanogaster as a non-essential gene, which 
affected the structural organisation of heterochromatin (Vernì et al., 2000). The yeast 
structure is mainly a helical (Kueng et al., 2006), and is formed from a C-terminal 
HEAT repeat, which is able to bind to the head domain of Smc3 (Chatterjee et al., 
2013). The C-terminus is conserved between species, with the structure of human 
and yeast Wapl being similar (Ouyang et al., 2013). Conversely, the N-terminal 
region of Wapl is divergent; apart from a conserved tyrosine-serine-arginine (YSR) 
motif (Ouyang et al., 2016) which is required for the interaction with Pds5 (Shintomi 
and Hirano, 2009). 
 
Three recent structures of Pds5 have revealed it forms a ‘jaw’ like HEAT repeat 
structure able to bind to Scc1 close to the Scc1-Smc3 interaction site through a 
conserved patch of residues on the surface of Pds5 (Lee et al., 2016; Muir et al., 
2016; Ouyang et al., 2016). This has further been supported by crosslinking data, 
which shows Pds5 forms multiple contacts with Smc3 and Scc1 (Huis in 't Veld et al., 
2014). In one of these crystal structures the co-factor inositol hexakisphosphate (IP6) 
was bound, which was shown to participate in the opening of the exit gate of cohesin 
(Ouyang et al., 2016). 
 
The topological entrapment of DNA by cohesin is catalysed by Scc2/4, with DNA 
passing through an ‘entry’ gate found between the Smc3-Scc1 interface (Murayama 
and Uhlmann, 2013). Opposing this action is Wapl and Pds5, which cause the 
removal of DNA from inside cohesin’s ring through a so called ‘exit’ gate. Much 
speculation and work has been conducted into understanding how DNA both enters 
and leaves cohesin’s topological embrace. The exit gate has been characterised 
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both in vitro and in vivo, and work has shown that the binding of ATP is required in 
vitro, but surprisingly not its hydrolysis; suggesting the nucleotide is required to cause 
dimerisation of the head domain (Murayama and Uhlmann, 2015). The exit gate has 
been shown to be between the Smc3-Scc1 interface, which is unexpectedly in the 
same location as the entry gate (Chan et al., 2012). This was firstly shown by fusing 
Smc3 and Scc1 in yeast cells, which revealed cohesin could no longer be removed 
from chromatin (Chan et al., 2012). Furthermore, recent work has shown more 
directly that the N-terminus of Scc1 is removed from Smc3 through monitoring the 
degradation of an N-terminal fragment of Scc1 in wild type or Wapl deletion strains 
(Beckouët et al., 2016). Finally, evidence was shown, in vitro, that the N-terminus of 
Scc1 could be caused to dissociate from Smc3 by the addition of Pds5 and Wapl 
(Murayama and Uhlmann, 2015). Surprisingly, in this assay system Wapl and Pds5 
could also act as a cohesin loader; explaining the observation that deleting Wapl in 
yeast cells caused a reduced amount of cohesin on chromatin (Rowland et al., 2009). 
 
In cells, the Scc3 subunit of cohesin is required as well as Wapl and Pds5 to cause 
the removal of cohesin from chromatin (Shintomi and Hirano, 2009). It is interesting 
to note that there are stoichiometric amounts of Pds5 and the other cohesin subunits 
found in yeast cells; however, this is not the case for Wapl (Chan et al., 2012). It 
could therefore be concluded that Wapl acts like an enzyme on the Pds5-cohesin 
complex with Pds5 and Scc3 helping regulate and stabilise an open cohesin 
conformation. 
 
If the anti-establishment activity of Wapl and Pds5 was predominant throughout the 
cell cycle cohesion between sister chromatids would not occur, which would result in 
chromosome mis-segregation. Cells have therefore evolved a mechanism to cause 
the controlled establishment of sister chromatid cohesion (see below), which they 
have coupled to DNA replication. 
 
1.2.3 Establishment 
The establishment of sister-chromatid cohesion is required to antagonise the anti-
establishment activity of Wapl and Pds5. Although the protein establishment factor-
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like protein 1 (Eco1) does not form part of the cohesin complex it was identified in 
yeast genetic screens to be an essential gene for chromosome segregation (Spencer 
et al., 1990; Michaelis et al., 1997). Further work revealed Eco1 was not required for 
maintaining sister-chromatid cohesion after S-phase or loading the complex onto 
chromatin. This implicated Eco1 in an establishment role, which occurred during 
DNA replication (Toth et al., 1999). 
 
Eco1 is highly conserved with vertebrates containing two copies of the gene. 
Mutations in one of the human orthologues, Esco2, causes the two developmental 
disorders called Roberts syndrome and the less severe SC Phocomelia (Schüle et 
al., 2005). Although Eco1 is conserved the mechanism of establishment in 
vertebrates varies slightly from yeast where the additional protein sororin is required. 
Sororin aids establishment by directly competing with Wapl for Pds5’s binding site 
(Nishiyama et al., 2010). 
 
Early analysis on the secondary structure of Eco1 revealed it contained a two domain 
structure with a N-terminal C2H2 Zinc finger domain and a C-terminal GCN5 related 
N-acetyl-transferase (GNAT) domain (Ivanov et al., 2002). In addition, between 
species the N-terminus is divergent in both length and composition signifying species 
specific roles for some orthologues of Eco1. It was further shown that Eco1 
possessed in vitro acetylation activity as it was able to auto-acetylate itself and 
subunits of the core cohesin complex. This suggested its main role in cells was in 
acetylating subunits of the cohesin complex, which would antagonise the activity of 
Wapl and Pds5 leading to the establishment of sister-chromatid cohesion. However, 
an in vivo target could not be identified (Ivanov et al., 2002). This caused the 
significance of the acetyltransferase domain of Eco1 to be questioned (Brands and 
Skibbens, 2005). This was further supported by the observation that mutating R222G 
and K222G in Eco1 caused a loss of acetylation activity in vitro, but yeast cells with 
this mutant did not show any defects in sister-chromatid cohesion (Unal et al., 2007). 
 
Two studies provided evidence that in yeast an Eco1 mutant strain could be 
supressed by the Smc3 mutation K113N, which would mimic a lysine acetylation at 
this residue (Ben-Shahar et al., 2008; Unal et al., 2008). Analysis on Smc3 by mass 
spectrometry (MS) also confirmed that not only was K113 acetylated in vivo but the 
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neighbouring residue, K112, was as well. This tandem lysine acetylation of Smc3 
was inhibited in yeast cells with mutant Eco1. The lysine acetylation was confirmed 
to be conserved as the corresponding residues in human Smc3, K105 and K106, 
were also found to be acetylated (Zhang et al., 2008). This provided the final 
evidence that Eco1 causes the establishment of sister-chromatid cohesion by 
acetylating Smc3 on residues K112 and K113 (human K105 and K106). 
 
The recent crystal structure of human Eco1 (hEsco1) has revealed that the C-
terminal region forms the standard GNAT family fold (Kouznetsova et al., 2016). 
However, it has an extended β-hairpin that protrudes from this globular domain, 
which is not found in other GNAT proteins. This insertion is conserved between 
species and is important in forming a dimer interface in solution. Furthermore, the 
authors show that hEsco1 is missing a conserved catalytic glutamate found in other 
GNAT proteins. They suggest that an aspartate from Smc3 functions in substrate-
assisted catalysis (Kouznetsova et al., 2016). 
 
Since the discovery that a post translational modification of K112 and K113 causes 
a change to the cohesin complex which triggered the establishment of sister-
chromatid cohesion speculation has ensued about the effect acetylation has on the 
cohesin complex. There have been three popular ideas for the functional significance 
of acetylation: (1) acetylation regulates the ATPase activity of the head domain of 
cohesin (2) modification of Smc3 inhibits Pds5 or Wapl binding and (3) DNA binding 
is inhibited upon Smc3 acetylation. The evidence for the effect acetylation has on the 
ATPase activity of cohesin is varied with studies showing mixed results (Çamdere et 
al., 2015; Heidinger-Pauli et al., 2010; Ladurner et al., 2014). However, in vitro, when 
acetylation mimics were made recombinantly there was no change in the background 
ATPase activity of cohesin (Ladurner et al., 2014). In yeast cells, contradictory to this, 
acetylation seems to locks cohesin in a state that is unable to hydrolyse ATP (Elbatsh 
et al., 2016). Recent evidence has shown that loader induced ATPase activity of 
cohesin is inhibited by acetylation (Murayama and Uhlmann, 2015). The authors 
suggest that the tandem lysines act as sensors, regulating the ATPase activity of the 
head domain. This has been hypothesised to be due to acetylation blocking DNA 
binding. Evidence for this model is reinforced by the crystal structure of Rad50 bound 
to DNA, which shows that the loop corresponding to K112 and K113 of Smc3 is in 
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the proximity of DNA (Rojowska et al., 2014). Support for acetylation inhibiting Wapl 
binding has recently been provided, as Wapl cannot cause the dissociation of the 
exit gate when Smc3 is acetylated in vivo (Beckouët et al., 2016). However, ATPase 
stimulated activity could be required to cause the dissociation of the exit gate; limiting 
the scope of this study. Further work needs to be conducted to clarify the functional 
role of acetylation. 
 
The functional significance of acetylation is an important question that needs 
answering. In addition to this, another vital avenue of research has been investigating 
the regulation of Eco1 as the timing of acetylation is crucial. Early work implicated 
that the establishment of sister-chromatid cohesion was linked with DNA replication 
(Toth et al., 1999). One model suggested that Smc3 is acetylated as the replication 
fork passes through cohesin. A potential problem with this model is that the 
replication fork may be too large to pass through cohesin’s ~50nm ring. It is possible 
that either cohesin is unloaded and then re-loaded directly after the replication fork 
or the replication fork undergoes a conformation change when it encounters cohesin 
(Uhlmann, 2009). The idea that establishment is coupled to the passing of the 
replication fork was supported by the discovery that Eco1 interacts directly with 
proliferating cell nuclear antigen (PCNA), which is a DNA sliding clamp (Moldovan et 
al., 2006). PCNA is a crucial replication factor able to bind multiple proteins through 
a conserved PCNA interaction motif or PIP box (Moldovan et al., 2007). However, 
direct binding was not shown in this study, and the PIP box identified did not contain 
two key aromatic residues, which are usually crucial in PCNA binding (Moldovan et 
al., 2007). 
 
Eco1 is also regulated by Pds5, as Pds5 acts outside its anti-establishment role to 
promote acetylation in vivo (Chan et al., 2013; Vaur et al., 2012). It has yet to be 
understood how Pds5 performs this role; whether it is directly through interacting with 
Eco1 or by stabilising the head domain of cohesin. This could explain why Pds5 is 
an essential gene but Wapl is not (Vernì et al., 2000). In vitro the hydrolysis of ATP 
is required for the acetylation of Smc3, suggesting Eco1 can only interact with the 
head domain when it is in the correct conformation (Ladurner et al., 2014). As well 
as being spatially regulated by PCNA, Eco1 has a cyclin-dependent kinase 1 (Cdk1) 
Chapter 1. Introduction 
25 
 
phosphorylation site. Phosphorylation of Eco1 occurs after S-phase causing its 
eventual degradation (Lyons and Morgan, 2011). 
 
Apart from Eco1, a number of other establishment factors have been discovered, 
which although they are non-essential cause chromosome mis-segregation defects. 
Currently, these non-essential factors include Ctf4 (Hanna et al., 2001), Ctf18, Dcc1, 
Ctf8 (Mayer et al., 2001), Tof1, Csm3, Mrc1 (Warren et al., 2004) and Chl1 
(Petronczki, 2004). Of these proteins only Ctf18, Dcc1, Ctf8, Csm3, Ctf4 and Chl1 
have been directly linked to cohesion establishment (Borges et al., 2013; Xu et al., 
2007). The above proteins have been separated into two distinct groups from their 
genetic interactions. The first group is made from Mrc1, Ctf18, Dcc1 and Ctf8; and 
the second group contains Tof1, Csm3, Ctf4, Chl1. 
 
Ctf18 forms a replication factor C (RFCCtf18) like complex with the proteins Dcc1 and 
Ctf8 (Mayer et al., 2001). This complex is present at replication forks during S-phase 
(Lengronne et al., 2006). Apart from sister chromatid cohesion, RFCCtf18 also 
functions with Mrc1 in intra S-phase checkpoints (Crabbé et al., 2010). Ctf4 forms a 
trimer able to interact with multiple components of the replisome (Simon et al., 2014). 
Recently, it has also been shown to interact directly with Chl1 (Samora et al., 2016). 
Chl1 is a DNA helicase (Hirota and Lahti, 2000) first identified in chromosome mis-
segregation screens. Recently, it has been implicated in lagging strand replication 
(Farina et al., 2008). Chl1 and Ctf4 function in an Eco1 independent establishment 
pathway by a currently unknown mechanism (Borges et al., 2013). 
 
Further work needs to be conducted into Eco1 and the role of acetylation, as well as 
the other non-essential establishment factors for a more complete understanding of 
this crucial stage in the cohesion cycle. Genetic work alone will be unable to unearth 
a complete functional model, and further biochemical and structural analysis will be 
required. 
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1.2.4 Release of cohesin 
After the establishment of sister-chromatid cohesion, newly replicated sisters remain 
topologically entrapped in cohesin’s ring until the onset of anaphase when cohesion 
is lost (Nasmyth and Haering, 2009). Without this physical linkage the positioning of 
chromosomes on the metaphase plate would be an almost impossible task for cells. 
Early work in budding yeast implicated the cysteine protein separase in the removal 
of cohesin from chromatin (Uhlmann et al., 2000). Furthermore, it was shown, in vitro, 
that separase could cleave the subunit Scc1 via two conserved protease sites found 
between the N- and C- terminal Smc binding regions (Hornig et al., 2002). Apart from 
Scc1, separase is also able to cleave other proteins involved in promoting anaphase, 
and its function seems to be conserved in all organisms (Hauf et al., 2001). 
 
Separase is large protein, which is over 2000 residues long in many species. From 
secondary structure prediction it was shown to have an N-terminus made from 26 
Armadillo (ARM) repeats followed by a central region, which was predicted to be 
unstructured (Hornig et al., 2002). After this central region, separase contains two 
protease domains, of which one is non-functional. These domains are cysteine 
proteases belonging to a family that comprises caspases (Hornig et al., 2002). 
 
The early release of sister-chromatids from cohesin would be disastrous for cells, 
leading to chromosome mis-segregation. Therefore, like the other stages of the 
cohesion cycle, the release of cohesin is tightly controlled. There are two known 
mechanisms to regulate separase (Gorr et al., 2005; Uhlmann et al., 2000). The first 
method involves the inhibitory chaperone called securin, which binds to the protease 
domain of separase acting as an inhibitory substrate (Uhlmann et al., 2000). In 
addition, Cyclin B is able to bind and inhibit separase once separase is 
phosphorylated by Cdk1 on residue S1121 (Gorr et al., 2005). On the onset of 
anaphase separase becomes active as APC ubiquitinates both cyclin B and securin. 
This leads to their eventual degradation by the proteasome, which allows separase 
to become fully active (Uhlmann et al., 2000). 
 
Once Scc1 is cleaved by separase sister-chromatids can be pulled to opposite poles 
of the cell. The cleavage of Scc1 means it needs to be replaced in the next cell cycle; 
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however, the other core subunits are reused. This means Smc3 must become 
deacetylated during anaphase to complete the cohesion cycle as acetylated cohesin 
cannot be loaded onto DNA (Borges et al., 2010). The Class 1 histone deacetylase 
called Hos1 has been implicated as the cohesin deacetylase in budding yeast 
(Borges et al., 2010). It has been shown that Hos1 becomes activated after cohesin 
is removed from chromatin, and Hos1 is only able to deacetylate cohesin once Scc1 
has been cleaved (Borges et al., 2010). 
 
1.2.5 The prophase pathway 
Although separase cleavage is the main contributor to the removal of cohesin from 
chromatin in yeast, higher eukaryotes have an additional mechanism to dissociate 
cohesin from DNA. This occurs exclusively during prometaphase and prophase, and 
is termed the ‘prophase pathway’ (Sumara et al., 2000). During prophase, in higher 
eukaryotes, cohesion is lost at chromosome arms but is maintained at the 
centromere region (Sumara et al., 2000). During mitosis, in budding yeast, cohesin 
is not removed during prophase but the prophase pathway does occur during meiosis. 
This suggests that the higher eukaryotic mitotic prophase pathway and yeast meiotic 
prophase pathway both have a common ancestor (Kitajima et al., 2004).  
 
Separase is not active during prophase; therefore, the loss of cohesin from chromatin 
during the prophase pathway occurs via a different mechanism (Sumara et al., 2000). 
To activate the removal of cohesin during prophase two kinases are required to 
phosphorylate the C-terminal domain of Scc3 called Aurora B and a polo-like kinase 
(PLK) (Hauf et al., 2005; Sumara et al., 2002). In X. laevis cells, either a reduction of 
PLK or Scc3 phosphorylation mutations reduces the activity of this pathway 
(Waizenegger et al., 2000). Aurora B did not act as a kinase suggesting it does not 
phosphorylate cohesin during prophase (Losada et al., 2002). To aid in the 
recruitment of PLK, Cdk1 has been shown to phosphorylate Sororin at T159. 
Mutating this residues meant PLK was not recruited to cohesin, and this caused a 
disruption in the prophase pathway (Zhang et al., 2011). In addition, the anti-
establishment factor Wapl is crucial for the removal of cohesin from chromosome 
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arms during prophase as mammalian cells depleted of Wapl caused cohesin to 
remain on arm regions during prophase (Gandhi et al., 2006).  
 
If cohesin was completely removed from chromatin, then sister-chromatid cohesion 
would be lost and chromosome mis-segregation would occur. To protect a proportion 
of cohesin, centromeric cohesin is maintained. The two proteins shugoshin 1 (Sgo1) 
and protein phosphatase 2A (PP2A) have been found to antagonise the action of 
PLK (Kitajima et al., 2006). Depletion in human cells of Sgo1 resulted in chromosome 
mis-segregation (Salic et al., 2004), and Sgo1 knock out mice are unviable (Lee et 
al., 2008). Both results show the importance of this protein in maintaining sister-
chromatid cohesion at the centromere. In addition to protecting cohesin at the 
centromere, Sgo1 has been found in small quantities at the arms of chromosomes, 
which suggested a proportion of cohesin is protected from Wapl removal during 
prophase (Shintomi and Hirano, 2009). Sgo1 acts in a complex with PP2A, as work 
revealed they interacted in vitro (Kitajima et al., 2006). Both proteins act together to 
de-phosphorylate Scc3, which protects cohesin from Wapl induced removal (Kitajima 
et al., 2006). Further pull down experiments showed that Sgo1 directly competes 
with Wapl for its binding site on Scc3 (Hara et al., 2014). In addition, Sororin is 
required to be kept in a hyper-phosphorylated state to help antagonise the activity of 
Wapl at the centromere. Unexpectedly, Sgo1 and PP2A have been shown to help 
with this process (Liu et al., 2012). 
 
From the above discussion on the cohesion cycle it can be clearly seen that each 
stage is tightly regulated, and requires the co-ordination of numerous proteins. In the 
next section I will discuss in more detail the RFCCtf18complex, which is a non-
essential establishment factor. 
 
1.3 The Function of RFCCtf18 
The RFCCtf18 complex was first discovered in budding yeast to cause chromosome 
mis-segregation in genetic screens (Mayer et al., 2001). Further work showed that it 
was directly involved in the establishment of sister-chromatid cohesion, as deletion 
of Ctf18 caused a reduction in acetylation of Smc3 by Eco1 (Borges et al., 2013). In 
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this section, work relating to RFCCtf18 is reviewed in detail, along with the discovery 
that it is involved in the DNA damage response checkpoint (Crabbé et al., 2010). 
 
1.3.1 The function of RFCCtf18 in cohesion establishment 
Early work indicated that Ctf18 was not essential but was important for chromosome 
segregation (Kouprina et al., 1993). A later study suggested that Ctf18 had a 
sequence which was similar to Rfc1, which indicated it could have an equivalent role 
(Kouprina et al., 1994). Rfc1 forms a 5 subunit complex with Rfc2-5, which is called 
RFCRfc1. RFCRfc1 functions during replication, and is able to load PCNA on both the 
lagging and leading strand (Kubota et al., 2014). Further work revealed that Ctf18 
interacts both physically and genetically with proteins known to function at the 
replication fork (Hanna et al., 2001). In this study using an in vivo cohesion assay, 
which observed the early separation of sister-chromatids, they also suggested that 
Ctf18s role in chromosome stability was due to its function in sister-chromatid 
cohesion (Hanna et al., 2001). Furthermore, chromatin immunoprecipitation (ChIP) 
experiments revealed that Ctf18 co-localised on chromatin with the replication fork 
and other establishment factors such as Eco1 (Lengronne et al., 2006). Monitoring 
the acetylation levels has shown that yeast cells without Ctf18 have a reduced level 
of Smc3 acetylation; suggesting Ctf18 functions to aid Eco1 acetylation of cohesin. 
This was further supported by the observation that Eco1 and Ctf18 interact in pull 
down experiments conducted in yeast cells (Kenna and Skibbens, 2003). 
 
Sequence alignments originally identified Ctf18 as a homolog to Rfc1 (Kouprina et 
al., 1994). However, confirmation of this did not come until pull down experiments 
identified that Ctf18 physically interacted with the four proteins Rfc2-5; forming an 
RFC like complex called RFCCtf18 (Mayer et al., 2004). EM analysis of this five subunit 
complex revealed it was structurally similar to RFCRfc1, and like RFCRfc1; RFCCt18 was 
able to interact with PCNA and load the trimer onto DNA in vitro (Shiomi et al., 2004). 
This was supported by the observation with ChIP analysis that deleting Ctf18 in yeast 
caused a decrease in the amount of PCNA present on chromatin (Lengronne et al., 
2006). However, a more complete in vitro study using recombinant proteins, 
indicated that RFCCtf18 could both unload and load PCNA onto a range of DNA 
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substrates (Bylund and Burgers, 2005). Furthermore, this work suggested that, in 
vivo, under physiological condition RFCCtf18 would act as a PCNA unloader. Taken 
together these results imply that RFCCtf18 may act both as a loader and unloader of 
PCNA from chromatin depending on the requirement of the cell to shift the 
equilibrium of this reaction. This complex mechanism will need further work to clarify 
how cells are able to regulated the interaction between PCNA and RFCCtf18. 
 
In addition to binding to Rfc2-5, Ctf18 also interacts with the stable sub-complex 
formed from defective in sister-chromatid cohesion protein 1 (Dcc1) and 
chromosome transmission fidelity protein 8 (Ctf8) (Mayer et al., 2001). This sub-
complex interacts both genetically and physically with Ctf18. Both Ctf8 and Dcc1 
have been shown to be non-essential cohesion establishment factors, as mutations 
in either protein causes an increase rate of chromosome mis-segregation in yeast 
(Mayer et al., 2001). Furthermore, both Ctf8 and Dcc1 are conserved throughout 
evolution with human Dcc1 being overexpressed in colorectal cancer (Yamaguchi et 
al., 2014). Pull down experiments revealed that the Dcc1-Ctf8 sub-complex interacts 
tightly with Ctf18 and Rfc2-5 (Mayer et al., 2001). This indicated that RFCCtf18 is a 7 
subunit complex formed from Ctf18, Rfc2, Rfc3, Rfc4, Rfc5, Dcc1 and Ctf8 (Figure 
1.3A). Interestingly, the PCNA loading or unloading activity of RFCCtf18 was not 
inhibited by removing Dcc1 or Ctf8. This suggested that the Dcc1-Ctf8 sub-complex 
had a function in regulating the RFCCtf18 complex (Bylund and Burgers, 2005). A 
study with recombinant proteins showed that the C-terminal region of Ctf18 was 
highly conserved, and a deletion of the last 80 residues of Ctf18 was enough to 
disrupt binding to the Dcc1-Ctf8 sub-complex (Figure 1.3B) (Bylund and Burgers, 
2005). Further work showed that conserved aromatic residues present in the C-
terminal domain of Ctf18 was responsible for the interaction with Dcc1 and Ctf8 
(García-Rodríguez et al., 2015). Furthermore, mutating these aromatic residues to 
alanine, in yeast, caused an increase in chromosome mis-segregation. The above 
results suggested that all seven subunits are required for RFCCtf18 to perform its role 
in sister-chromatid cohesion. 
 
To improve our understanding of RFCCtf18 further work will need to be conducted into 
the two accessory subunits, Dcc1 and Ctf8. These proteins will be crucial in 
unlocking how RFCCtf18 functions in sister-chromatid cohesion as they appear to be 
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the key regulators of this complex. In the next section RFC complexes are further 
reviewed, looking more closely at the variety of tasks they perform throughout the 
cell cycle. 
 
 
Figure 1.3. Organisation of RFCCtf18. 
A) Diagram of RFCCtf18. Ctf18 (dark blue) has an extended C-terminal domain that binds 
to the Ctf8 (yellow)-Dcc1 (red) sub-complex. B) Sequence alignment of the conserved 
C-terminal region of Ctf18. The highlighted red residues indicate a conserved SNAVR 
motif, and the highlighted yellow residues show hydrophobic residues important for 
interacting with Dcc1 and Ctf8. The stars (*), dots (.) and colons (:) represent positions 
with fully conserved amino acids, positions with comparable properties or positions with 
weakly similar properties respectively. 
 
1.3.2 Comparison of RFC like complexes 
RFC like complexes are formed from at least five subunits. They all contain the four 
small subunits Rfc2, Rfc3, Rfc4 and Rfc5; and one larger subunit, which defines the 
function of the complex (Figure 1.4A). Each subunit belongs to the family of proteins 
called AAA+ ATPases, which show sequence conservation (Kubota et al., 2014). In 
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addition, all of the complexes interact with DNA clamps either loading or unloading 
them from chromatin. 
 
There are 4 RFC complexes encoded in the eukaryotic genome; defined by the large 
subunit (Figure 1.4B). RFCRfc1 is the prototypical member, and is one of the most 
well studied RFC complexes. It has been shown to load PCNA at the start of DNA 
replication on both the lagging and leading strand of DNA replication (Hedglin et al., 
2013). PCNA is a trimer, forming a ring shaped complex that once loaded, 
topologically entraps DNA (Moldovan et al., 2007). It operates in replication as a 
polymerase clamp, and acts as a platform for additional proteins to be recruited. To 
load PCNA onto DNA, RFCRfc1 requires ATP binding to open the ring of PCNA. It 
then loads PCNA at a 3’ primer template junction with ATP hydrolysis causing the 
dissociation of RFCRfc1 from PCNA (Hedglin et al., 2013). The only complex that 
interacts with a different DNA clamp is RFCRad24. This complex loads the Rad9-Hus1-
Rad1 (9-1-1) clamp at sites of DNA damage, which activates a DNA damage 
checkpoint response by recruiting factors that interact specifically with this clamp 
(Green et al., 2000). Until recently, RFCElg1 was the least understood clamp loader 
complex as, in vitro, data indicated it could bind to PCNA but was unable to load or 
unload it from DNA. However, recent evidence has suggested it is vital for unloading 
PCNA at the termination of replication (Kubota et al., 2013). This would explain the 
early genetic work, which showed that Elg1 was important for chromosome stability 
and maintenance. The final clamp loader is RFCCtf18, which is the only complex 
formed from seven subunits. As discussed above, this complex functions in the 
establishment of sister-chromatid cohesion. 
 
In addition to the function of RFCCtf18 in the establishment of sister-chromatid 
cohesion, more recent work has implicated RFCCtf18 in the DNA replication 
checkpoint (DRC) (Crabbé et al., 2010). The authors used ChIP analysis to show 
that the firing of late origins was inhibited by Ctf18 under replication stress. This 
revealed that RFCCtf18 was involved in the DRC as under replication stress the firing 
of late origins was delayed. Furthermore, the deletion of Ctf18 resulted in a reduction 
of phosphorylation of Rad53; a read-out for the activation of this checkpoint (Crabbé 
et al., 2010). Three studies have suggested that RFCCtf18 carries out its role in the 
DRC through a direct interaction with polymerases-ε (García-Rodríguez et al., 2015; 
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Murakami et al., 2010; Okimoto et al., 2016). Pull down and yeast two-hybrid assays 
were conducted in human and yeast cells respectively. The results showed that 
RFCCtf18 directly bound to polymerases-ε (García-Rodríguez et al., 2015; Murakami 
et al., 2010). This was suggested to occur through the heterotrimer formed from 
Ctf18-Dcc1-Ctf8, which created a binding module for the N-terminal region of Pol2, 
which is a subunit of polymerases-ε (García-Rodríguez et al., 2015).  
 
RFC complexes are key regulators of the cell cycle helping preserve genome 
integrity. In the next section intra-S checkpoints will be reviewed, with analysis of the 
DRC and DNA damage checkpoint (DDC). 
 
 
Figure 1.4. Subunits of the RFC Like Complexes. 
A) The domain organisation of Rfc2, Rfc3, Rfc3 and Rfc5, with the AAA+ ATPase domain 
in orange and the region responsible for complex formation in blue. B) The large subunits 
defining the RFC complexes. AAA+ ATPase domain are indicated in orange. Ctf18 has 
the additional Dcc1-Ctf8 binding domain present at its C-terminus (brown). 
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1.3.3 Intra-S phase checkpoints 
To maintain genome integrity cells have evolved checkpoints, which act as pause 
points during the cell cycle. In budding yeast, checkpoints exist between G2/M and 
G1/S transitions. In addition, there are intra-S checkpoints that function to provide 
cells time to repair damaged DNA during replication stress. The intra-S checkpoint 
causes a range of downstream effects such as the suppression of origin firing, 
expression of DNA stress genes, replication fork stabilisation and inhibiting cell cycle 
transition (Branzei and Foiani, 2009). Two phosphoinositide 3-kinases (PI3K) are 
crucial in intra-S checkpoint response, called Mec1 and Tel1 (ATR and ATM 
respectively in humans). These two kinases respond to different stimuli: Mec1 is 
activated by base adducts, replication stress, ultra-violet (UV) induced damage and 
double strand breaks (DSBs); as Tel1 responds primarily to DSBs (Cimprich and 
Cortez, 2008). In addition, Mec1 binds to the protein Dcd2 (ATRIP in humans) and 
this interaction is required to activate it (Majka et al., 2006). 
 
Analysis of the Mec1 checkpoint by a genome wide study in Saccharomyces 
cerevisiae revealed that this pathway could further be separated into two branches 
based on their genetic interactions, called the DDC and DRC (Pan et al., 2006). 
Furthermore, later work supported this conclusion as the authors showed that they 
could isolate the DRC and DDC based on their role in the suppression of the firing 
of late replication origins (Crabbé et al., 2010). In this study, ChIP analysis was 
conducted using BrdU incorporation as an analysis of replication origin firing. Both 
pathways require the activation of Mec1. However, it is the way in which Mec1 
becomes activated that determines the downstream effects (Crabbé et al., 2010). In 
both the DDC and DRC Rad53 (Chk2 in humans) becomes activated by Mec1 as 
without this kinase Rad53 becomes hyper-phosphorylated at a slower rate (Crabbé 
et al., 2010). 
 
The activation of the DRC (Figure 1.5) occurs in budding yeast by an accumulation 
of ssDNA (Aparicio et al., 1999). However, a recent study using X. laevis egg extracts 
indicated that primed ssDNA was required to activate the DRC along with 
Polα/primase (Cimprich and Cortez, 2008). In cells, exposed ssDNA is prone to 
breakages or the formation of secondary structure elements. Therefore, a protein 
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called replication protein A (RPA) has evolved to bind and stabilise ssDNA. RPA is 
composed of three subunits with oligonucleotide binding motifs: RPA1, RPA2 and 
RPA3. The build-up of RPA-coated ssDNA is detected by Mec1, which then leads to 
Rad53 hyper-phosphorylation (Aparicio et al., 1999). The activation of Rad53 is 
mediated by the protein Mrc1. As well as mediating Rad53 hyper-phosphorylation, 
Mrc1 (Claspin in humans) is thought to stabilise forks through binding to Polε through 
its C-terminal domain (Lou et al., 2008). In addition to stabilising stalled forks, Rad53 
aids in keeping the polymerase localised at the replisome (Cobb et al., 2003). As 
discussed above, RFCCtf18 has been implicated in assisting in the activation of the 
Mrc1-Rad53 checkpoint. Deleting either Ctf18, Dcc1 or Ctf8 causes both a reduction 
and delay in the hyper-phosphorylation of Rad53 in Hydroxyurea (HU) (Crabbé et al., 
2010). HU reduces the pool of dNTPs, which causes replication stress and hence 
the stalling of replication forks. This then leads to the activation of intra-S checkpoints 
and the eventual hyper-phosphorylation of Rad53. Therefore, monitoring Rad53 
phosphorylation in cells grown in HU can help clarify proteins involved in stimulating 
the DRC or DDC. The results suggest, along with Mrc1, RFCCtf18 must in some way 
aid in the activation of Rad53 by Mec1. It has been proposed that RFCCtf18 carries 
out this function by unloading or loading PCNA from stalled replication forks, which 
could then recruit Mec1. However, further work needs to be conducted to uncover, 
with more clarity, the mechanism in which RFCCtf18 functions. The use of Mrc1 
separates the function of the DRC from the DDC, as the DDC uses the protein Rad9 
to activate Rad53 (Pan et al., 2006). 
 
The DDC uses similar proteins to the DRC; however, it becomes activated 
predominantly through DNA breaks. In addition, it stimulates a different branch of the 
Mec1-Rad53 checkpoint (Putnam et al., 2009). Although the DDC and DRC are 
comparable, their relative kinetics are different. The DDC is slower taking minutes to 
become activated. However, the DRC is fast causing a response in seconds, but this 
checkpoint requires numerous forks to be stalled before it is stimulated (Shimada et 
al., 2002). In the DDC, the Rad24 variant of the RFC like complexes loads the 9-1-1 
clamp at sites of DNA damage (Navadgi-Patil and Burgers, 2008). The 9-1-1 clamp 
can recruit other DNA damage proteins, which aids in the checkpoint response. Rad9 
(53BP1 in humans), like Mrc1, is then able to mediate Rad53 hyper-phosphorylation 
by Mec1 (Putnam et al., 2009). 
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As can be seen from the above discussion, these checkpoints use multiple proteins 
to monitor DNA replication. It is interesting that both the DRC and DDC use RFC like 
complexes to help in the stimulation of Rad53. Further work will be needed to 
uncover how the cohesion RFC functions in the DRC. 
 
In the final section of this chapter work is reviewed relating to the range of diseases 
that have been uncovered to be caused by mutations in the cohesin specific subunits. 
Special attention is given to Eco1, which causes the rare genetic condition called 
Roberts syndrome. 
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Figure 1.5. Proposed Activation Mechanism of the DRC. 
During replication stress the replisome can stall. This leads to a build-up of RPA coated 
ssDNA, which Mec1 recognises. Mrc1 can then mediate the hyper-phosphorylation of 
Rad53 by Mec1. 
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1.4 Role of Cohesin in Diseases 
The cohesin complex performs a number of functions outside its role is sister-
chromatid cohesion. For instance, during interphase cohesin binds to DNA to form 
chromatin loops (Remeseiro et al., 2013b) and cohesin has been shown to directly 
affect transcription (Remeseiro et al., 2013a). It is therefore unsurprising, due to the 
variety of tasks performed by cohesin, that mutations in its subunits cause diseases. 
Not only has cohesin recently been linked to cancers, there are also a range of 
genetic conditions called cohesinopathies, which have been shown to be due to 
mutations in cohesin specific subunits. In this section, cohesins role in cancers and 
the two genetic disorders Cornelia de Lange syndrome (CdLS) and Roberts 
syndrome are discussed. 
 
Although the specific role of cohesin in cancers is still poorly understood it is known 
that a number of cancers such as bladder and acute myeloid leukaemia have been 
shown to contain mutations in cohesin subunits (Barber et al., 2008). The recent 
analysis of 4742 cancer samples has revealed that SA2 (human Scc3) is mutated in 
a significant number of tumours (Solomon et al., 2013). In addition, bladder cancers 
have the highest rate of mutations in SA2, with aggressive and low grade tumours 
having a mutation rate of 10-15% and 30% respectively. In addition, Nibl (human 
Scc2) has been shown to be mutated at an increased frequency in colorectal cancer 
(Barber et al., 2008). This was also revealed to by the case for Dcc1, which was 
overexpressed in this type of cancer (Yamaguchi et al., 2014). Dcc1 forms part of 
the RFCCtf18 complex, and it will be interesting to observe if the other subunits have 
a similar function in cancers. Patients with high expression levels of Dcc1 have a 
reduced survival rate indicating the importance in improving our understanding of 
this complex. 
 
Apart from having an effect in cancer progression, mutations in cohesin specific 
subunits cause the genetic disease called CdLS, which was first identified by 
Cornelia de Lange in 1933. This disease is an inherited genetically dominant 
developmental disorder, which effects multiple tissue types, and can be classified 
due to an underdeveloped nervous system and growth retardation. (Ireland et al., 
1993). 
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The analysis of patients with CdLS revealed that it is caused by mutations 
predominately in three proteins Nipbl (Scc2 homologue), Smc1 and Smc3. Nipbl is 
the catalytic subunit of the cohesin loader complex, as Smc1 and Smc3 form an Smc 
heterodimer in the core cohesin complex. Analysis of patients has revealed that 
~50% of patients have mutations in the gene encoding Nipbl. These mutation lead 
to a non-functional protein, and are either insertions or point mutations usually found 
in the coding regions of the gene (Gillis et al., 2004). 
 
In addition to CdLS, the two autosomal receive disorders called Roberts syndrome 
and SC Phocomelia are caused by mutations in human Eoc2 (hEsco2). hEsco2 is 
an acetyltransferase involved in establishing sister-chromatid cohesion during S-
phase. John Roberts first identified Roberts syndrome in two children. Although both 
Roberts syndrome and SC Phocomelia are similar they can be separated due to 
different facial features. They are both extremely rare with under 100 reported cases 
characterised as most patients survive no further than the neonatal period. Both 
conditions show similar phenotypes such as server mental retardation; and prenatal 
and postnatal growth defects (Liu and Krantz, 2008). At a cellular level, Roberts 
syndrome and SC Phocomelia are diagnosed due to chromosome abnormalities 
(Judge, 1973). 
 
Currently 28 genetic mutations have been identified, which cause Roberts syndrome 
and SC Phocomelia. These range from frame-shifts, missense and point mutations 
(Gordillo et al., 2008). W539G and G581R are currently the only two point mutations 
identified (Vega et al., 2010). Both of these mutations inhibit the auto-acetylation of 
hEsco2 in vitro; suggesting, it is the loss of a functional C-terminal GNAT domain 
that causes Roberts syndrome. Mapping both these residues onto the hEsco1 
structure reveals that W539 is buried and stabilises an α-helix close to the active site. 
However, G581 is close to the CoA binding site. Mutating this residue to arginine 
would restrict access of CoA to its binding pocket (Kouznetsova et al., 2016). 
 
From the above discussion it can be seen that mutations in a number of cohesin 
specific subunits cause cancers and a range of rare genetic diseases. Further work 
will be needed to clarify cohesins function in these conditions. In the next sections 
the aims of this project and a summary of results are presented. 
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1.5 Aims of Project and Summary of Results 
In summary, the cohesin complex is formed from the four proteins: Smc1, Smc3, 
Scc1 and Scc3 (Nasmyth and Haering, 2009). A variety of complexes interact with 
cohesin throughout the cell cycle to load, establish and release cohesin from 
chromatin. Mutations in cohesins accessory factors have been shown to cause 
cancers and diseases (Liu and Krantz, 2008). Therefore, the study of these proteins 
is crucial to help improve our understanding of not only their role in the cohesion 
cycle but also how they function in human diseases. 
 
The establishment of sister-chromatid cohesion is carried out predominately by Eco1, 
a GNAT family acetyltransferase (Ivanov et al., 2002). Eco1 acetylates Smc3 on 
residue K112 and K113, which antagonises the action of Wapl and Pds5 (Ben-
Shahar et al., 2008). The anti-establishment complex acts to eject cohesin from 
chromatin through an exit gate, which is positioned between the Smc3-Scc1N 
interface (Murayama and Uhlmann, 2013). In addition to Eco1, a range of other non-
essential establishment factors have a role in stabilising cohesin bound to chromatin. 
These include the RFCCtf18 like complex, which is the only RFC complex formed of 
seven subunits (Mayer et al., 2004). The additional subunits, Dcc1 and Ctf8, form a 
stable sub-complex, and currently, have an unknown function as they do not 
participate in PCNA unloading or loading (Bylund and Burgers, 2005). In addition to 
functioning in the establishment of sister-chromatid cohesion, RFCCtf18 has been 
shown to participate in the DRC, which is an intra-S checkpoint (Pan et al., 2006). 
This checkpoint has a range of downstream effects, one of which is the stabilisation 
of stalled replication forks. 
 
The aim of this thesis was to gain further insights into the range of establishment 
factors involved in sister-chromatid cohesion. To do this, a structural approach was 
taken, using the technique of x-ray crystallography alongside biochemistry. 
 
Work was initially started on the Dcc1-Ctf8 sub-complex bound to the C-terminal 
region of Ctf18. I was able to crystallise and solve the atomic resolution structure of 
this complex. To arrive at the final structure, multiple rounds of construct design and 
crystal optimisation was required. The crystal structure indicated that Ctf18 bound to 
Chapter 1. Introduction 
41 
 
the Dcc1-Ctf8 sub-complex as an extended peptide. Unexpectedly, it was shown that 
Dcc1 contained a C-terminal region formed of three winged helix (WH) domains, 
which could bind to both ssDNA and dsDNA. In addition, these WH domains 
supported binding to Pol2, which is a subunit of polymerase-ε. To uncover a 
biological function for these WH domains, ChIP-qPCR was conducted, which 
indicated that they were responsible for recruiting the RFCCtf18 complex to chromatin. 
 
The crystal structure of the xEco2, the X. laevis homologue to Eco1, was also solved 
with two Smc3-Acetyl CoA conjugate peptide (Ac-CoA-K105 and Ac-CoA-K106). 
The structure of xEco2 bound to Ac-CoA-K105 and Ac-CoA-K106 revealed that 
xEco2 binds to the two tandem lysine residues in different conformations. 
Furthermore, with the use of MS analysis I was able to show that acetylation of K105 
occurs faster than the acetylation of K106. 
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Chapter 2. Materials and Methods 
2.1 Cloning 
2.1.1 Expression cloning 
The general cloning was conducted by restriction free (RF) cloning (van den Ent and 
Löwe, 2006). Primers were synthesised (SIGMA) to match the coding region of the 
gene of interest with the addition of an overhang corresponding to the vector. For RF 
primer sequences used in this thesis see Appendix 1. A polymerase chain reaction 
(PCR) was carried out in Hi-Fi Buffer (Bioline), 1 mM dNTP, 0.4 mM both forward 
and reverse primers, 50 mUμL-1 Velocity polymerase (Bioline) and 0.1 ngμL-1 
template DNA. The reaction was carried out at the temperatures indicated in Table 
2.1. The completed PCR was purified by 0.8% agarose gel electrophoresis run at 80 
V for 45 minutes. The gel was visualised by ethidium bromide exposed with ultra 
violet (UV) light. The PCR product was cut using a sterilised razor and gel extracted 
using a commercial kit (QIAGEN). A second PCR reaction was conducted in Phusion 
reaction buffer (NEB), 0.5 mM dNTP, 0.8 ngμL-1 vector, 50 mUμL-1 Phusion 
polymerase (NEB) and at least a 20 times molar excess of the insert compared to 
the vector. The second PCR was completed at the temperatures shown in Table 2.2. 
The reaction was subjected to DpnI (NEB) digestion for 2 hours at 37 °C. This mixture 
(2 μL) was transformed into chemically competent XL-1 blue cells (Agilent). Antibiotic 
selection was used to determine colonies which had obtained the appropriate vector. 
Colonies were picked and grown at 37 °C for 16 hours in the selection antibiotic. The 
plasmid was purified using a commercial available kit (QIAGEN) and sequenced 
using a standard protocol to confirm that the construct had been inserted into the 
vector. 
 
 
Table 2.1. Reaction Conditions for the First PCR in RF Cloning. 
Temperature (°C) Time (min.)
Initial Denature 98 0.5
Denature 98 0.5
Anneal 55 1 25 cycles
Extension 72 0.5 min per Kb
Final extension 72 0.5
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Table 2.2. Reaction Conditions for the Second PCR in RF Cloning. 
 
2.1.2 Mutagenesis cloning 
Mutagenic PCR was conducted using the Quick-change II protocol (Agilent). Primers 
which contained the appropriate mutation were commercially synthesised (SIGMA). 
For mutagenic primer sequences used in this thesis see Appendix 2. A PCR was 
carried out in Pfu buffer (Agilent), 0.5 mM dNTP, 0.4 mM both forward and reverse 
primers, 50 mUμL-1 Pfu polymerase (Agilent) and 0.1 ngμL-1 template DNA. The 
reaction was completed at the temperatures presented in Table 2.2. The PCR was 
digested for 2 hours at 37 °C by DpnI. This mixture was then directly transformed 
into chemically competent XL-1 blue cells (Agilent) using a standard head shock 
protocol. Colonies were picked from an antibiotic selection plate and grown at 37 °C 
for 16 hours. The plasmid was purified using a commercial available kit (QIAGEN), 
and sequenced using a standard protocol to confirm that the point mutation had been 
incorporated into the gene. 
 
2.2 Protein Expression 
The constructs used in this thesis were cloned from genomic DNA into either pET-
28a, pCDFDuet or pETDuet based vectors as described in section 2.1. Appropriate 
subunits were tagged with an N-terminal His6 and TEV protease site. For protein 
expression cloned constructs were freshly transformed into BL21(DE3)-RIL 
competent cells (Agilent) using a standard heat shock protocol. Cells were selected 
with an appropriate antibiotic grown for 18 hours at 37 °C. Colonies were picked and 
grown in 5 mL fresh lysongeny broth (LB) for 18 hours at 37 °C in the appropriate 
Temperature (°C) Time (min.)
Initial Denature 98 0.5
Denature 98 0.5
Anneal 55 1 18 cycles
Extension 72 2 min per Kb
Final extension 72 0.5
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selection antibiotic. The overnight culture was used to inoculate 1 L of LB. Cells were 
grown at 37 °C with shaking at 200 rpm until an OD of 0.6 was reached. At this point, 
IPTG was added to induce protein expression (0.25 mM). Cultures were cooled to 
16 °C and left for 18 hours; after which, cells were harvested at 6000 xg, 4 °C for 20 
minutes. Pellets were washed in cold double distilled water, and snap frozen in liquid 
nitrogen. Frozen cells were stored for future use at -80 °C. 
 
To obtain selenomethionine labelled protein cells were grown in the same conditions. 
However, the 1 L inoculated cultures were expanded in minimal media containing 
selenomethionine as the only source of methionine. 
 
2.3 Protein Purification  
2.3.1 Dcc1 containing constructs 
Several constructs were amplified from genomic DNA to determine the ones best 
suited for crystallisation. For the heterotrimer, the subunits Ctf18, Dcc1 and Ctf8 were 
cloned into the vectors pET-28a, pETDuet and pCDFDuet respectively. An N-
terminal His6 tag and TEV protease site were added to the Ctf18 subunit. For the 
expression of the Dcc1-Ctf8 sub-complex, Dcc1 and Ctf8 were cloned into pETDuet 
and pET-28a respectively. In this heterodimer Ctf8 was cloned with the addition of 
an N-terminal His6 tag and TEV protease site. For the expression of the C-terminal 
region of Dcc1 (residue 90-380), Dcc1 was cloned into pET-28a with the addition of 
an N-terminal His6 tag and TEV protease site. Constructs were cloned and expressed 
by the methods presented in section 2.1 and 2.2 respectively. 
 
The Dcc1 constructs were purified by the following procedure. Pellets were re-
suspended in Buffer A containing 50 mM Tris pH 7.5, 300 mM NaCl, 10% glycerol, 
10 mM imidazole and 0.5 mM TCEP. Cells were then sonicated for 4 minutes using 
a standard protocol, and centrifuged at 35000 x g, 4 °C for 1 hour. The supernatant 
was loaded onto a pre-equilibrated 5 mL His-Trap HP (GE Healthcare) column in 
Buffer A. The column was washed with 100 mL of Buffer A before the protein was 
eluted in a 75 mL gradient between 10 mM to 0.5 M imidazole. TEV protease was 
added to the protein to a final concentration of 0.04 mgmL-1, 4 °C for 18 hours. To 
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improve protein purity, the constructs were diluted to an NaCl concentration of 50 
mM and loaded onto a pre-equilibrated MonoQ 10/300 GL (GE Healthcare) column 
in 10 mM Tris pH 7.5, 50 mM NaCl and 0.5 mM TCEP. To elute the protein, a gradient 
of 100 mL was used between 50 mM to 1 M NaCl. Protein containing fractions were 
concentrated to 1 mL in a 5000 Da concentrator (Generon) and loaded onto a pre-
equilibrated HiLoad 16/60 Superdex 75 column (GE Healthcare) in 10 mM Tris pH 
7.5, 150 mM NaCl and 0.5 mM TCEP. Fractions were collected of the protein peak 
and purity was analysed by SDS-PAGE. Dcc1 constructs were concentrated in a 
5000 Da concentrator (Generon) and used for crystallisation trials. Alternatively, for 
use in biochemical assays the protein was snap frozen in liquid nitrogen in 50 µL 
aliquots and stored at -80 °C at 10 mgmL-1. 
 
2.3.2 Full length Eco1 
Full length Eco1 was amplified from genomic DNA and cloned into a pET-28a vector 
with the addition of an N-terminal His6 tag and TEV protease site. The cloning and 
expression of Eco1 was carried out by the methods described in section 2.1 and 2.2. 
For protein purification frozen Eco1 pellets were re-suspended in Buffer B which 
contained 50 mM HEPES pH 7.5, 300 mM NaCl, 10 % glycerol, 10 mM imidazole 
and 0.5 mM TCEP. Cells were sonicated for 4 minutes using a standard protocol and 
then centrifuged at 35000 x g, 4°C for 1 hour. The supernatant was loaded onto a 
pre-equilibrated 5 mL His-Trap HP (GE Healthcare) in Buffer B. The column was 
washed with 100 mL of Buffer B, and Eco1 was eluted in a 75 mL gradient of 
imidazole between 10 mM to 0.5 M. The cleavage of the His6 tag was carried out by 
the addition of TEV protease to a final concentration of 0.04 mgmL-1, 4 °C for 18 
hours. To further improve protein purity Eco1 was diluted with double distilled water 
until the NaCl concentration was at 50 mM. This solution was loaded onto a MonoS 
10/300 GL (GE Healthcare) column pre-equilibrated in 10 mM HEPES pH 7.5, 50 
mM NaCl and 0.5 mM TCEP. Eco1 was eluted in a 100 mL gradient between 50 mM 
to 1 M NaCl. The protein was collected in 3 mL fractions and concentrated to 1 mL 
in a 5000 Da concentrator (Generon) at 6000 xg, 4°C. Concentrated Eco1 was 
loaded onto a pre-equilibrated HiLoad 16/60 Superdex 75 column (GE Healthcare) 
in 10 mM Tris pH 7.5, 50 mM NaCl and 0.5 mM TCEP. The protein peak was 
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collected and analysed for purity by SDS-PAGE. Purified Eco1 was concentrated to 
10 mgmL-1 in a 5000 Da concentrator (Generon) and snap frozen in liquid nitrogen 
in 50 µL aliquots. Eco1 was stored long term at -80 °C. 
 
2.3.3 xEco2 ACT domain 
The xEco2 acetyltransferase (xEco2 ACT) domain (residue 523-702) was amplified 
from cDNA and cloned into a pET-28a vector with the addition of an N-terminal His6 
tag and TEV protease site. Cloning and protein expression were conducted by the 
methods presented in Section 2.1 and 2.2 respectively. Frozen cells were re-
suspended and sonicated using a standard protocol in 50 mM Tris pH 8.5, 300 mM 
NaCl, 10 % glycerol, 10 mM imidazole and 0.5 mM TCEP (Buffer C). xEco2 ACT 
lysate was centrifuged at 35000 x g, 4 °C for 1 hour and the resulting supernatant 
loaded onto a 5 mL His-Trap HP (GE Healthcare) pre-equilibrated in Buffer C. The 
column was washed with 100 mL of Buffer C and the acetyltransferase was eluted 
in a 75 mL gradient of imidazole between 10 mM to 0.5 M. The cleavage of the His6 
tag was carried out by the addition of TEV protease to a final concentration of 0.04 
mgmL-1, 4 °C for 18 hours. xEco2 ACT was further purified by diluting the protein 
until the NaCl concentration was below 50 mM and then loaded onto a pre-
equilibrated MonoQ 10/300 GL (GE Healthcare) in 10 mM Tris pH 8.5, 50 mM NaCl 
and 0.5 mM TCEP. The protein was eluted in a gradient of 100 mL ranging from 50 
mM to 1 M NaCl. In the final purification step, the xEco2 ACT was concentrated to 1 
mL in a 3000 Da concentrator (Generon) and loaded onto a HiLoad 16/60 Superdex 
75 column (GE Healthcare) pre-equilibrated in 10 mM Tris pH 8.5, 150 mM NaCl and 
0.5 mM TCEP. Protein containing fractions were analysed for purity by SDS-PAGE. 
Purified xEco2 ACT was concentrated for use in crystallisation trials in a 3000 Da 
concentrator (Generon). 
 
2.4 Limited Proteolysis 
To optimise protein constructs for crystallisation limited proteolysis was carried out 
at 4 °C in a buffer of 10 mM Tris pH7.5, 150 mM NaCl and 0.5 mM TCEP. Constructs 
at 1 mgmL-1 were digested by either chymotrypsin or trypsin at a final concentration 
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of 0.01 mgmL-1 and 0.005 mgmL-1 respectively. The reaction was mixed and samples 
were taken after 1 hour, 2 hours and 16 hours. Digested samples were analysed by 
SDS-PAGE. For further analysis, the gel was transferred onto a nitrocellulose 
membrane using an iBlot (Novex). The membrane was stained using coomassie blue 
and protein bands were cut using a sterilised razor. To determine the appropriate 
cleavage site, N-terminal Edman degradation was employed with intact-mass by 
MALDI. 
 
2.5 Crystallisation of Protein Constructs 
2.5.1 Dcc1 C-terminal domain  
The Selenomethionine incorporated C-terminal region of Dcc1 (residue 90-380) was 
concentrated to 15 mgmL-1 and crystallised at 20 °C in 0.2 M potassium sodium 
tartrate and 18 % PEG 3350. Sitting drops of 2 μL were used, which contained an 
equal volume of protein and reservoir solution. The crystals were harvested after 2 
days in 20 % ethylene glycol and stored in liquid nitrogen. Datasets were collected 
at two wavelengths on the I03 beamline at Diamond Light Source. To solve the initial 
structure the AutoSHARP package was used (Bricogne et al., 2003). From these 
structure factors an initial model was produced using Buccaneer (Cowtan, 2006). To 
produce the final model, multiple round of refinement and rebuilding were carried out 
in Coot (Emsley and Cowtan, 2004) and Refmac5 (Murshudov et al., 2011) 
respectively. Water molecules were added during the final stages of refinement using 
Coot. Final refinement was carried out against a 2 Å native dataset. Final R-factors 
of 0.19 for R-work and 0.23 for R-free indicate an accurate model at this resolution. 
Full statistics for data collection and refinement are shown in Table 2.3, 2.4 and 2.5. 
 
2.5.2 Ctf18666-740–Dcc1–Ctf8  
The Ctf18666-740-Dcc1-Ctf8 complex was concentrated to 35 mgmL-1 and crystallised 
at 20 °C in 4 μL sitting drops with equal volume of reservoir and protein solution. The 
reservoir contained 0.1 M Bis-Tris propane pH 6.3, 0.2 M NaBr and 17 % PEG 3350. 
Crystals were harvested after 10 days in 15 % ethylene glycol and stored in liquid 
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nitrogen. A native dataset was collected on beamline I03 at Diamond Light Source. 
Molecular replacement was carried out in Phaser (McCoy et al., 2007) using Dcc190-
380 as a search model. An initial model was traced using AutoBuild (Adams et al., 
2010) and multiple rounds of rebuilding and refinement were carried out in Coot 
(Emsley and Cowtan, 2004) and Refmac5 (Murshudov et al., 2011) respectively. 
Coot was used to find water molecules in the last round of refinement. R-factors of 
0.20 for R-work and 0.26 for R-free indicate an accurate model at this resolution. 
Final data collection and refinement statistics are shown in Table 2.6. 
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Table 2.3. Data Collection Statistics for Dcc190-380 at the Peak Wavelength. 
 
 
 
Table 2.4. Data Collection Statistics for Dcc190-380 at the Inflection Wavelength. 
 
Dataset Peak Dcc190-380
Wavelength 0.9796
Resolution range 79.19 - 2.75 (2.82 - 2.75)
Space group P 21 21 21
Unit cell 96.69 111.75 112.23  90.00  90.00  90.00
Total reflections 415363 (28991)
Unique reflections 32295 (2349)
Multiplicity 12.9 (12.3)
Completeness (%) 99.9 (99.9)
Mean I/sigma(I) 15.7 (3.3)
Wilson B-factor 55.8
R-merge 0.143 (0.822)
R-meas 0.149 (0.858)
CC1/2 0.996 (0.901)
No.Sites 33
Figure of merit - acentric  (centric) 0.35491 (0.11335) 
Phasing Power 1.473
Dataset Inflection Dcc190-380
Wavelength 0.9797
Resolution range 112.75 - 2.96 (3.04 - 2.96)
Space group P 21 21 21
Unit cell 96.82  112.02  112.75   90.00   90.00   90.00
Total reflections 336993 (24158)
Unique reflections 26214 (1898)
Multiplicity 12.9 (12.7)
Completeness (%) 99.9 (99.8)
Mean I/sigma(I) 15.8 (3.8)
Wilson B-factor 45.9
R-merge 0.132 (0.746)
R-meas 0.137 (0.778)
CC1/2  0.996 (0.881)
No.Sites 33
Figure of merit - acentric  (centric) 0.35491 (0.11335) 
Phasing Power 0.391
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Table 2.5. Data Collection and Refinement Statistics for Dcc190-380. 
 
Dataset Native Dcc190-380
Wavelength 0.92
Resolution range 29  - 2.002 (2.074  - 2.002)
Space group P 1 21 1
Unit cell 68.682 100.697 83.495 90 100.669 90
Total reflections 288441 (23107)
Unique reflections 71317 (6489)
Multiplicity 4.0 (3.6)
Completeness (%) 0.95 (0.87)
Mean I/sigma(I) 8.43 (1.31)
Wilson B-factor 29.31
R-merge 0.1158 (0.9735)
R-meas 0.1333 (1.138)
CC1/2 0.995 (0.523)
No.Sites -
Figure of merit - acentric  (centric) -
Phasing Power -
CC* 0.999 (0.829)
Reflections used in refinement 71312 (6489)
Reflections used for R-free 3560 (324)
R-work 0.1903 (0.2844)
R-free 0.2356 (0.3249)
CC(work) 0.946 (0.641)
CC(free) 0.927 (0.577)
Number of non-hydrogen atoms 8634
macromolecules 8112
Protein residues 1008
RMS(bonds) 0.014
RMS(angles) 1.41
Ramachandran favored (%) 97
Ramachandran allowed (%) 2.5
Ramachandran outliers (%) 0
Rotamer outliers (%) 2.8
Clashscore 5.43
Average B-factor 36.33
macromolecules 36.05
solvent 40.74
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Table 2.6. Data Collection and Refinement Statistics for Ctf18666-740-Dcc1-Ctf8. 
 
Dataset Ctf18666-740-Dcc1-Ctf8
Wavelength 0.9763
Resolution range 60.64  - 2.29 (2.372  - 2.29)
Space group P 1 21 1
Unit cell 58.61 164.22 60.64 90 90.55 90
Total reflections 138884 (5577)
Unique reflections 46232 (2926)
Multiplicity 3.0 (1.9)
Completeness (%) 0.90 (0.57)
Mean I/sigma(I) 7.15 (1.31)
Wilson B-factor 43.9
R-merge  0.08522 (0.4577)
R-meas 0.1022 (0.5954)
CC1/2 0.994 (0.732)
No.Sites -
Figure of merit - acentric  (centric) -
Phasing Power -
CC* 0.999 (0.919)
Reflections used in refinement 46206 (2922)
Reflections used for R-free 2252 (175)
R-work 0.2018 (0.2967)
R-free 0.2586 (0.3716)
CC(work) 0.950 (0.820)
CC(free) 0.914 (0.591)
Number of non-hydrogen atoms 8784
macromolecules 8518
Protein residues 1050
RMS(bonds) 0.01
RMS(angles) 1.54
Ramachandran favored (%) 96
Ramachandran allowed (%) 2.8
Ramachandran outliers (%) 1.1
Rotamer outliers (%) 2.3
Clashscore 9.77
Average B-factor 52.99
macromolecules 53.07
solvent 50.5
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2.5.3 xEco2 ACT domain 
xEco2 ACT domain was crystallised at 20 °C with the protein concentrated to 15 
mgmL-1. Crystals were obtained of a peptide free form and bound to two different 
substrate peptides conjugated to CoA, called Ac-CoA-K105 and Ac-CoA-K106 (see 
Chapter 6). The peptide free form of xEco2 ACT domain crystallised in 0.2 M NaCl, 
0.1 M imidazole pH 7 and 0.864 M ammonium phosphate. Crystals were harvested 
after 3 days in liquid nitrogen with the addition of 30 % ethylene glycol. Ac-CoA-K106 
and xEco2 ACT domain crystallised in 40 % ethylene glycol, 0.1 M HEPES pH7.5 
and 5 % PEG 3000. Crystals were harvested after 3 days and stored in liquid nitrogen. 
Ac-CoA-K105 and xEco2 ACT domain crystallised in 0.18 M MgCl2, 10% glycerol, 
27% 2-propanol and 0.09 M HEPES pH 7.5. These crystals were harvested after 5 
days in 25 % ethylene glycol and stored in liquid nitrogen. Data was collected on 
beamline I02 at Diamond Light Source for Ac-CoA-K106 and the peptide free form 
of xEco2 ACT domain. For Ac-CoA-K105 data was collected on beamline I03 at 
Diamond Light Source. 
 
The structure of Ac-CoA-K106 was solved by molecular replacement conducted in 
Phaser (McCoy et al., 2007) using hEsco2 (Kouznetsova et al., 2016) as the search 
model. AutoBuild (Adams et al., 2010) was then used to trace a start model and 
multiple rounds of rebuilding and refinement were conducted in Coot (Emsley and 
Cowtan, 2004) and Phenix.Refine (Adams et al., 2010) respectively. Full data 
collection and refinement statistics are shown in Table 2.7. Final R-factors of 0.21 
for R-work and 0.24 for R-free indicate an accurate model at this resolution. The Ac-
CoA-K105 structure was solved by molecular replacement in Phaser (McCoy et al., 
2007) using xEco2 ACT domain as a search model. Multiple rounds of rebuilding and 
refinement were carried out in Coot (Emsley and Cowtan, 2004) and Phenix.Refine 
(Adams et al., 2010) respectively. Full data collection and refinement statistics are 
shown in Table 2.8. Final R-factors of 0.21 for R-work and 0.23 for R-free indicate 
an accurate model at this resolution. In both cases the peptide was built in the final 
stage of refinement after which water was added using coot. The peptide free 
structure of xEco2 ACT domain was solved by molecular replacement in Phaser 
(McCoy et al., 2007) using xEco2 ACT domain as a search model. Multiple rounds 
of refinement and rebuilding were carried out in Phenix.Refine (Adams et al., 2010) 
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and Coot (Emsley and Cowtan, 2004) respectively. Full data collection and 
refinement statistics are shown in Table 2.9. Final R-factors of 0.22 for R-work and 
0.27 for R-free indicate an accurate model at this resolution. 
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Table 2.7. Data Collection and Refinement Statistics for xEco2-K106. 
 
Dataset Ac-CoA-K106
Wavelength 0.9795
Resolution range 59.16  - 1.99 (2.061  - 1.99)
Space group P 1 21 1
Unit cell 107.236 57.7683 70.9545 90 89.9746 90
Total reflections 197266 (19580)
Unique reflections 59859 (5936)
Multiplicity 3.3 (3.3)
Completeness (%) 0.98 (1.00)
Mean I/sigma(I) 8.25 (1.65)
Wilson B-factor 31.92
R-merge 0.06494 (0.7646)
R-meas 0.07758 (0.9127)
CC1/2 0.998 (0.615)
CC* 0.999 (0.873)
Reflections used in refinement 58984 (5707)
Reflections used for R-free 2817 (270)
R-work 0.2080 (0.3658)
R-free 0.2374 (0.3866)
CC(work) 0.955 (0.811)
CC(free) 0.939 (0.721)
Number of non-hydrogen atoms 6005
Macromolecules 5497
Ligands 244
Protein residues 689
RMS(bonds) 0.007
RMS(angles) 0.77
Ramachandran favored (%) 97
Ramachandran allowed (%) 2.7
Ramachandran outliers (%) 0.6
Rotamer outliers (%) 3.8
Clashscore 3.67
Average B-factor 45.96
Macromolecules 46.41
Ligands 35.36
Solvent 46.39
Number of TLS groups 23
Chapter 2. Materials and Methods 
 
55 
 
 
Table 2.8. Data Collection and Refinement Statistics for xEco2-K105. 
 
Dataset Ac-CoA-K105
Wavelength 0.9795
Resolution range 46.97  - 2.3 (2.382  - 2.3)
Space group P 1 21 1
Unit cell 57.3015 60.6099 66.9053 90 99.6344 90
Total reflections 131452 (13235)
Unique reflections 20265 (2010)
Multiplicity 6.5 (6.6)
Completeness (%) 1.00 (1.00)
Mean I/sigma(I) 6.78 (2.02)
Wilson B-factor 31.9
R-merge 0.2701 (1.834)
R-meas 0.2943 (1.992)
CC1/2 0.98 (0.639)
CC* 0.995 (0.883)
Reflections used in refinement 20227 (2001)
Reflections used for R-free 988 (99)
R-work 0.2102 (0.3180)
R-free 0.2297 (0.3884)
CC(work) 0.948 (0.841)
CC(free) 0.909 (0.684)
Number of non-hydrogen atoms 2999
Macromolecules 2719
Ligands 124
Protein residues 348
RMS(bonds) 0.005
RMS(angles) 0.63
Ramachandran favored (%) 95
Ramachandran allowed (%) 4.5
Ramachandran outliers (%) 0.3
Rotamer outliers (%) 2.4
Clashscore 3.71
Average B-factor 44.17
Macromolecules 44.67
Ligands 33.44
Solvent 44.09
Chapter 2. Materials and Methods 
 
56 
 
 
Table 2.9. Data Collection and Refinement Statistics for xEco2-Peptide Free. 
 
Dataset Peptide free
Wavelength 0.9795
Resolution range 28.83  - 2.978 (3.084  - 2.978)
Space group P 21 21 21
Unit cell 58.475 66.287 109.763 90 90 90
Total reflections 55624 (4904)
Unique reflections 9148 (860)
Multiplicity 6.1 (5.7)
Completeness (%) 0.99 (0.96)
Mean I/sigma(I) 7.70 (1.52)
Wilson B-factor 83.52
R-merge 0.2968 (1.159)
R-meas 0.3252 (1.27)
CC1/2 0.968 (0.449)
CC* 0.992 (0.787)
Reflections used in refinement 9089 (837)
Reflections used for R-free 908 (83)
R-work 0.2247 (0.3684)
R-free 0.2669 (0.3897)
CC(work) 0.956 (0.547)
CC(free) 0.899 (0.566)
Number of non-hydrogen atoms 2725
Macromolecules 2629
Ligands 96
Protein residues 340
RMS(bonds) 0.007
RMS(angles) 0.88
Ramachandran favored (%) 94
Ramachandran allowed (%) 6.1
Ramachandran outliers (%) 0.3
Rotamer outliers (%) 5.7
Clashscore 7.06
Average B-factor 72.81
Macromolecules 73.25
Ligands 60.61
Solvent -
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2.6 EMSA 
2.6.1 Polyacrylamide EMSA 
To determine the binding of Dcc1 to DNA an electrophoretic mobility shift assay 
(EMSA) was performed by native-PAGE with both a 25-mer oligo d(T) ssDNA and 
21-mer dsDNA, which had a sequence of TCTCCACAGGAAACGGAGGGGT. Both 
substrates were commercially synthesised (SIGMA) to contain a 6-FAM fluorescent 
tag at the 5’ end of the sequence. To produce dsDNA an oligo of complementary 
sequence was ordered without a fluorescent tag. Both oligos were then mixed in an 
equal molar ratio and heated to 95 °C. The DNA was then annealed by controlled 
cooling over 70 minutes to 25 °C. The dsDNA was purified to remove any ssDNA by 
loading the sample onto a pre-equilibrated Resource 15Q column (GE Healthcare) 
in 50 mM phosphate buffer pH 7.5. The dsDNA was eluted in a 120 mL gradient 
between 0 to 1 M KCl. 
 
A 6 % non-denaturing polyacrylamide gel made from bis-acrylamide (Fisher) with a 
19:1 ratio of bis-acrylamide to crosslinker in 1 x Tris/borate/EDTA (TBE) was pre-run 
at 3 mA for 60 minutes at 4 °C in 0.5 x TBE. 1 μM DNA was used for the binding 
reactions and the protein was titrated at increasing concentrations in 10 mM Tris pH 
7.5, 150 mM NaCl and 0.5 mM TCEP. The samples were loaded onto the gel and 
run for 75 minutes at 5 mA, 4 °C. The gel was visualised on a Typhoon 9400 excited 
at 488 nm at 500 V and the emission was detected at 520 nm.  
 
2.6.2 Agarose EMSA 
To determine the binding affinity of the head domain of cohesin to DNA a human 
head complex was expressed and purified from insect cells using standard protocols 
(Smc1Δ226-1003, Smc3Δ230-964, full-length Scc1 and Scc3). Mutant Smc3 was made 
using the method described in section 2.1. A 700 base pair dsDNA was amplified 
from a plasmid and used at a final concentration of 14 nM. The protein was titrated 
at increasing concentration in 50 mM Tris pH 8.0, 50 mM NaCl and 0.5 mM DTT. 
The samples were loaded onto a 0.8 % agarose gel, run for 20 minutes at 80 V in 
TBE. UV light was used to visualize an ethidium bromide gel. 
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2.7 Glycerol Gradient 
To analyse the interaction between Pol2 and the Ctf18C-Dcc1-Ctf8 heterodimer a 20-
50 % glycerol gradient was prepared in 20 mM HEPES pH 7.5, 25 mM NaCl and 1 
mM TCEP; using a gradient master (Biocomp) in a 13 x 51 mm polyallomer centrifuge 
tubes (Beckman). The prepared gradient was left to cool to 4 °C for 1 hour before a 
120 μL solution containing a final concentration of proteins at 9 μM in 20 mM HEPES 
pH 7.5, 25 mM NaCl and 1mM TCEP was added to the top of the glycerol gradient. 
Ultracentrifugation was conducted on the samples at 44000 rpm, 4 °C for 18 hours. 
After which, the gradient was separated into 400 μL fractions and analysed by SDS-
PAGE. 
 
2.7.1 Expression and purification of Pol2 
The N-terminal region of Pol2 (residue 1-544) was cloned from S. cerevisiae genomic 
DNA into pET28a with the addition of an His6 N-terminal tag and TEV protease site 
using the procedure presented in Section 2.1. The expression was carried out by the 
same method presented in Section 2.2. 
 
Pol2 pellets were re-suspended in Buffer A. Cells were then sonicated for 4 minutes 
using a standard protocol and the sample was centrifuged at 35000 x g, 4 °C for 1 
hour. The supernatant was loaded onto a pre-equilibrated 5 mL His-Trap HP (GE 
Healthcare) column in Buffer A. The column was washed with 100 mL of Buffer A 
before the protein was eluted in a 75 mL gradient from 10 mM to 0.5 M imidazole. 
TEV protease was added at to a final concentration of 0.04 mgmL-1, 4 °C for 18 hours. 
To improve protein purity Pol2 was diluted to an NaCl concentration of 50 mM and 
loaded onto a pre-equilibrated MonoQ 10/300 GL (GE Healthcare) column in 10 mM 
Tris pH 7.5, 50 mM NaCl and 0.5 mM TCEP. To elute pol2, a gradient of 100 mL was 
used of NaCl between 50 mM to 1 M. Protein containing fractions were concentrated 
to 1 mL in a 20000 Da concentrator (Generon) and loaded on a pre-equilibrated 
HiLoad 16/60 Superdex 75 column (GE Healthcare) in 10 mM Tris pH 7.5, 150 mM 
NaCl and 0.5 mM TCEP. Fractions were collected and purity was analysed by SDS-
PAGE. Pol2 containing fractions were concentrated to 10 mgmL-1and snap frozen in 
liquid nitrogen in 50 μL aliquots, which were stored at -80 °C. 
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2.8 Consensus Motif 
2.8.1 Acetylation of cohesin subunits in vitro 
Acetylation of cohesin subunits by Eco1 was carried out with 70 μM and 0.7 μM of 
Eco1 and cohesin subunits (Smc1-Smc3-Scc1-Scc3, Scc2-Scc4, Pds5 and Wapl) 
respectively in 50 mM Tris pH 8, 50 mM NaCl, 0.5 mM NaCl, 0.5 mM DTT, 5 mM 
MgCl2, 1.5 mM Acetyl-CoA and 1 mM ATP. The acetylation reaction was heated to 
37 °C. After 90 minutes the reactions were stopped by the addition of SDS-loading 
buffer. Samples were analysed by SDS-PAGE and the proteins were visualised by 
coomassie blue staining. Appropriate bands were cut with a sterilized razor, and 
samples analysed for post-translational modification by MS. In addition, a time 
course experiment was carried out with the core cohesin complex in the same 
conditions as above. However, additional samples were taken at 0, 10, 20, 30 and 
40 minutes. 
 
2.8.2 Analysis of peptides and generation of a consensus motif 
After background acetylation by insect cells had been taken into consideration a 
consensus acetylation motif was generated using the iceLogo server (Colaert., 2009). 
Peptides acetylated by Eco1 were manually split into three categories of forward, 
reverse or no direction (see Chapter 6 for further details). 
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Chapter 3. Theory of Crystallography 
The technique called x-ray crystallography helps improves our understanding of 
proteins and their function by determining their atomic structure. The first step to 
solving a protein structure is to obtain a pure protein at relatively large quantities (~5 
mg of protein). The protein then needs to be stable to enable the formation of protein 
crystals. This is usually the limiting step in x-ray crystallography (Saccardo et al., 
2016). 
 
Once a protein crystal is grown the crystallisation condition needs to be optimised to 
improve the crystal’s diffraction. This can be a challenging process, usually, taking 
many rounds of refinement. The best crystals are harvested in liquid nitrogen, and 
then shot with high powered x-rays. Once a full dataset is acquired the phases need 
to be determined to allow an initial electron density map to be calculated. There are 
three major methods used to solve the phase problem known as isomorphous 
replacement, anomalous diffraction and molecular replacement (Rhodes, 2010). The 
growing number of atomic co-ordinates deposited in the protein data bank (PDB) has 
led to molecular replacement being the most common method used today to 
determine phase information. 
 
Once an initial electron density map has been calculated the map is then refined 
using standard procedures before a polypeptide chain is built. Multiple rounds of 
rebuilding and refinement are carried out to produce the final model. To analyse the 
validity of the solved structure statistical tools are employed throughout the 
refinement. 
 
Once the final model has been produced the atomic structure is analysed to help 
determine protein function. Multiple databases and online servers exist to do this. 
For instance, the ConSurf server (Ashkenazy et al., 2016), which analyses the 
surface conservation of a protein; or the Dali server (Holm and Rosenström, 2010), 
which compares a new structure against co-ordinates in the PDB. 
 
In this chapter the practical methods of producing crystal are discussed. Then the 
theory of x-ray crystallography is described in detail starting with the symmetry of 
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crystals. Next, the process of turning the diffraction images into an electron density 
map is presented; along with methods to solve the phase problem. Finally, the 
process of refinement is examined. 
 
3.1 Protein Crystallisation 
3.1.1 Properties of crystals 
Protein crystals are defined as solid structure which are made up of a basic repeating 
unit (Rhodes, 2010), and they are different from amorphous precipitation as they are 
ordered. Crystal which diffract to a high resolution have well-ordered identical unit 
cells. However, protein crystals are usually made from an imperfect arrangement, 
which is measured by the mosaic spread (Rhodes, 2010). The mosaic spread causes 
the diffracted x-ray beam to be a cone shaped rather than a regular beam. Therefore, 
diffraction needs to be recorded over a small angle to measure all reflections. 
 
Protein crystals can be extremely fragile as unlike salt crystals they are held together 
through hydrogen bonds between the protein and water molecules. This also means 
the diffraction has to be recorded in the mother liquor because dehydrating the 
protein crystal will result in the breaking of the crystal lattice. 
 
3.1.2 Growing protein crystals 
The formation of protein crystal only occurs when the molecule is stable and can be 
purified to a high standard. Once the protein is pure it is mixed with a precipitant at 
a concentration just below the concentration required to precipitate the protein 
(Figure 3.1) (Khurshid et al., 2014). The concentration of both protein and precipitant 
is then gradual increased by the removal of water, which causes the protein to 
precipitate. This process hopefully leads to the formation of protein crystals (Garcıá-
Ruiz, 2003). The slower protein precipitation occurs the more likely the molecule will 
crystallise rather than form amorphous precipitation. Standard protein precipitants 
include molecules like polyethylene glycol, ammonium sulphate, ethanol or MPD. 
There are two stages to crystal growth called nucleation and growth. Firstly, 
nucleation occurs, which is the establishment of a molecular clusters; and secondly, 
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growth of the crystal follows, which is the addition of proteins to this initial micro-
crystal. 
 
 
Figure 3.1. Phase Diagram of Protein Against Precipitant. 
 
Normally it is possible to crystallise the protein in different crystal forms, which could 
vary in their reproducibility, diffraction, size, shape or symmetry. The different crystal 
forms are then optimised to produce crystals which can diffract to a high-resolution. 
Sometimes when a model for molecular replacement is not available the phases 
needs to be determined experimentally. One method to do this requires the 
production of multiple heavy metal derivatives. These can be made by co-
crystallisation or soaking the crystal in a heavy metal solution. 
 
The optimisation of crystals occurs through varying a variety of conditions; for 
example, the temperature, precipitant concentration, pH, protein concentration, drop 
size or salt concentration (McPherson and Cudney, 2014). Varying the above 
conditions can sometimes not improve the overall diffraction quality and other 
procedures can be attempted such as crystal seeding; the use of small molecules; 
detergents or antibodies (McPherson and Cudney, 2014). Finally, if crystals still 
cannot be improved the protein construct may need to be re-designed. 
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3.1.3 Crystal data-collection 
Once high quality crystals have been grown they need to be harvested. Old methods 
include room temperature shooting, which involved transferring the crystal along with 
the mother liquor to a glass capillary. However, cryo methods to harvest and shoot 
the protein crystals are now normally used (Pflugrath, 2015). To do this, the crystal 
firstly needs to be cryo-protected to stop the formation of ice crystals by the addition 
of glycerol, ethylene glycol or other similar small molecules. Once the crystal is cryo-
protected it is then shot at liquid nitrogen temperatures (-196 °C). There are many 
advantages of cryo data-collection; for instance, at lower temperatures the crystal 
lattice is more stable; has greater resistance to radiation damage; and crystals can 
easily be transported in dry-shippers (Pflugrath, 2015). 
 
3.2 Crystal Symmetry 
3.2.1 Unit cell symmetry 
All crystals can be defined by their unit cell, which is the smallest single repeating 
unit of a crystal. Any unit cell is described by having three axes called a, b and c; and 
three angles α, β and γ. There are a number of different unit cells defined by their 
angles and relative axes lengths. For instance, when a ≠ b ≠ c and α ≠ β ≠ γ the unit 
cell is called a triclinic cell. A monoclinic cell is defined when a ≠ b ≠ c and α = γ, β > 
90 °. A hexagonal cell has the criteria that a = b, α = β and γ = 120 °. For a tetragonal 
or cubic cell all three angles equal 90 °. However, for a cubic cell all axes are equal 
in a length (a = b = c) whilst for a tetragonal cell the c axis is different (a = b ≠ c) 
(Rhodes, 2010). 
 
3.2.2 Bragg’s law 
The angle of diffraction from a crystal lattice is related to sets parallel planes (Bragg, 
1913). This model describes a reflection being caused by a set of parallel plane in 
the crystal. Each set of parallel planes in a crystal are described by three indices 
(miller indices) h, k and l; separated with an inter-planer spacing dhkl. The h, k and l 
define the number of planes in the x-, y- and z-direction respectively between lattice 
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point. For instance, if a set of parallel plane has the indices (300) then there would 
be 3 planes between lattice points in the x-direction.  
 
Bragg’s law states that a reflection can only be observed from a set of parallel planes 
if the x-ray travels an integral distance of the wavelength (λ) between the planes 
(Equation 1). Only when this is satisfied do reflected x-rays construct in phase 
leading to a strong reflection. However, if the distance travelled is not an integral 
number of wavelengths then the reflected x-rays will be out of phase and add up 
destructively. 
 𝑛𝜆 = 2𝑑&'( sin 𝜃 
(Eq. 1) 
Equation 1 (Bragg’s law) can be derived from drawing a set of parallel planes 
between lattice points (Figure 3.2). For instance, if two parallel x-rays of wavelength 
λ strike the parallel planes at two different lattice points the x-rays will reflect at the 
same angle of incidence (θ). From the diagram in Figure 3.2: 
 sin 𝜃 = 	𝐵𝐶𝐴𝐵	 
(Eq. 2) 
Therefore: ABsin 𝜃 = 	𝐵𝐶 
(Eq. 3) 
As BC = dhkl and the extra distance travelled by R2 is 2BC then:  
 2BC = 	2d567sin 𝜃 
(Eq. 4) 
For a reflection to be observed 2BC has to equal an integral number of λ, which 
derives Equation 1. 
 
Bragg’s law means that the number of reflection depend on the parallel planes in a 
unit cell. Therefore, the position and number of spots in a diffraction pattern is related 
to the unit cell dimensions and not the cell contents. 
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Figure 3.2. Bragg’s law Derived From Diffraction From Parallel Planes. 
 
3.2.3 The reciprocal lattice 
The reflections produced from a set of parallel planes are present in reciprocal space. 
Reciprocal space is inversely proportion to real space so that the volume of the 
reciprocal unit cell (Vreciprocal) relates to volume of real unit cell (Vreal) by Equation 5 
(Rhodes, 2010). 
 𝑉9:;<=9>;?( = 1𝑉9:?( 
(Eq. 5) 
Therefore, if the real unit cell edges are in  Å the reciprocal cell edges would have 
the units Å-1. It also means a small real unit cell will have a large reciprocal lattice 
and a large real unit cell would have a small reciprocal lattice. For protein crystals, 
as the unit cell dimension are in Å they have an inherently large reciprocal lattice. 
 
3.2.4 Space groups 
Crystal unit cells can be further broken down into symmetrically related units called 
the asymmetric unit. For instance, in a protein crystal in any one-unit cell there are 
normally multiple proteins which can be related by symmetry operations like a 
translation or rotation. There are more complex symmetry operations such as a 
screw axis, which are formed from a rotation and a translation. The combination of 
symmetry elements in a unit cell gives rise to its space group. There are 230 possible 
space group; however, the chiral nature of proteins limits the use of the reflection 
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symmetry operator, which leads to protein crystals only having 65 possible space 
groups (Hahn, 2005).  
 
Space groups are defined by a letter and a number such as, P21. The letter indicates 
the lattice type or Bravais lattice, and the numbers reveal the symmetry operation. 
There are thirteen Bravais lattice types, which are determined first. In a cubic system 
there are three lattices known as Primitive (P), Internal (I) and Face-centred (F) 
(Figure 3.3). Usually for a given crystal there are a number of lattice types to choose 
from, and the standard procedure is to choose the highest symmetry Bravais lattice. 
For instance, a F lattice has higher symmetry than a P lattice. In the P21 spacegroup, 
the 21 indicates that the protein has a two-fold screw axis. This means the molecule 
rotates 180 ° and translates half the axial length. Alternatively, a 31 would mean there 
is a three-fold screw axis and the molecule would rotate 120 ° and move a third of 
the axial length (Hahn, 2005). 
 
The space group can be determined by analysing the reflections intensities from sets 
of parallel planes. The first step is to calculate the lattice type and unit cell dimensions. 
It is then possible to determine the precise space group by defining the additional 
symmetry operators. In some cases, this can be revealed from systematic absences. 
For instance, a two-fold screw axis along the b-axis will cause missing reflections 
from the hkl planes when k is an odd number (Hahn, 2005). 
 
The variability of crystals in both their size and strength of diffraction means that after 
reflections have been collected the frames need to be scaled. The collection of the 
same reflection in multiple frames can aid this scaling process. 
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Figure 3.3. Cubic Lattices. 
The dots signify lattice points, and the letters P, I and F represent the Primitive, Internal 
and Face-centred cubic lattice types respectively. 
 
3.3 Calculating the Electron Density 
The electron density of a unit cell is calculated from the reflection intensities recorded 
from a diffraction pattern and the phases, which cannot be obtained from the 
reflections. The electron density repeats itself; therefore, it can be approximated by 
a Fourier sum, and represented as a periodic function. To understand the structure 
factor (Fhkl) and the resulting electron density equation r(x, y, z) the theory of waves 
will firstly be described. 
 
3.3.1 Mathematical description of waves 
The trigonometry functions of sin or cos can be used to describe any periodic function 
in one-dimension (Equation 6 and 7). Where F, h and a represent the amplitude, 
frequency and phase respectively. 
 
Chapter 3. Theory of Crystallography 
 
68 
 
𝑓 𝑥 = Fcos2π(ℎ𝑥 + 	𝛼) 
(Eq. 6) 
Or: 
 𝑓 𝑥 = Fsin2π(ℎ𝑥 + 	𝛼) 
(Eq. 7) 
A complex wave can be approximated by a Fourier sum (Rhodes, 2010). Therefore, 
no matter how complex the wave is by selecting the correct value for the frequency, 
amplitude and phase it is possible to describe any wave (Rhodes, 2010). 
 
𝑓 𝑥 = F5cos2πL&MN (ℎ𝑥 + 	𝛼&) 
(Eq. 8) 
Furthermore, waves can be described by a complex number (Equation 9). The phase 
is implicit in this complex number equation. 
 
𝑓 𝑥 = F5[cos2πL&MN ℎ𝑥 + 𝑖 sin 2𝜋(ℎ𝑥)] 
(Eq. 9) 
Equation 9 can further be simplified as: 
 𝑒<T = 𝑖 sin 𝜃 + 	cos 𝜃 
(Eq. 10) 
Therefore: 
 𝑓 𝑥 = 	 𝐹&𝑒VWX<(&Y)&  
(Eq. 11) 
Equation 11 represents a complex periodic function in one direction. Furthermore, 
the Fourier sum can be used to describe a wave in three dimensions (Equation 12). 
 𝑓 𝑥, 𝑦, 𝑧 = 	 𝐹&'(𝑒VWX<(&Y]'^](_)('&  
(Eq. 12) 
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Equation 12 can be used to represent the electron density in three dimensions as 
will be shown in the next sections. 
 
3.3.2 Fourier transform 
Another mathematical function is called a Fourier transform (FT) (Rhodes, 2010). 
This is useful as it allows the movement between the real and reciprocal space. The 
principle behind the FT is calculating the reciprocal function of a complex sum. In this 
way, the FT is reversible and carrying it out twice on any function will result in the 
original function being obtained. 
 
3.3.3 Description of the structure factor 
A reflection can be represented by a Fourier sum, which is called the structure facture 
(Fhkl). The contribution of a single atom to the structure factor can be described when 
taking into account the atoms scattering factor (fj) (Rhodes, 2010). 
 𝑓&'( = 		 𝑓 𝑒WX<(&Ya]'Ya](a) 
(Eq. 13) 
However, any single structure factor is the sum of contribution from every atom in 
the unit cell, and is described by a Fourier sum. 
 
𝐹&'( = 	 𝑓 𝑒WX< &Ya]'Ya](aL`Mb  
(Eq. 14) 
The term fj is equivalent to the average electron density. Therefore, the structure 
factor can also be written in terms of r(x, y, z). Although r(x, y, z) is an average 
density over a set volume by using an infinitely small volume it is possible to obtain 
the precise value of r(x, y, z) at any given co-ordinate. This can be done by 
integrating all values of x, y and z over the unit cell (v) in the Fourier sum, which 
gives the following equation. 
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𝐹&'( = 	 𝜌(𝑥, 𝑦, 𝑧d )𝑒WX<(&Y]'Y](Y)	𝑑𝑣 
(Eq. 15) 
Carrying out a FT on Equation 15 derives r(x, y, z) from the structure factors. 
 𝜌 𝑥, 𝑦, 𝑧 = 	 1𝑉 𝐹&'(𝑒VWX<(&Y]'^](_)('&  
(Eq. 16) 
The electron density can be determined from the periodic function presented in 
Equation 16. To do this, the structure factors need to be calculated, which can be 
obtained from intensity of the reflection as Fhkl is proportional to the square root of 
the measured reflection intensities (Iobs) (Rhodes, 2010). In addition, the frequency 
and phase of each term is required. The frequency can be can be calculated from 
the indexed reflections as the frequency is inversely proportional to the inter-planner 
spacing of the plane that caused the reflection. However, the phase cannot be 
measured from the diffraction pattern and further information is required to calculate 
initial phase estimates. 
 
Once initial phases are determined multiple rounds of phase improvement are 
carried out to enhance the overall electron density. This is done, firstly, by calculating 
r(x, y, z) based on initial phase estimates acalc and the reflection intensities (Iobs). The 
phases are then improved by identifying the position of atoms or using techniques 
such as solvent flattening, which helps identify solvent boundaries. Structure factors 
are then re-calculated to determine improved phases. This process is repeated until 
Icalc reaches Iobs (Rhodes, 2010). 
 
3.4 Solving the Phase Problem 
To obtain r(x, y, z) from equation 16, the phase of each structure factor in the Fourier 
series needs to be estimated. The electron density can then be represented as a 
contour map. Initial phases are usually estimates, which are improved through 
multiple rounds of refinement. 
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In this section the mathematical relationship between r(x, y, z) and the phase of each 
reflection will be described. Then the three common methods of obtaining phases 
will be discussed. 
 
3.4.1 Representation of r(x, y, z) with phases 
In Equation 16. r(x, y, z) is represented in terms of structure factors (Fhkl) which have 
a phase, intensity and frequency. Both the intensity and frequency of a reflection can 
be measured from the diffraction pattern. To reveal how phase information is 
obtained it is useful to represent r(x, y, z) in another form (see below). 
 
Structure factors are described as being complex vectors with a real component 
known as the intensity and an imaginary comment termed the phase (Figure 3.4). In 
this way the phase represents an angle between the vector and the real axis. A useful 
representation of phases can be derived from the diagram as follows. Where |F| is 
proportional to the square root of the amplitude. 
 sin 2𝜋𝛼 = 	 |𝐴||𝐹| 
(Eq. 17) 
and: 
 cos 2𝜋𝛼 = 	 |𝐵||𝐹| 
(Eq. 18) 
Representing Equation 17 and 18 as a complex number gives rise to the following 
equation for a structure factor: 
 𝐹 = |𝐹|(cos 2𝜋𝛼 + 	𝑖 sin 2𝜋𝛼) 
(Eq. 19) 
Therefore: 
 𝐹 = |𝐹|𝑒WX<g 
(Eq. 20) 
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Substituting F into Equation 16 gives rise to the following: 
 𝜌 𝑥, 𝑦, 𝑧 = 	 1𝑉 |𝐹&'(|𝑒WX<ghij𝑒VWX<(&Y]'^](_)('&  
(Eq. 21) 
Or: 
 𝜌 𝑥, 𝑦, 𝑧 = 	 1𝑉 |𝐹&'(|𝑒VWX<(&Y]'^](_Vghij)('&  
(Eq. 22) 
Equation 22 describes r(x, y, z) in terms of amplitude, phase and frequency (Rhodes, 
2010). Using this equation, it is possible to determine an initial electron density map. 
The methods used to obtain phase information shall be discussed below. 
 
 
Figure 3.4. Structure Factors Represented as Complex Numbers. 
 
3.4.2 Isomorphous replacement 
One method of experimental phase determination is called isomorphous 
replacement or the heavy atom method (Taylor, 2010). The principle behind this 
technique is to incorporate atoms into the unit cell and observe the effect on the 
diffraction pattern. The reflections reflect the lattice; therefore, adding atoms will 
cause a change in the observed reflections. For the change to be observable the 
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incorporated atom has to diffract x-rays more strongly compared to the atoms in a 
protein. Atoms with a high molecular mass are, therefore, chosen as good 
candidates for isomorphous result. 
 
To obtain crystals with heavy atoms incorporated into the unit cell, crystals can either 
by soaked or co-crystallised with a heavy atom of choice. Common ions include 
platinum, gold, mercury or uranium. Heavy metals are usually poisonous to the 
crystal lattice; as a result, the concentration and type of ion used usually requires 
extensive testing (Sun et al., 2002). Furthermore, the heavy metal has to bind to the 
protein in the same position in every unit cell at a high occupancy otherwise the 
contribution to the diffraction pattern from the heavy metal will be unobservable. The 
heavy atom also cannot alter the unit cell dimensions or crystal symmetry else the 
difference in the diffraction pattern will not solely be due to the addition of a heavy 
atom to the unit cell. 
 
Once two data-sets of sufficient quality are obtained, the next step in gaining phase 
information is to find the location of the heavy atoms. To do this, the difference 
between the intensity of each reflections is calculated:  
 |𝐹&|W = 	 ( 𝐹&= − 𝐹 =)W 
(Eq. 23) 
Where |Fh|, |Fhp| and |Fp| is the intensity of reflections caused by the heavy atom, 
heavy atom and protein, and protein alone respectively. Equation 23 is squared to 
make the observation positive. 
 
The next step is to calculate a Patterson function, which is another Fourier sum 
(Taylor, 2010). A Patterson function is a different way to represent the unit cell 
content. However, in this description the phase of each structure factor is not 
required. A basic Patterson function is described as follows: 
 𝑃 𝑢, 𝑣, 𝑤 = 	 1𝑉 |𝐹&'(|W𝑒VWX<(&o]'p](q)('&  
(Eq. 24) 
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In Equation 24, P (u, v, w) is a mathematical representation of the vectors between 
atoms in a unit cell. For a protein molecule the resulting vector map is too 
complicated to interpret. However, for a unit cell which contains a few atoms their 
position can readily be identified. The location of peaks in specific locations in the 
Patterson map can help identify symmetry elements, such as a rotation axis, which 
makes finding the position of atoms easier. For proteins soaked in heavy atoms 
computer programmes usually trial several solutions to determine the correct location 
of the heavy atoms. 
 
Combining Equation 24 with 23 gives rise to a Patterson function of just the heavy 
atoms (|Fh|= DF). 
 Δ𝑃 𝑢, 𝑣, 𝑤 = 	 1𝑉 Δ𝐹&'(W𝑒VWX<(&o]'p](q)('&  
(Eq. 25) 
It is therefore possible to find the location of the heavy atom in the unit cell and their 
resulting phases from two datasets. 
 
One of the potential issues with the use of a Patterson function is that it is unable to 
determine the difference between inverted images, which is known as the hand 
problem. As a result, the Patterson function gives rise to two solutions called the left 
and right hand. If high resolution data is available both hands are taken forward and 
the electron density map is refined, which should give one solution with a significantly 
better electron density. 
 
Once the phases of the heavy atoms have been solved an estimate of the phase of 
the protein needs to be determined. This can be done with the aid of a Harker 
diagram (Figure 3.5) in combination with the following equation: 
 𝐹= = 𝐹=& − 𝐹& 
(Eq. 26) 
Using a Harker diagram the vector representing the structure factor -Fh is plotted. 
Next, a circle is drawn with a radius equal to |Fph|, with its centre at the end of the 
vector representing -Fh. Finally, a circle with a radius equal to |Fp| is plotted at the 
Chapter 3. Theory of Crystallography 
 
75 
 
origin (Figure 3.5). The points these two circles intersect gives rise to the phase of 
Fp. It is common for the circles to intersect more than once meaning an exact value 
for the phase cannot be determined. If the intersections lie close together then an 
average is usually taken, which is normally enough for an initial phase estimate. 
However, sometimes this is not feasible and it may be necessary to determine phase 
information by the use of an additional derivatives. 
 
 
Figure 3.5. Solving Phases Using a Harker Diagram. 
 
3.4.3 Anomalous scattering 
Another method to determine phase information is to use the fact that atoms absorb 
photons at a specific wavelength and then re-admit them with a different phase 
(Taylor, 2010). Atoms absorb x-rays strongly at a wavelength just lower than their 
emission wavelength, which is called the absorption edge. The wavelength of x-rays 
is around the absorption edge of heavy atoms. Therefore, again a second derivative 
is usually required to obtain an anomalous signal unless the protein already contains 
an appropriate atom such as in zinc finger domains. 
 
The development of producing proteins with selenomethionine incorporated into the 
polypeptide chain has made anomalous scattering one of the most common 
experimental phasing methods. For instance, if the crystallised protein was 
recombinantly expressed in Escherichia coli then it is possible to grow the cells in 
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minimal media where selenomethionine is the only source of the amino acid 
methionine. In this way, selenomethionine is incorporated into the protein. The 
selenium atom can then act as an anomalous diffractor if the correct wavelength is 
selected (Walden, 2010). 
 
Once a suitable crystal derivative has been obtained a dataset needs to be collected 
at the heavy atoms absorption edge. The anomalous signals can be identified from 
observing Friedel pairs. Friedel law states that the reflections caused by planes hkl 
and -hkl are equal. However, Friedel law is no longer true when an anomalous 
diffractor is present (Taylor, 2010). It is possible to generating a Patterson function 
from the difference in Friedel pairs using Equation 27. 
 𝐹stuW = 	 (𝐹vs] − 𝐹vsV )W 
(Eq. 27) 
Where FANO is the anomalous signal, and F+ and F- are the Friedel pairs. 
 
Once the position of the anomalous scatter is identified a Harker diagram can again 
be constructed to determine the phase of the protein. 
 
One problem with anomalous scattering is the difference between Friedel pairs is 
small (Rhodes, 2010). This means the phase information determined by the 
anomalous diffraction may not be enough to determine a suitable electron density 
map. It may therefore require another derivative or a combination of other phasing 
methods to determine phases with sufficient accuracy. Alternatively, to increase the 
phasing power of an anomalous signal it is possible to collect datasets at multiple 
wavelengths. This method is called multi-wavelength anomalous dispersion (MAD) 
(Walsh et al., 1999). 
 
3.4.4 Molecular replacement 
The most common method for determining phase information is called molecular 
replacement (Rhodes, 2010). For this technique a solved structure needs to exist 
which is a structural homologue. The structure factors from this model are then used 
as an initial estimate for phase information of the new protein. 
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There are two procedures for molecular replacement depending if the search model 
is isomorphous to the new protein. If the new protein is isomorphous then the phases 
of the search model can be used directly to calculate initial estimates for the new 
structure factors. The model is then refined to improve the phase information. 
 
The more challenging task is if the search model and the new protein are not 
isomorphous. To determine phase information in this case, the orientation and 
position of the search model needs to identified in the unit cell. Once the location of 
the new protein is discovered new structure factors can be calculated. 
 
To place a molecule in the unit cell both the position and orientation need to be found. 
It should, therefore, be possible to search every location and orientation of the model 
to find the correct location. However, to simplify the above problem the search can 
be split into two stages. Firstly, the orientation of the search model is determined, 
and then the position of search model in the unit cell is calculated. Phaser is the 
computer programme, usually, used to carry out molecular replacement (McCoy et 
al., 2007). To determine both the orientation and position of the search model Phaser 
uses maximum-likelihood calculations in reciprocal space (Evans and McCoy, 2007). 
 
Older methods of molecular replacement used a Patterson function to determine the 
orientation of the search model; as a Patterson map is independent of the models 
position in the unit cell but depends on its orientation. Matching the Patterson maps 
gives an estimate of the orientation of the protein in the unit cell. Once the orientation 
is determined the position of the protein in the unit cell can be identified by calculating 
estimates of the structure factors, and then measuring how they compare with the 
observed structure factors. 
 
3.5 Refinement 
The initial phases obtained from the methods described above are estimates and 
produce an electron density map which is usually difficult to interpret. There are 
multiple methods to improve phases, which make the map more interpretable. This 
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is an iterative process which bootstraps the initial phase estimates to phases which 
are more accurate. These methods include refinement in both the real and reciprocal 
space. 
 
The initial phase estimates in each Fourier sum vary in reliability as some phases 
are more accurate than others. To take this into account a weighting factor between 
0-1 (w) is given to each term in the Fourier series so that:  
 𝜌 𝑥, 𝑦, 𝑧 = 	 1𝑉 𝑤&'(|𝐹&'(|𝑒VWX<(&Y]'^](_Vghij)('&  
(Eq. 28) 
For a phase which has a low accuracy the weighting factor is close to zero. However, 
once phases are improved the weighting factors changes to a higher number, which 
means it will have a greater impact on the calculation of the Fourier sum. After 
multiple rounds of refinement and improvement in phases ρ(x, y, z) will become more 
accurate and interpretable (Rhodes, 2010). 
 
The process of refinement involves making a change to the map or model, and then 
the structure factors are re-calculated using this new information. Next the phases 
from these structures are used with the observed reflection intensities to re-calculate 
ρ (x, y, z). 
 
The methods available for real space refinement will firstly be discussed such as 
solvent flattening, which is a process to improve solvent to protein boundaries; non-
crystallographic symmetry (NCS); and model building, which involves building and 
editing the protein structure at an atomic level. Then methods of reciprocal space 
refinement will be described with a final discussion on the statistical methods used 
to monitor the refinement. 
 
3.5.1 Real space refinement 
Solvent flattening is a method to improve phases by adding additional constraints by 
assuming in real space the solvent density is flat (Rhodes, 2010). To carry out this 
technique the map is initially divided into equally sized grids and the average electron 
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density of this area is calculated. This area is then given a value of zero if the overall 
average is negative or if the electron density is positive the area is given the value 
corresponding to the average. This should improve the map by removing any uneven 
density and help define the protein envelope. The structure factors are then re-
calculated and the phases used with the observed reflections to re-calculate the map. 
 
NCS averaging takes advantage of addition symmetry present in the unit cell due to 
the protein, which cannot be extended over the whole crystal (Murshudov et al., 
2011). This usually occurs if in the asymmetric unit there are two protein molecules 
related by a symmetry operator such as a two-fold rotation. The operator function 
can be identified by a number of methods. For instance, if the phases were 
determined by the heavy atom method it is possible to calculate the symmetry 
operator between groups of heavy atoms. Once the symmetry operator is found in 
the unit cell, the map can be averaged between the additional symmetry elements. 
In addition, restraints can be placed on certain phases in reciprocal space to take 
into account the NCS operator. 
 
Once the phases are improved using the above two methods it should be possible 
to observe clear protein density in the electron density map. This could be in the form 
of secondary structure elements such as a helices or in some cases amino acid sides 
chains. If molecular elements cannot be identified it suggests additional phase 
information is required (Rhodes, 2010). 
 
In the atomic model building stage a poly-alanine chain is firstly built, and where 
feasible side chains are added. Bonds restraints are added throughout the 
refinement as the geometry of amino acids and their side chains have already been 
determined. Once a round of rebuilding has occurred new structure factors are 
calculated based on the co-ordinates of the atoms and their scattering factor (fj). The 
new phases are used in combination with the observed intensities to calculate a new 
map, and this map is then used to carry out an additional round of rebuilding. This 
process is repeated until the phases can no longer be improved. 
 
During the atomic building stage, in the refinement process, the model can easily 
become biased toward to the atomic co-ordinates as they contribute an increasingly 
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larger proportion to the phase information. To remove any bias during the atomic 
building process the following two maps are plotted (Rhodes, 2010): 
 𝜌 𝑥, 𝑦, 𝑧 = 	 1𝑉 (|𝐹>| − |𝐹;|𝑒VWX<(&Y]'^](_Vghij)('&  
(Eq. 29) 
and: 𝜌 𝑥, 𝑦, 𝑧 = 	 1𝑉 (2|𝐹>| − |𝐹;|𝑒VWX<(&Y]'^](_Vghij)('&  
(Eq. 30) 
Where Fo are the observed intensities and Fc are the calculated intensity.  
 
Equation 29 and 30 represents a Fo-Fc and 2Fo-Fc maps respectively. A 2Fo-Fc map 
is the normal map that the proteins are built into. This map helps remove bias as it 
takes into account both the observed and calculated intensities. The Fo-Fc map 
reveals if there is any significant difference between the atomic model and the 
observed intensity. If there are extra electrons in an area this will be revealed by 
positive density in an Fo-Fc map. Alternatively, if an atom is placed in a position with 
lower electron density this will appear as negative density. Using these two maps it 
is possible to spot any inaccuracies in the atomic model. 
 
3.5.2 Reciprocal space refinement 
In addition to refining the structure in real space it is also possible to carry out phase 
improvement in reciprocal space. This is because for any atomic model the value of 
|Fc| should match for |Fo|. It is therefore possible to refine the co-ordinates of the 
protein to produce a better match for Fc. This used to be routinely done using the 
mathematical method called least square which has the following formula 
(Murshudov et al., 2011). 
 𝜙 = 	 𝑤&'(( 𝐹> − 𝐹; )W&'(  
(Eq. 31) 
Where whkl is the waiting factor of each term. 
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Additional parameters can be added to equation 31 such as B-factors, bond 
restraints and occupancy, which help to improve the model. Normally, at the start of 
the refinement these addition parameters act as restraints as they are given pre-set 
values. This helps prevent the model from getting trapped in an incorrect minimum, 
but as the model improves these restraints are released, which should help lead to 
a convergence of |Fo| and |Fc|. Modern refinement programmes normally use 
maximum-likelihood calculations in reciprocal space to decrease the difference 
between |Fc| and |Fo| (McCoy, 2004). 
 
3.5.3 Monitoring the refinement 
Throughout the refinement a range of statistical indexes exist to allow the accuracy 
of the model to be determined. One of the most common statistical tools is called the 
residual index (R-factor) (Brünger, 1992). The R-factor takes into account the 
difference between the observed and calculated intensities in the following equation: 
 𝑅 = 	 | 𝐹>yz − 𝐹;?(; ||𝐹>yz|  
(Eq. 32) 
For a model where the observed intensities are in agreement with the calculated 
intensities the R-factor will be small and should approach zero. However, an R-factor 
of almost 0.5 represents a random distribution of atoms in a unit cell. For a model 
which has a resolution of 2 Å, it should be possible to obtain an R-factor of below 0.2. 
 
At the start of refinement 5 % of reflections are randomly taken as a free R-set 
(Brünger, 1992). This free R-set is not used to calculate the structure factors and is 
not refined against during model building. Comparing the calculated reflections 
against the free R set should give an unbiased analysis on how accurate the model 
is at describing the observed reflections. 
 
Apart from the R-factors there are a number of other parameters which can help 
assess how accurate a model is which include the protein geometry, bond angles 
and steric clashes (Rhodes, 2010). 
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In this chapter I have described how to obtain crystals from aqueous protein solutions 
and then optimise them to produce crystals that diffract strongly. Then crystal 
symmetry was discussed; along with how this relates to the diffraction pattern of a 
crystal. Finally, the method of obtaining an electron density map from the diffraction 
pattern was described. 
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Chapter 4. Structure of Ctf18C-Dcc1-Ctf8 
4.1 Summary on the Function of RFCCtf18 
The RFCCtf18 complex is made from the seven subunits Ctf18, Rfc2-5, Dcc1 and Ctf8 
(Mayer et al., 2001). It was first discovered due to its genetic roles in the 
establishment of sister-chromatid cohesion, and more recently has been shown to 
effect the DRC (Crabbé et al., 2010; Pan et al., 2006). RFCCtf18 belongs to a class of 
clamp loading or unloading complexes known as RFC like complexes. These 
complexes all contain the four subunits Rfc2-5, and are defined by their large subunit 
(Kubota et al., 2014), which in the case of RFCCtf18 is Ctf18. There are four RFC like 
complexes encoded in the eukaryotic genome, with RFCCtf18 being the only complex 
formed from seven subunits (Mayer et al., 2001). Work has demonstrated that in vitro 
RFCCtf18 can both load and unload PCNA from a range of DNA substrates; however, 
it was suggested that the main in vivo target was as a PCNA unloader (Bylund and 
Burgers, 2005). This was different to the conclusion drawn by ChIP analysis, which 
rationalised that RFCCtf18 was a PCNA loader as in Ctf18 deletion strains the amount 
of PCNA on chromatin was reduced (Lengronne et al., 2006). Furthermore, in vitro, 
it was discovered that the two subunits, Dcc1 and Ctf8, took no part in the unloading 
or loading activity of PCNA (Bylund and Burgers, 2005). It is interesting to note that 
deleting either Dcc1 or Ctf8 has the same phenotype in yeast as a ctf18D strain in 
both the DRC and sister-chromatid cohesion. Therefore, I hypothesised that these 
subunits must play a regulatory role on the complex. To gain an insight into the 
possible function of the Dcc1-Ctf8 sub-complex I decided to obtain the crystal 
structure of this heterodimer. It was hoped that I would then be able to rationalise 
how Dcc1 and Ctf8 regulate the RFCCtf18 complex. 
 
4.2 Expression and Purification of Dcc1-Ctf8 
The expression of the full length Dcc1-Ctf8 sub-complex was carried out in E. coli by 
the protocol presented in Section 2.2. The sub-complex expressed well and could be 
purified to a high standard using a three-step purification protocol (Figure 4.1A). The 
resulting protein was concentrated, and crystallisation trials were attempted at 10 
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mgmL-1 and 20 mgmL-1 in a range of commercial available screens. Crystals were 
obtained in a range of conditions and were optimised by varying the pH and 
precipitant concentration. Unfortunately, after multiple rounds of optimisation the 
crystal diffraction could not be improved beyond ~20 Å; therefore, I decide the 
construct needed to be improved. To do this a range of sequence alignments for both 
subunits were carried out to see if there appeared to be any conserved domains; 
unfortunately, the analysis did not reveal any clear results (data not shown). 
Consequently, limited proteolysis was attempted. 
 
Limited proteolysis uses a ‘small’ amount of protease to cut a protein at flexible or 
unstable regions. It is hoped that the identification of these boundaries will enable 
the design of new stable constructs that may crystallise and diffract to a higher 
resolution. The results from limited proteolysis conducted on the Dcc1-Ctf8 sub-
complex revealed that Dcc1 and Ctf8 both degraded to a stable construct (Figure 
4.1B). The resulting bands were analysed by both Edman N-terminal sequencing 
and in-tact mass by MALDI (this work was performed by the PNAC facility at the 
University of Cambridge). The data indicated that the proteases had cleaved Dcc1 
and Ctf8 at residue 90 and 18 respectively. As a result, these construct boundaries 
were re-cloned and expressed in E. coli. The purification of Dcc1FL and Ctf818-133 
resulted in the formation of a stable complex which purified to a high quality (Figure 
4.1C). However, when the expression of Dcc190-380 and Ctf818-133 was attempted the 
proteins could not be purified; suggesting that the N-terminal region of Dcc1 was 
required for the interaction with Ctf8. 
 
The complex formed from Dcc1FL and Ctf818-133 was purified and placed into crystal 
trials at 15 mgmL-1 using a variety of commercially available crystal screens. 
Potential hits were optimised by changing the pH and concentration of the precipitant. 
Unfortunately, even after multiple rounds of crystal optimisation the diffraction could 
not be improved beyond a resolution of 3.5 Å. 
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Figure 4.1. Construct Design for the Dcc1-Ctf8 Sub-Complex. 
A) Purification of the full length Dcc1-Ctf8 sub-complex, the SDS-PAGE presented is of 
the final purification step. B) Limited proteolysis carried out on the Dcc1-Ctf8 sub-
complex. Degraded bands labelled ‘D’ were analysed by MS to determine new construct 
boundaries. C) Purification of the sub-complex of Dcc1FL and Ctf818-133, the SDS-PAGE 
presented is of the final purification step. 
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4.3 Crystallisation of the C-Terminus of Dcc1 
As a result of the poor diffraction of the Dcc1-Ctf8 crystals, Dcc190-380 was expressed 
on its own. The single protein expressed well from E. coli and purified to a mono-
species after a three-step procedure (Figure 4.2A). Crystallisation was attempted in 
a range of commercially available screens at 15 mgmL-1. The construct crystallised 
as a hollow rod shape in a variety of conditions, growing to a maximum length of 
~900 µm in 0.2 M potassium sodium tartrate and 18 % PEG 3350 (Figure 4.2B). 
These crystals were harvested after two days in liquid nitrogen with the addition of 
20 % ethylene glycol. The largest crystal diffracted to a resolution of 2 Å at Diamond 
Light Source on beamline I04-1. To determine a usable electron density map, the 
phase problem needed to be solved. The phases can usually be determined by either 
molecular replacement or experimental phasing. However, as there is no known 
structural homologue for Dcc1 the latter method has to be used. 
 
To determine the phases for Dcc190-380, protein containing only selenomethionine 
was obtained and crystallised. To do this, Dcc190-380 was expressed in E. coli in 
minimal media where selenomethionine was the only source of methionine. This 
protein was then purified in the same three-step procedure as the native protein. 
Crystals trays were set up at 15 mgmL-1 in an optimisation grid screen from the 
condition that produced the best dataset for the native crystals. Selenomethionine 
crystals grew as large plates to a length of ~700 µm (Figure 4.2C) and were 
harvested in the same way as the native crystals. The crystals were shot at Diamond 
Light Source on beamline I03 and a two wavelength multi-wavelength anomalous 
diffraction (MAD) dataset was collected at the peak (0.9796 Å) and inflection (0.9797 
Å) wavelengths to a resolution of 3 Å (Figure 4.2D). 
 
From the MAD dataset the AutoSHARP package (Bricogne et al., 2003) was able to 
determine the position of 33 out of 36 selenomethionines in the unit cell. The initial 
estimate of 36 selenomethionines was calculated based on 4 molecules in the 
asymmetric unit. This was determined using the Matthews coefficient, which gave a 
probability of 0.65 for 4 molecules (Vm = 2.15 Å3Da-1) and a percentage solvent of 
41.77 % (Matthews, 1968). From the initial phases a map was generated and refined 
using standard procedures such as solvent flattening and non-crystallographic 
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symmetry (NCS) averaging. NCS averaging was carried out based on the Mathews 
coefficient of 4 molecules being in the asymmetric unit. Buccaneer was then used to 
trace an initial model (Cowtan, 2006), and multiple round of refinement and rebuilding 
were carried out in Coot (Emsley and Cowtan, 2004) and Refmac5 (Murshudov et 
al., 2011) respectively. This structure was then used as a model for molecular 
replacement in Phaser for the high resolution native dataset (McCoy et al., 2007). 
After which, further rebuilding and refinement were conducted. Data collection and 
final refinement statistics are given in Table 2.5. The final structure of Dcc190-380 is 
shown in Figure 4.2E and is discussed in detail in the next sections. 
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Figure 4.2. Crystallisation of Dcc190-380. 
A) The final step in purification of Dcc190-380 analysed by SDS-PAGE. B) Crystallisation 
of native Dcc190-380. C) Crystallisation of selenomethionine Dcc190-380. D) Diffraction 
pattern of native Dcc190-380 crystals. E) Overall crystal structure of Dcc190-380. 
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4.4 Dcc1 Contains Three Tandem Winged Helix Domains 
The role of Dcc1 in the RFCCtf18 complex is currently unknown as it takes no part in 
the loading or unloading of PCNA (Bylund and Burgers, 2005). However, when Dcc1 
is mutated it shows the same phenotype as Ctf18 deletion strains. To determine if 
the C-terminus of Dcc1 was similar to any solved structures the co-ordinates of Dcc1 
were uploaded to the DALI server (Holm and Rosenström, 2010). The DALI server 
uses an algorithm that compares all known structures against the co-ordinates 
uploaded; it was hoped that uncovering structural homologues could help identify a 
function for the Dcc1 subunit. 
 
The results from the DALI server unexpectedly revealed that Dcc1 contained three 
tandem WH domains (Figure 4.3A and B). These domains have been called WH1, 
WH2 and WH3 which have the residue boundaries of 182-252, 253-318 and 319-
380 respectively. They were identified by having a high Z-score with WH containing 
proteins for instance WH1, WH2 and WH3 had scores of 5.7, 7.4 and 4.9 with PKZ 
(PDB ID: 4KMF), Cullin-1 (PDB ID: 3TDU) and DsrD (PDB ID: 1WQ2) respectively 
(Figure 4.3C). 
 
WH domains usually contain the secondary structure of a1-b1-a2-a3-b2-b3 (Harami 
et al., 2013). All of the identified WH domains have this morphology; however, in 
WH2 a3, b2 and b3 are partially disordered. This indicates they could be mobile or 
unstable in the crystal lattice, which could possible allow the C-terminus some 
flexibility permitting WH3 to exist in multiple geometries. 
 
The discovery that Dcc1 has multiple WH domains gives an indication for the 
potential role of this subunit. WH domains structurally have been conserved 
throughout evolution and perform a variety of functions throughout the cell (Harami 
et al., 2013). Many proteins use WH domains to interact with DNA substrates. For 
instance, the transcription factor HNF3g binds to dsDNA through the secondary 
structure elements a3, b2 and b3 of its WH domain. The use of these three structural 
features is generally conserved in the WH-DNA interactions (Harami et al., 2013). 
Other DNA binding WH domains can interact with a variety of other nucleotide 
substrates in either a sequence dependent or independent manner such as Z-DNA, 
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RNA hairpin structures, ssRNA and ssDNA. Alternatively, other WH domains are 
involved in protein-protein interactions like the cohesin subunit Scc1, which binds to 
Smc1 via a WH domain present at its C-terminus (Haering et al., 2004). From the 
above discussion it is probably that WH1, WH2 and WH3 participate in either protein-
protein interaction through binding to Ctf8, Ctf18 or an unknown protein partner, or 
Dcc1 could bind to a specific DNA substrate (See Chapter 5). 
 
The N-terminal region of Dcc1 in the crystal structure from residue 114-182 is folded 
and most likely acts as a linker to another domain. This part of Dcc1 did not show 
any clear results from the DALI server search. The residues 90-113 were 
unstructured in this crystal suggesting they could be unstable without the rest of the 
N-terminal region of Dcc1 or require the binding of another protein to form a stable 
structure. Furthermore, the results that Dcc1 was cleaved at residue 90 indicates that 
this part of Dcc1 is flexible. 
 
The determination of the structure of the C-terminal region of Dcc1 means a model 
is now available which could be used in molecular replacement for the 3.5 Å dataset 
collected on the Dcc1-Ctf818-133 crystals. However, due to the flexibility of both the N-
terminal region of Dcc1 and Ctf8 I was unable to determine any additional information 
on the interaction between Dcc1 and Ctf8. 
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Figure 4.3. Organisation of the Three WH Domains of Dcc1. 
A) Domain organisation of Dcc1. B) The localisation of the three WH domains on Dcc1. 
C) Structural alignments of the three WH domain containing proteins PKZ (PDB ID: 
4KMF, orange), Cullin-1 (PDB ID: 3TDU, blue) and DsrD (PDB ID: 1WQ2, green). 
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4.5 Crystallisation of Ctf18C-Dcc1-Ctf8  
To further investigate the Dcc1-Ctf8 sub-complex I firstly wanted to discover the 
structure of Ctf8 and secondly look at how the complex interacts with Ctf18. The co-
expression of the full RFCCtf18 complex has been previously carried out in budding 
yeast (Bylund and Burgers, 2005), and the authors were able to show that deletion 
of the last 80 residues of Ctf18 was enough to disrupt binding of the 5 subunit 
complex to the Dcc1-Ctf8 sub-complex. Therefore, it was suggested that the C-
terminus of Ctf18 acts a bridge between the core RFCCtf18 complex and the Dcc1-
Ctf8 sub-complex (Figure 4.4A). To fulfil both of the above aims I decided to form a 
heterotrimer through co-expressing Ctf18, Dcc1 and Ctf8. It was hoped this would 
result in a well expressed complex which could stabilise Ctf8 and the N-terminal 
region of Dcc1. The crystallisation of this heterotrimer would further provide 
information on the interaction between Ctf18 and the Dcc1-Ctf8 sub-complex. 
 
To design a stable complex a sequence alignment was carried out of Ctf18 from five 
organisms (Figure 4.4B). The results of this alignment indicated there was limited 
sequence conservation over the whole C-terminal region. However, the extreme C-
terminus, from residue 717 to 741, had high sequence conservation. As a result of 
this alignment, the three constructs Ctf18598-741, Ctf18539-741 and Ctf18666-741 were 
cloned into pET-28a with the addition of a His6 tag and TEV protease site. The 
vectors were transformed into E. coli for co-expression and purification with Dcc1 
and Ctf8 using the protocol presented in section 2.3. 
 
From the three Ctf18 constructs cloned only Ctf18666-741 expressed, indicating that 
the longer constructs were insoluble in solution, possible because they require the 
N-terminal region of Ctf18 to be folded correctly. Ctf18666-741 formed a heterotrimer in 
solution with Dcc1 and Ctf8, which was stable throughout the three-step purification 
procedure. The Ctf18666-741-Dcc1-Ctf8 complex (hereafter called Ctf18c-Dcc1-Ctf8) 
could be purified to a high standard and expressed at a level sufficient to be placed 
into crystal trials (Figure 4.5A). The protein was concentrated to 15 mgmL-1 and 
crystal trays were set up in a variety of commercially available screens. An initial hit 
in 0.1 M Bis-Tris propane pH 6.5, 0.2 M NaBr and 25 % PEG 3350 was identified, 
which diffracted to ~4 Å. To improve the resolution crystals were optimised by varying 
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the pH and precipitant concentration, which produced slightly better crystals. 
However, to further improve crystals quality larger drops of 4 µL were used along 
with an increased protein concentration of 35 mgmL-1. These crystals grew as thick 
plates to a size of ~700 µm (Figure 4.5B). The crystals were harvested after 10 days 
in 15 % ethylene glycol and stored in liquid nitrogen. Data was collected at Diamond 
Light Source on beamline I03, and the best crystal diffracted to 2.3 Å (Figure 4.5C). 
 
To solve the structure of Ctf18c-Dcc1-Ctf8 molecular replacement was carried out in 
Phaser using Dcc190-380 as a starting model (McCoy et al., 2007). AutoBuild (Adams 
et al., 2010) was used to trace an initial model after which, multiple rounds of 
rebuilding and refinement were carried out in Coot (Emsley and Cowtan, 2004) and 
Refmac5 (Murshudov et al., 2011) respectively. Full refinement and data collection 
statistics are shown in Table 2.6. 
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Figure 4.4. Construct Determination for Ctf18-Dcc1-Ctf8. 
A) Cartoon representation of the structure of RFCCtf18, Ctf18 (dark blue), Ctf8 (yellow) 
and Dcc1 (Red). B) Sequence alignment of the C-terminus of Ctf18 from yeast to humans. 
Arrows indicate the construct design for expression with the Dcc1-Ctf8 sub-complex. 
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Figure 4.5. Purification and Crystallisation of Ctf18C-Dcc1-Ctf8. 
A) Purification of Ctf18c-Dcc1-Ctf8. The SDS-PAGE shows the final step in the three-
step purification procedure. B) Optimised crystals of Ctf18c-Dcc1-Ctf8. C) Diffraction 
from optimised native crystals of Ctf18c-Dcc1-Ctf8. 
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4.6 Overall Structure of Ctf18c-Dcc1-Ctf8 
In the Ctf18c-Dcc1-Ctf8 heterotrimer the C-terminus of Dcc1 folds back towards its 
N-terminus making the structure look like a ‘hook’. The interaction domain consists 
of the N-terminus of Dcc1, Ctf8 and Ctf18c (Figure 4.6). The N-terminus of Dcc1 and 
Ctf8 make a large dimer interface which is formed from 18 intertwined b-strands and 
two a-helices. The heterodimer interface is well conserved (see Figure 4.8 in section 
4.7) with the formation of multiple antiparallel b-strands between Dcc1 and Ctf8. The 
number of interactions between Ctf8 and Dcc1 make it unlikely that Ctf8 can exist by 
itself in cells, and Dcc1 is probably required for the correct folding of Ctf8 both in vitro 
and in vivo. 
 
Ctf18c binds to the Dcc1-Ctf8 heterodimer interface as an extended peptide, forming 
an N-terminal antiparallel b-strand with Ctf8, and a partially buried C-terminal helix. 
This helix binds to a b-barrel like structure formed from antiparallel b-strands from 
both Dcc1 and Ctf8 (Figure 4.6). Interestingly, crystals formed from full length Dcc1 
and Ctf8 did not diffract strongly, indicating that the heterodimer is stabilised by 
Ctf18c. Residues 666-713 of Ctf18c are unstructured in this structure, suggesting they 
form a flexible linker to the RFC like domain of Ctf18. The C-terminus of Dcc1 is 
found in the same conformation as the Dcc190-380 structure, and is made 
predominantly from a-helices. 
 
To determine if the dimerisation motif found in the Dcc1-Ctf8 sub-complex has any 
structural homologs the co-ordinates of the heterotrimer were uploaded to the DALI 
server (Holm and Rosenström, 2010). The results indicated that the heterodimer 
interface is similar to four other proteins, which fold to form a ‘triple’ b-barrel structure. 
The four complexes identified were the three transcription factors Rap30/74 (Gaiser 
et al., 2000), Sfc1/7 (Taylor et al., 2013) and A49/34.5 (Geiger et al., 2010); as well 
as the trimer RNase H2 (Shaban et al., 2010) (Figure 4.7). The ‘triple’ b-barrel fold 
seems to be used as an architectural domain linking different domains of larger 
complexes. In addition, the Ctf18c-Dcc1-Ctf8 heterotrimer has the same modular 
organisation to the above transcription factors as they have this domain followed by 
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WH domains, which raises the possibility that the Dcc1-Ctf8 sub-complex evolved 
from a distant relative of one of these transcription factors. 
 
 
Figure 4.6. Structure of the Ctf18c-Dcc1-Ctf8 Heterotrimer. 
Ctf18 (dark blue), Ctf8 (yellow) and Dcc1 (red). The N- and C-terminus of the extended 
peptide of Ctf18c are indicated with ‘N’ and ‘C’ respectively. 
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Figure 4.7. Comparison of Known 'Triple' b-Barrel Complexes. 
Two of the three b-barrels are indicated in each complex. RNase H2 is formed from the 
three subunits RNase H2A (pink), RNase H2B (blue) and RNase H2C (yellow). The 
Rap30/74 heterodimer contains the subunits Rap30 (blue) and Rap74 (yellow). The 
A39/A34.5 heterodimer is made from the proteins A39 (yellow) and A34.5 (blue). The 
PDB codes are indicated in the figure. 
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4.7 Ctf18 Binds to Dcc1-Ctf8 as an Extended Peptide 
The C-terminal region of Ctf18 binds to a conserved groove that runs along the Dcc1-
Ctf8 heterodimer (Figure 4.8A), with Ctf18 making multiple contacts with both Dcc1 
and Ctf8. The N-terminus of Ctf18c makes an antiparallel b-strand with Ctf8 on the 
third barrel, with the residue E724 from Ctf18 forming a salt bridge with the conserved 
R128 of Ctf8. The extreme C-terminal a-helix of Ctf18 is partially buried in the first 
barrel of the heterodimer (Figure 4.8B). This first barrel forms a hydrophobic pocket, 
which is made from aromatic residues from both Ctf8 and Dcc1. W736 and W740 of 
Ctf18 interact with a range of hydrophobic residues from this barrel including the N-
terminal proline of Ctf8 which contacts W736 of Ctf18. Due to the importance of these 
two tryptophans of Ctf18 it is surprising that these residues are poorly conserved in 
an alignment between yeast to humans (Figure 4.4B). However, on closer inspection 
these residues are normally hydrophobic, suggesting the overall binding mechanism 
is likely to similar between all organisms. 
 
Work conducted in budding yeast supports the crystal structure of Ctf18C-Dcc1-Ctf8 
as, in vivo, mutating both W736 and W740 to alanine causes a dissociation of the 
Dcc1-Ctf8 sub-complex from RFCCtf18 in co-immunoprecipitation experiments 
(García-Rodríguez et al., 2015). In addition, these mutant strains have a sensitivity 
to hydroxyurea and a delayed activation of the DRC; shown by a reduced level of 
Rad53 phosphorylation, and these strains also have an increased defect in sister-
chromatid cohesion. Taken together, the above results indicate that W736 and W740 
are crucial for the stable binding of Ctf18 to Dcc1 and Ctf8.  
 
The mechanisms that RNase H2A contacts the RNaseH2B-H2C heterodimer is 
similar to the interaction between Ctf18C and the Dcc1-Ctf8 sub-complex (Figure 4.7). 
The C-terminus of RNase H2A binds across the ‘triple’ β-barrel structure like the 
extended peptide conformation of Ctf18 (Shaban et al., 2010). However, RNase H2A 
also makes a range of contacts with the side of the dimerisation domain. This is not 
observed in the Ctf18C-Dcc1-Ctf8 structure as residues 666-713 were unstructured 
in this structure. 
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Figure 4.8. Ctf18 Binds to a Conserved Groove on the Dcc1-Ctf8 Heterodimer. 
A) Structural conservation of Dcc1 and Ctf8, conserved residues (maroon) and 
unconserved residues (light green). Ctf18 is shown in dark blue. B) Surface view of the 
interaction between Ctf18 (dark blue) and Dcc1 (red)-Ctf8 (yellow). Left panel indicates 
the salt bridge formed from R126 and E724 from Ctf8 and Ctf18 respectively. Right panel 
shows the partially buried C-terminal helix of Ctf18. 
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Chapter 5. Biochemical Analysis of Ctf18C-Dcc1-Ctf8 
5.1 Analysis of the WH Domains of Dcc1 
WH domains are usually either involved in protein-protein interactions or bind to a 
variety of DNA substrates. Due to the location of RFCCtf18 at the replication fork it is 
likely that Dcc1 could contain additional DNA interacting sites. To determine if the 
WH domains of Dcc1 can bind DNA the surface conservation and charge were 
analysed (Figure 5.1). The results indicated that the surface of WH3 and WH2 were 
highly conserved (Figure 5.1B), and these regions corresponded to a highly basic 
patch when the surface charge of Dcc1 was studied (Figure 5.1C). Basic residues 
are usually involved in binding DNA as the backbone of DNA is highly negatively 
charged. The conserved basic residues found in WH3 were predominantly located 
on a3, b2 and b3, which is similar to other WH containing proteins that interact with 
DNA. This further supports the conclusion that Dcc1 can interact with DNA; however, 
additional biochemical clarification is required. 
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Figure 5.1. Surface Analysis of the WH Domains of Dcc1. 
A) Cartoon representation of the C-terminus of Dcc1 coloured as follows; linker region 
(red), WH1 (yellow), WH2 (green) and WH3 (blue). B) Surface conservation of the C-
terminus of Dcc1 in the same orientation as in (A). Conserved and unconserved residue 
are shown in maroon and light green respectively. C) Surface charge of the C-terminus 
of Dcc1 in the same orientation as in (A). Basic and acidic areas are shown in blue and 
red respectively. The dotted cycle indicates a conserved basic patch located on WH3 of 
Dcc1. 
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5.2 Dcc1 can Bind to Both ssDNA and dsDNA 
To further analyse if the WH domains of Dcc1 were able to interact with DNA an 
electrophoretic mobility shift assay (EMSA) was conducted (Figure 5.2A). Both 
ssDNA and dsDNA were kept at a constant concentration throughout the 
experiments with a fluorescently labelled tag located at the 5’ end of each substrate, 
and for dsDNA the tag was located on only one strand (see methods). The Dcc1 C-
terminal domain was titrated in at increasing concentrations, and samples were 
separated by native-PAGE. If Dcc1 bound to DNA a gel shift would be observed as 
Dcc1 would retard the DNA substrates in the gel. 
 
The results from the EMSA, surprisingly, indicated that the C-terminal domain of 
Dcc1 could bind to both ssDNA and dsDNA (Figure 5.2A). This was shown as both 
substrates were retarded in the gel by increasing concentrations of Dcc1. 
Furthermore, Dcc1 had a higher affinity for dsDNA compared to ssDNA, as more 
dsDNA was retarded in the gel. The smeary bands present in the native gel meant it 
was not possible to determine binding affinities for Dcc1 to ssDNA or dsDNA. 
 
To further clarify the interaction between Dcc1 and DNA five basic residues were 
identified, which were K326, K357, K364, K367 and R380 (Figure 5.2B). These 
residues were mutated to alanine and expressed and purified, along with a construct 
that contained a deletion of WH3 (Dcc1ΔWH3; residue 1-317) and full length Ctf8. The 
above mutated proteins were used in an EMSA to determine if they disrupted binding 
to DNA (Figure 5.3). As expected, Dcc1ΔWH3 completely abolished both ssDNA and 
dsDNA binding. In addition, mutations in K364A, R367A and R380A showed a mild 
reduction in both ssDNA and dsDNA binding (Figure 5.3), which suggests the binding 
site for ssDNA and dsDNA must overlap. To increase the effect of individual point 
mutation the triple mutation K364A, R367A and R380A was expressed and purified 
and the EMSA repeated. Together these mutation completely abolished DNA binding, 
which was equivalent to the Dcc1ΔWH3 deletion (Figure 5.3). 
 
On further analysis of the Dcc1ΔWH3 construct a small gel shift was observed with 
ssDNA but not dsDNA when a lower concentration of DNA was used and the gel was 
overexposed (Figure 5.4A and 5.4B). This suggests that WH1 and WH2 contribute 
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to ssDNA binding, which is enhanced in the presence of WH3. Unfortunately, a 
mutation in WH2/WH1 that reduced the affinity of Dcc1 to ssDNA could not be 
identified. 
 
 
Figure 5.2. DNA Binding of Dcc1. 
A) EMSA analysis of Dcc1 with both ssDNA and dsDNA. Dcc1 was titrated at increasing 
concentrations into a constant amount of either ssDNA or dsDNA. Both substrates were 
fluorescently labelled and the concentration of Dcc1 used in each sample is indicated 
above the gel. B) Sequence alignment of the C-terminus of Dcc1 from yeast to human 
arrows indicate the basic residues mutated. 
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Figure 5.3. DNA Binding of Mutant Dcc1. 
Mutant proteins were analysed against wild type protein for their effect on both ssDNA 
and dsDNA binding. The mutants used are indicated above the gel along with their 
concentrations. The bar charts below each gel were determined by analysing the amount 
of DNA that was not retarded compared to the control ssDNA and dsDNA. 
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Figure 5.4. ssDNA Binding of WH1 and WH2 of Dcc1. 
A) Analysis of WT and Dcc1ΔWH3 viewed at different voltages. The concentration of Dcc1 
is labelled above the gel. B) Dcc1ΔWH3 was titrated at increasing concentrations against 
a constant concentration of ssDNA and dsDNA. The concentration of Dcc1ΔWH3 is 
indicated above the gel. 
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5.3 Ctf18C-Dcc1-Ctf8 can Interact With Pol2 
Previous studies identified that RFCCtf18 was able to physically interact with 
polymerase-ε via pull down experiments, and this was shown to be conserved from 
yeast to humans (García-Rodríguez et al., 2015; Murakami et al., 2010; Okimoto et 
al., 2016). Furthermore, analysis using co-immunoprecipitation experiments 
revealed that the heterotrimer formed from Ctf18, Dcc1 and Ctf8 was required for the 
interaction with the N-terminal region of Pol2, which is the catalytic subunit of 
polymerase-ε (García-Rodríguez et al., 2015). 
 
From the above information and the structure of Ctf18C-Dcc1-Ctf8 solved in this 
thesis it is likely that Pol2 binds to the ‘triple’ β-barrel formed from Dcc1, Ctf8 and 
Ctf18. To test if this is the case, the in vitro interaction between the N-terminal region 
of Pol2 (residue 1-544) and Ctf18C-Dcc1-Ctf8 was analysed with the use of a glycerol 
gradient (Figure 5.5). As predicted, the results indicated that the N-terminal region of 
Pol2 could interact with the heterotrimer (Figure 5.5A and B). 
 
To further test if Ctf18 is required for the interaction with Pol2 the experiment was 
repeated with only the Dcc1-Ctf8 sub-complex (Figure 5.5B). The results revealed 
that the Dcc1-Ctf8 sub-complex could not interact with Pol2, which indicated the 
importance of the C-terminus of Ctf18 in binding Pol2. 
 
To determine if the three WH domains of Dcc1 contribute to the interaction with Pol2, 
the glycerol gradients were repeated with Ctf18C-Dcc1Δ3-Ctf8 and Ctf18C-Dcc1Δ2-3-
Ctf8 (Figure 5.5B). Unfortunately, Ctf18C-Dcc1Δ1-3-Ctf8 could not be expressed in E. 
coli and was not tested. Unexpectedly, the results revealed that both Ctf18C-Dcc1Δ3-
Ctf8 and Ctf18C-Dcc1Δ2-3-Ctf8 could not interact with the N-terminal region of Pol2, 
which suggested that WH3 of Dcc1 must also aid in binding Pol2. The above results 
implied that the N-terminus of Pol2 must bind across the trimerisation domain formed 
from Ctf18C, Dcc1 and Ctf8. 
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Figure 5.5. Glycerol Gradients Between Pol2 and Ctf18C-Dcc1-Ctf8 
A) The SDS-PAGE analysis of the glycerol gradients of the N-terminus of Pol2, Ctf18C-
Dcc1-Ctf8 (18C-1-8) and Dcc1-Ctf8 (1-8), Ctf18C-Dcc1Δ3-Ctf8 (18C-1 Δ3-8) and Ctf18C-
Dcc1Δ2-3-Ctf8 (18C-1 Δ2-3-8). B) The SDS-PAGE analysis of the glycerol gradients of Dcc1 
constructs with Pol2. The fraction number is presented above the gel. 
 
5.4 Dcc1 is Involved in the Recruitment of Ctf18 to Chromatin 
Work in this section has been conducted by both Dr. Catarina Samora and Hon Liu 
(see footnotes). 
 
Previous work indicated that cells have a delayed activation of S-phase checkpoints 
in hydroxyurea (HU) when Ctf18, Dcc1 or Ctf8 were deleted (Crabbé et al., 2010). 
The DRC is stimulated by an accumulation of ssDNA; therefore, I hypothesised that 
the WH domains of Dcc1 could be responsible for recruiting RFCCtf18 to sites of 
replication stress. To test this, ChIP-qPCR was conducted with an anti HA-antibody 
against HA-Ctf18 1  (the ChIP-qPCR was conducted by Dr. Catarina Samora; 
therefore, this method is not presented in this thesis). The amount of Ctf18 was 
measured at three early and one late firing replication origins. The late firing origins 
should be inhibited in HU and have a much lower amount of Ctf18 compared to the 
early firing origins. The results indicated that dcc1Δ cells had a significantly reduced 
level of Ctf18 at the early firing origins (Figure 5.6A). This result was also the same 
for Dcc1ΔWH3; although, this mutant did not fully replicate the dcc1Δ. This is 
unsurprising, as the Ctf18-Dcc1-Ctf8 heterotrimer interacts with polymerase-ε and 
could be recruited to stalled replication forks by multiple mechanisms. To check that 
Dcc1ΔWH3 was still stable the gel filtration profiles of both Ctf8-Dcc1 and Ctf8- 
Dcc1ΔWH3 were analysed (Figure 5.6B). The results indicated that Ctf8-Dcc1ΔWH3 was 
soluble, and as expected, its elution volume is slightly later than Dcc1-Ctf8 because 
Ctf8- Dcc1ΔWH3 has a lower molecular weight. 
 
To further analyse the effect of a deletion of WH3 on the DRC the sensitivity of dcc1Δ, 
Dcc1ΔWH3, Dcc1ΔWH2-3 and Dcc1ΔWH1-3 to HU was compared to WT cells2 (Figure 
                                               
1. ChIP-qPCR was carried out by Dr. Catarina Samora in Dr. Frank Uhlmann’s group. 
2. The sensitivity to HU, and the Rad53 phosphorylation assay was carried out by Hon Liu in Dr. Frank Uhlmann’s group. 
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5.7A). As expected all the deletions caused an increase in sensitivity to HU. 
Additional analysis was conducted by measuring the rate of Rad53 phosphorylation 
in HU, which is a method to measure the activity of the DRC (Figure 5.7B). The 
results indicated that all deletions caused a delay in Rad53 phosphorylation, which 
was similar to the dcc1Δ strain. This indicated an impaired checkpoint response. 
 
Taken together these results suggest that WH3 of Dcc1 has a role in recruiting 
RFCCtf18 to replication forks, either through binding directly to DNA or through its 
interaction with Pol2. In addition, all the WH domains of Dcc1 participate in 
checkpoint activation. 
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Figure 5.6. WH3 is Responsible for Localising RFCCtf8 to Replication Origins. 
A) The amount of Ctf18 present at replication origins was measured in HU-arrested cells. 
Three early firing origins (ARS605, ARS606 and ARS 607) were studied along with one 
late firing origin (ARS609). The analysis of Ctf18 was carried out by ChIP-qPCR with the 
use of an anti-HA antibody against HA-Ctf18. Three independent experiments were 
conducted and the means and standard errors plotted on the graph. B) Gel filtration 
profiles on a HiLoad 16/60 Superdex 75 column (GE healthcare) in 10 mM Tris 7.5, 150 
mM NaCl and 0.5 mM TCEP of the two sub-complexes: Ctf8-Dcc1 and Ctf8-Dcc1 ΔWH3. 
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Figure 5.7. Analysis on the Function of the WH Domain of Dcc1 in vivo. 
A) Spot assay in different hydroxyurea (HU) concentrations, at a 10-fold serial dilution. 
The cell strains and HU concentration used are indicated in the panel. B) Rad53 
phosphorylation was monitored in the cell lines indicated above the gel. In G1, cells were 
arrested and then released in 0.2 M HU. Samples were taken at the indicated time point. 
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Chapter 6. Structure of xEco2 ACT Domain 
6.1 Summary on the Function of Eco1 
Sister-chromatid cohesion is known to be established during S-phase. This occurs 
through the action of Eco1, which acetylates the cohesin subunit Smc3 at residue 
K112 and K113 (K105 and K106 in higher eukaryotes). In cells the acetylation of 
K113 is more important than K112 acetylation, with the latter being almost 
dispensable for sister-chromatid cohesion (Zhang et al., 2008). Acetylation of these 
tandem lysine residues antagonises the anti-establishment activity of Wapl and Pds5 
(Ben-Shahar et al., 2008). Recent work has suggested that acetylation of the tandem 
lysine motif negatively regulates the DNA induced hydrolysis of ATP by the head 
domain of cohesin (Murayama and Uhlmann, 2015). 
 
Eco1 has a C-terminal Gcn5-relate N-acetyltransferase (GNAT) domain, which is 
well conserved throughout evolution (Ivanov et al., 2002). The N-terminus of Eco1 is 
divergent in both length and composition; however, all homologues contain both an 
N-terminal C2H2 zinc finger (ZnF) motif and a PIP box. The ZnF enhances acetylation 
of cohesin in vivo but it is still unclear how the ZnF performs this function (Onn et al., 
2009). The N-terminal PIP box helps recruit Eco1 to the replisome via its interaction 
with PCNA (Moldovan et al., 2006). Apart from being spatially regulated, Eco1 is also 
degraded after S-phase through its ubiquitination by the combined action of Cdk-1 
and Cdc4 (Lyons and Morgan, 2011). 
 
Almost all eukaryotic organisms contain at least one copy of the gene encoding for 
Eco1 with functional specificity given by the varying N-terminus. For instance, the 
human genome contains two copies of Eco1 called human Eco1 (hEsco1) and 
human Eco2 (hEsco2). hEsco2 is the somatic acetyltransferase; mutations in this 
gene cause the genetic diseases SC Phocomelia and Roberts Syndrome. 
 
Not only can Eco1 acetylate the tandem lysine motif of Smc3 during S-phase, Eco1 
can also target Scc1 in response to a DSB (Heidinger-Pauli et al., 2009) and Eco1 
can auto-acetylate itself in vitro (Ivanov and Nasmyth, 2005). To improve our 
understanding on the specificity of Eco1 two in vitro acetylation assays were 
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developed. Firstly, the rate of K112 and K113 acetylation was monitored by MS, and 
secondly a substrate motif was generated from a list of Eco1 acetylated peptides 
identified from the in vitro acetylation of a range of cohesin subunits. To rationalise 
the results from the above two experiment the crystal structure of X. laevis Eco2 
(xEco2) acetyltransferase (ACT) domain was solved with two conjugated substrate 
peptides. Finally, the role of acetylation was investigated, in vitro, with the use of 
acetylation mimics to determine the impact on DNA binding. 
 
6.2 K112 Acetylation is Faster Than K113 Acetylation 
Work in this section has been conducted in collaboration with the Protein Analysis 
and Proteomics Platform at the Francis Crick Institute (see footnotes). 
 
The conserved tandem lysine residues of Smc3 become acetylated during S-phase. 
Previous genetic experiments discovered that K112 acetylation was less important 
than K113 acetylation (Zhang et al., 2008) as mutating K113R caused poor cell 
survival and increased chromosome mis-segregation, and K112R showed only a 
mild phenotype. To further understand the mechanism of Smc3 acetylation mass 
spectrometry (MS) was used in combination with an in vitro assay3 (Figure 6.1A). 
The MS analysis observed the abundance of the K112/K113 peptide 
(TVGLKKDDYQLNDR). Acetylation of K113 would block trypsin cleavage between 
K112/K113; therefore, to simplify the analysis before trypsin cleavage in gel reductive 
di-methylation was performed (Boersema et al., 2009). This meant trypsin could no 
longer cleave between the two lysine residues even if K113 was not acetylated. In 
this analysis a methylated lysine (me2K112 or me2K113) indicates that this lysine 
residue is not acetylated. 
 
The results from the MS analysis indicated that the abundance of me2K112me2K113 
decreased throughout the time course (Figure 6.1B). Furthermore, both the mono-
acetylated peptide AcK112me2K113 and the tandem acetylated peptide 
AcK112AcK113 increased throughout the experiment (Figure 6.1C and D). The 
mono-acetylated peptide me2K112AcK113 could not be identified in the MS analysis. 
                                               
3. MS was carried out in collaboration with the Protein Analysis and Proteomics Platform at the Francis Crick Institute. 
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To further improve the analysis MS/MS was conducted along with parallel reaction 
monitoring (PRM) and Q-Exactive mass spectrometry. The y9 peptide (Figure 6.2A) 
produced through the breakage between K112 and K113 could be observed in the 
resulting spectrum. For instance, at 25.5 minutes the AcK112me2K113 (1194.57, y9) 
peptide was observed in the spectrum but the me2K112acK113 (1208.55, y9) 
peptide could not be identified (Figure 6.2B and C). The above results suggest that 
K112 acetylation occurs at a faster rate than the acetylation of K113. 
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Figure 6.1. Analysis of the Acetylation of the Tandem Lysines of Smc3. 
A) Description of the in vitro acetylation assay using di-methylation to improve the 
analysis. B) Abundance of no acetylation (me2K112me2K113) recorded at each time 
point. C) Abundance of K112 and K113 (AcK112AcK113) acetylation at each time point. 
D) Abundance of K112 (AcK112me2113) acetylation at each time point. 
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Figure 6.2. Abundance of Peptide Fragments. 
A) The production of the y9 peptide in the MS/MS analysis through the breakage of the 
K112 and K113 peptide bond. B) Analysis of the abundance of different peptide ions, 
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AcK113 (1208.55) is shown in red C) Analysis of the abundance of different peptide ions, 
AcK112 (1194.57) is shown in red. 
 
6.3 Eco1 can Acetylate a Variety of Substrates 
Work in this section has been conducted in collaboration with the Protein Analysis 
and Proteomics Platform at the Francis Crick Institute (see footnotes). 
 
Apart from acetylating the tandem lysine motif of Smc3, Eco1 is also able to both 
self-acetylate itself in vitro (Ivanov et al., 2002) and acetylate Scc1 in response to a 
DSB (Heidinger-Pauli et al., 2009). Neither Eco1 or Scc1 contain a conserved 
tandem lysine motif; therefore, it could be hypothesised that Eco1 has a broad 
substrate motif. To test this further, cohesin and its accessory subunits were 
recombinant expressed (Scc2-Scc4, Smc1-Smc3-Scc1-Scc3, Pds5 and Wapl) and 
acetylated in vitro by Eco1 (Figure 6.3A). The resulting acetylated proteins were 
analysed by MS to produce a list of lysine residues which became acetylated4. A 
control for each protein was used to determine acetylation which was not due to Eco1. 
For instance, acetylation of the proteins could have occurred during expression or 
purification. 
 
The results from the MS analysis indicate that acetylated lysine residues were 
predominately flanked by an aliphatic (ϕ) and an acidic/polar (B/Z) residues. 
Furthermore, this motif occurred in either orientation suggesting Eco1 had a bi-
direction motif. To further investigate this, the peptides were separated into three 
groups: forward, reverse and no-direction (Appendix 3). The iceLogo server (Colaert 
et al., 2009) was then used to determine if there was an abundance of a specific 
amino acid. The following amount of peptides were used in each class; 36 forward 
peptides (ϕ-AcK-B/Z), 42 reverse peptides (B/Z-AcK-ϕ) and 27 peptides with no 
identifiable direction (X-AcK-P/R) (Figure 6.3A, B and C). The mixed direction group 
were usually flanked by a proline or arginine which indicated the b-hairpin 
conformation seen in the Smc3-Scc1N structure (Gligoris et al., 2014) is an important 
aspect of Eco1 specificity. 
                                               
4. MS was carried out in collaboration with the Protein Analysis and Proteomics Platform at the Francis Crick Institute. 
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Figure 6.3. Generation of a Consensus Motif for Eco1 Acetylation. 
A) Assay for analysis of in vitro acetylation of a range of cohesin subunits by Eco1. B) 
Analysis of peptides by the iceLogo server identified in the forward direction. C) Analysis 
of peptides by the iceLogo server identified in the reverse direction. D) Analysis of 
peptides by the iceLogo server identified with no direction. 
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6.4 Crystallisation of xEco2 ACT Domain 
Some work in this section has been conducted by Dr. Celine Bouchoux (see 
footnotes). 
 
To gain further insights into Eco1 specificity the crystal structure of Eco1 bound to its 
canonical substrate was determined. To do this X. laevis Eco2 acetyltransferase 
(xEco2 ACT) domain was cloned (residue 523-702) based on the hEsco1 structure 
(Figure 6.4). This protein, xEco2, was chosen as the coding sequence for the gene 
was readily available in the laboratory. The protein expressed well and purified to a 
mono-species using a three step purification procedure (Figure 6.4B). The activity of 
this purified enzyme was not tested in this thesis. 
 
The relative affinity of xEco2 to the head domain of cohesin was weak; therefore, to 
artificially increase the affinity two 13 residue peptides were synthesised with Ac-
CoA conjugated to either K105 (Ac-CoA-K105) or K106 (Ac-CoA-K106) by an 
isopropionyl bridge (K112 and K113 in S. cerevisiae) (Lau et al., 2000; Poux et al., 
2002) (Figure 6.4C and D). These peptides would mimic an intermediate binding 
state and help provide further evidence for the importance of the conserved tandem 
lysine motif (Figure 6.4E). 
 
To crystallise xEco2 ACT domain, the protein was concentrated to 15 mgmL-1. Initial 
crystal trials were conducted in a variety of commercially available screens with 
xEco2 alone or mixed with either conjugated peptide. Crystals of both xEco2 alone, 
Ac-CoA-K105 and Ac-CoA-K106 were obtained in variety of conditions (Figure 6.4F). 
xEco2 without peptide, Ac-CoA-K105 and Ac-CoA-K106 crystals diffracted to a 
maximum resolution of 3 Å, 2.4 Å and 1.9 Å respectively (Figure 6.4G). The three 
structures were solved by molecular replacement using either hEsco1 (Kouznetsova 
et al., 2016) or xEco2 ACT domain as a search model in Phaser (McCoy et al., 2007). 
An initial model was traced in AutoBuild (Adams et al., 2010) and multiple rounds of 
rebuilding and refinement were carried out in coot (Emsley and Cowtan, 2004) and 
Phenix.Refine (Adams et al., 2010) respectively. Full crystallographic statistics for 
data collection and refinement are given in Table 2.7, 2.8 and 2.9. 
 
Chapter 6. Structure of xEco2 ACT 
 
121 
 
 
Figure 6.4. xEco2 ACT Expression and Crystallisation. 
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A) Secondary structure of xEco2. The ZnF and ACT domains are shown in blue and pink 
respectively. B) SDS-PAGE analysis of the final purity of xEco2 ACT domain in the third 
purification step. C) Peptide Ac-CoA-K105. Ac-CoA is conjugated to K105 of Smc3. D) 
Peptide Ac-CoA-K106. Ac-CoA is conjugated to K106 of Smc3. E) Sequence alignment 
of Smc3 target motif from yeast to humans. F) Crystallisation of xEco2 ACT. G) 
Diffraction of xEco2 ACT crystals at Diamond Light Source on beamline I02. 
 
6.5 Overall Structure of xEco2 ACT Domain 
xEco2 ACT domain forms a globular structure resembling the GNAT family, which is 
made from three α-helixes and seven β-strands (Figure 6.5). xEco2 ACT domain 
forms a structure with two globular regions termed the N- and C-lobe. CoA binds 
between these two domains interacting predominantly with β5 of the N-lobe and α3 
of the C-lobe. The N-lobe is formed from β1, β2, α1, α2, β3, β4 and β5 (Figure 6.5); 
between β4 and β5 a conserved Eco1 specific insertion forms an extended β-hairpin 
structure. This hairpin structure is also seen in the human structure of hEsco1. The 
C-lobe contains α3, β6 and β7 as well as a C-terminal extension (C-extension), which 
undergoes conformational rearrangements depending on the substrate bound (see 
below). The two peptides interact in different conformations with xEco2; however, 
both peptides bind predominantly to the β-hairpin and C-extension. 
 
The overall electron density of both peptides is of good quality. However, the density 
for peptide Ac-CoA-K105 is significantly better than Ac-CoA-K106 as for Ac-CoA-
K106 side chain density can be seen for most residues (Figure 6.6) but for Ac-CoA-
K105 only strong density for the peptide backbone could be observed (Figure 6.6A). 
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Figure 6.5. Overall Structure of xEco2 Bound to two Substrate Peptides. 
A) The crystal structure of xEco2 ACT domain without peptide bound. The colouring is 
as follows; N-lobe (pink), C-lobe (orange), b-hairpin (blue), C-extension (green) and CoA 
(red). B) Crystal structure of xEco2-Ac-CoA-K105. The colouring is the same as in (A) 
and the peptide is shown in yellow. C) Crystal structure of xEco2-Ac-CoA-K106. The 
colouring is the same as in (B). 
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Figure 6.6. Peptide Density for Both K105 and K106 Crystal Structures. 
A) Crystal structure of xEco2-Ac-CoA-K105 showing the electron density of a 2Fo-FC 
map of Ac-CoA-K105.The colouring is as follows; xEco2 ACT (pink) peptide (yellow), 
CoA (red) and 2Fo-Fc map (blue). B) Crystal structure of xEco2-Ac-CoA-K106 showing 
the electron density of a 2Fo-FC map of Ac-CoA-K106.The colouring is the same as in 
(A). Both maps are contoured to 1 σ. 
 
Chapter 6. Structure of xEco2 ACT 
 
125 
 
6.6 xEco2 Uses a Conserved Glutamate as a Catalytic Residue 
The authors of a previous study suggested that hEsco1 acetylates its targets using 
substrate assisted catalysis (Kouznetsova et al., 2016). They rationalised that a 
conserved aspartate on Smc3 acted as a general base for nucleophilic attack on the 
tandem lysine motif. This was supported by the observation that hEco1 was missing 
a conserved glutamate on b5 at residue 768, which is mutated to a conserved glycine 
in all Eco1 homologues. However, carrying out a structural alignment with xEco2 
ACT and PCAF, a GNAT family member, shows that although the glutamate on b5 
is missing the conserved E594 of xEco2 on b4 is in a related position. PCAF uses 
E570 as a general base for nucleophilic attack towards the target lysine; therefore, it 
could by concluded that E594 of xEco2 carries out the same function as this residue 
is only 0.1 Å further away from the substrate (Figure 6.7A). In addition, D107 of Smc3 
in Ac-CoA-K106 forms crucial contacts with the b-hairpin  indicating it is unlike to 
function in the catalytic mechanism. Taken together the above arguments suggests 
that hEsco1 and xEco2 do not operate by substrate assisted catalysis. 
 
Previous work has also identified that hEsco1 ACT domain crystallises and behaves 
in solution as if it is a dimer (Kouznetsova et al., 2016). This dimer is formed from 
multiple contacts between both b-hairpins. However, xEco2 ACT domain crystallises 
with both conjugate peptides in a different conformation from hEsco1 raising the 
possibility that xEco2 does not form a dimer in solution. To test this, size exclusion 
chromatography and multi-angle laser light scattering (SEC-MALLS) was employed. 
The results indicated that xEco2 ACT domain behaves as a monomer in solution 
(Figure 6.7B) as xEco2 ACT domain had a calculated mass of 25.5 kDa, which is 
similar to its predicted mass of 21.8 kDa. The addition of Ac-CoA-K106 (2.5 kDa) to 
xEco2 increased the observed mass to 26.7 kDa suggesting the peptide did not 
change the oligomeric state of xEco2. The above results reveal that xEco2 ACT 
domain is a monomer in solution, which is different from hEsco1. 
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Figure 6.7. Structural Alignment of xEco2 with PCAF 
A) Crystal structure of xEco2-Ac-CoA-K106 (pink) aligned with human PCAF (blue). 
E594 of xEco2 and E570 of PCAF are shown in stick representation. Ac-CoA-K106 
peptide is shown in yellow and CoA is shown in red. Distances between the lysine and 
the glutamate residue are indicated in black. B) Analysis of the oligomeric state by SEC-
MALLS of xEco2 ACT domain alone (red) and with Ac-CoA-K106 (blue). The masses of 
both peaks are indicated in kDa. 
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6.7 xEco2 Binds to the two Peptides in Different Conformations 
All Eco1 homologues contain a range of conserved structural features, which are 
important for the interaction with Smc3 (Figure 6.8) such as the β-hairpin, C-
extension and a hydrophobic pocket. The two peptides use different binding 
mechanisms to xEco2 ACT domain which, suggests their relative kinetics could be 
distinct. In addition, the Ac-CoA-K105 structure has weaker electron density than Ac-
CoA-106 (Figure 6.6A and B), which implies that Ac-CoA-K105 has a weaker affinity 
to xEco2 than Ac-CoA-K106. Ac-CoA-K105 forms a b-hairpin structure, with position 
-1 (P-1) to P-4 from the conjugated lysine forming an anti-parallel b-sheet with the C-
extension of xEco2 (Figure 6.9A). The unlinked lysine at P+1 in this structure 
interacts with D677 and W623 via a salt bridge and hydrogen bond respectively. The 
salt bridge interaction between D677 and K106 suggests the importance of having a 
basic residue at P+1 in the peptide motif identified with no direction (Figure 6.3D). 
Furthermore, a hydrophobic interaction was observed between I102 and V702 from 
the peptide (P-3) and xEco2 respectively. Further interactions were seen between 
L562 and F564 of xEco2 and the conjugated K105, which also form the base of the 
CoA binding pocket. 
 
The Ac-CoA-K106 peptide forms an extended b-conformation when it is bound to 
xEco2 ACT (Figure 6.9B), which is similar to how the corresponding residues look in 
the Smc3-Scc1N crystal structure (Gligoris et al., 2014). The relative position of 
xEco2 on the Smc3 peptide has changed by 180 ° when comparing the two peptides. 
Ac-CoA-K106 binds to xEco2 ACT through multiple interaction with the second 
strand of the b-hairpin. In addition, key interactions were found between the two 
loops at the C-terminus of a1 and between the loop connecting a3 and b6. Like the 
other peptide structure L562 and F564 of xEco2 interact with CoA at the base of its 
binding pocket. However, these residues also bind through their aliphatic moieties to 
K105 and A104 at P-1 and P-2 respectively, from the conjugated lysine (K106). The 
residue D107 of the Smc3 peptide at P+1 interacts with xEco2 via a hydrogen bonds 
with the indole side chain of W623. In addition, D107 also forms a salt bridge with 
R621 of xEco2. Taken together these results support the peptide motif analysis, 
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which shows that Eco1 required P+1 to be acidic or polar, and both P-1 and P-2 to 
be aliphatic (Figure 6.3B and C). 
 
The strong interaction between xEco2 and Ac-CoA-K106 is further supported by the 
binding of Y109 from the Smc3 peptide to a hydrophobic pocked formed from V602 
of the C-extension; W623 and C625 from the b-hairpin; and V697 from b7 (Figure 
6.9B). Destabilising this hydrophobic pocket by mutating both W192A and M193A in 
yeast, which correspond to W623 and C625 respectively in xEco2 causes a reduction 
in viability of yeast cells and an abolishment of Smc3 acetylation5 (Figure 6.9C and 
D). Deleting the b-hairpin (yeast 189-198) also showed the same phenotype, which 
indicates the importance of both structural features (Figure 6.9C and D). 
 
6.7.1 Roberts syndrome and yeast temperature sensitive mutations 
Previous work has identified that the yeast temperature sensitive mutation G211D 
caused an increase in chromosome mis-segregation (xEco2; G635). Mutating G635 
on xEco2 would disrupt CoA binding reducing the activity of this enzyme. This is 
supported by the reduction in viability and loss of the acetylation of Smc3 (Figure 
6.9C and D) when the mutation G211D on Eco1 was introduced to yeast cells. In 
addition, the residue corresponding to the Roberts syndrome mutation in xEco2 
(xEco2 W640; hEsco1 W639G; Eco1 W216G) would disrupt the integrity of the ACT 
domain. This was reinforced by the results in yeast cells, which show mutating 
W216G causes yeast cells to have a lower viability and a reduction in the acetylation 
of Smc3 (Figure 6.9C and D). 
 
6.7.2 Rearrangement of C-extension upon substrate binding 
When xEco2 is bound to Ac-CoA-K105, the peptide forms a b conformation with the 
C-extension of xEco2 (Figure 6.10A). This means the C-extension is in the same 
conformation for both the peptide free and Ac-CoA-K105 structures (Figure 6.10). 
However, upon binding Ac-CoA-K106 the C-extension is displaced and flips almost 
180 ° (Figure 6.10B and C). This extreme movement is caused by the displacement 
                                               
5. Yeast in vivo work (Figure 6.9C and D) was carried out by Dr. Celine Bouchoux in Dr. Frank Uhlmann’s group. 
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of F700 by Y109 at P+2. The change in C-extension confirmation upon substrate 
binding is similar to the activation of Cdks, which undergo T-loop switching (Morgan, 
1997). 
 
The difference in substrate binding of K105 and K106 (K112 and K113 in yeast) to 
xEco2 ACT domain could explain the difference in the rates observed in the MS 
experiments. For instance, upon binding K106 the conserved phenylalanine has to 
be displaced by the tyrosine at P+2, which could be kinetically unfavourable. 
However, upon binding K105 the C-extension maintains the same conformation, 
possible making this substrate more favourable. 
 
6.7.3 Docking of both xEco2 substrate structures onto Smc3 
The peptide confirmation observed in Ac-CoA-K105 and Ac-CoA-K106 structures 
are similar to the corresponding regions in the Smc3-Scc1N structure (Gligoris et al., 
2014). This further provides evidence that the two peptide structures observed in this 
thesis are likely to be correct. In addition, it permitted the docking of xEco2 ACT 
domain onto the yeast structure of Smc3 in two positions (Figure 6.11A and B). The 
structural analysis reveal that switching from K105 to K106 causes Eco1 to rotate as 
it translates along the b-hairpin of Smc3. 
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Figure 6.8. Sequence Alignment of Eco1 From Yeast to Humans. 
Structural features are identified above the sequence alignment with the colouring as 
follows N-lobe (pink), b-hairpin (dark blue), C-lope (orange) and C-extension (green). 
Key conserved residues are indicated throughout the sequence alignment. In blue are 
residues important for binding CoA. In pink shows the conserved catalytic resides. In 
yellow are shown the residues that form the hydrophobic pocket, crucial for substrate 
binding. In red, the conserved glycine and tryptophan are shown, which are found 
mutated in a yeast temperature sensitive strain and Roberts syndrome respectively. In 
green, are additional basic residues important for substrate binding. In brown is the 
conserved aromatic residue found in the C-extension. 
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Figure 6.9. Difference in Binding Between the Peptides to xEco2. 
A) Structure of xEco2 ACT domain bound to Ac-CoA-K105 with key residues shown in 
stick representation. The colouring is as follows N-Lobe (pink), C-lobe (orange), b-hairpin 
(blue), C-extension (green), CoA (red) and peptide (yellow). B) Structure of xEco2 ACT 
bound to Ac-CoA-K106 with key residues shown in stick representation. The colouring 
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is the same as in (A). C) Analysis of the survival of yeast in Eco1 mutations strains using 
a spot assay. Mutations are indicated in the panel. D) Analysis of acetylation of Smc3 by 
Eco1 mutations in vivo using a western blot. Mutations are indicated above the gel. 
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Figure 6.10. C-Extension Moves Upon Binding K106. 
A) Orientation of the peptide, Ac-CoA-K105, on the surface of xEco2 ACT. Unconserved 
and conserved residues are shown in light green and maroon respectively. CoA and the 
peptide are shown in red and yellow respectively. B) Orientation of the Ac-CoA-K106 
peptide on the surface of xEco2 ACT. Colouring is the same as in (A). C) Comparison of 
the movement of the C-extension in the peptide free xEco2 ACT (red), Ac-CoA-K105 
(green) and Ac-CoA-K106 (blue). 
 
Chapter 6. Structure of xEco2 ACT 
 
134 
 
 
Figure 6.11. Docking of xEco2 Onto Smc3 
A) Ac-CoA-K105 (green) structure is docked onto the Smc3(orange)-Scc1N (pink) 
structure (PDB: 4UX3). In red is shown the peptide-Ac-CoA conjugate. B) Ac-CoA-K106 
(blue) structure is docked onto the Smc3 (orange)-Scc1N (pink) structure (PDB:.4UX3). 
In red is shown the peptide-Ac-CoA conjugate. 
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6.8 Acetylation Does not Impact Pds5 Binding 
During S-phase the tandem lysine motif of Smc3 becomes acetylated. This post-
translation modification causes the establishment of sister-chromatid cohesion 
through antagonising the releasing activity of Wapl and Pds5. Although the role of 
acetylation is well understood, how it affects the realising activity of Wapl and Pds5 
is not. It could be hypothesised that acetylation blocks Wapl and Pds5 binding to 
Smc3. To test this, the human cohesin head domain (hsCohd) with acetylation mimic 
(K105Q and K106Q) was recombinantly expressed in insect cells along with human 
Pds5 (hsPds5). Both proteins were purified using a standard three step procedure 
and purified proteins were mixed in equi-molar ratios and loaded onto a pre-
equilibrated gel filtration column. The results show that mutant hsCohd could still 
interact with Pds5 shown by the co-migration of Pds5 and hsCohd (Figure 6.12A and 
B). This results suggested that the acetylation of Smc3 does not change the affinity 
of Pds5 to cohesin. 
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Figure 6.12. Pds5 Binds to Acetylated hsCohd. 
A) Gel filtration absorbance profiles for mutant hsCohd (hsQQ) (green), human Pds5 
(red) and both hsQQ and pds5 (purple) mixed in an equi-molar ratio on a pre-equilibrated 
Superdex S200 10/300 GL column (GE Healthcare). B) SDS-PAGE analysis was 
conducted on the absorbance peaks from the three gel filtration experiments. 
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6.9 Acetylation Reduces DNA Binding 
The release of cohesin from DNA requires the hydrolysis of ATP by the head domain 
of cohesin, which is stimulation by Wapl, Pds5 and DNA (Murayama and Uhlmann, 
2015). The acetylation of Smc3 at K112 and K113 (K105 and K106 in higher 
eukaryotes) reduces the rate of stimulated ATP hydrolysis (Murayama and Uhlmann, 
2015). Therefore, it has been suggested that the tandem lysines of Smc3 could act 
as DNA sensors (Murayama and Uhlmann, 2015). To better understand the 
interaction between DNA and cohesin an atomic model of the head domain of 
cohesin bound to DNA was made using the DNA-Rad50 structure as a model 
(Rojowska et al., 2014) (Figure 6.13A). The analysis supports the idea that DNA is 
in close proximity to a range of conserved basic residues found on the coiled-coil of 
Smc3; more importantly, K112 and K113 of Smc3 would also contact DNA.  
 
To test if the tilted model of DNA binding is correct WT human head domain was 
purified along with the two Smc3 mutants K105R/K106R (RR) and K105Q/K106Q 
(QQ) (Figure 6.13B). The purified complexes were titrated against a constant 
concentration of DNA and an EMSA experiment was carried out (Figure 6.13C). The 
results indicate that the QQ complex had a reduced affinity for DNA compared to WT 
and RR head domain complexes. This suggests that acetylation of Smc3 reduces 
the affinity of the head domain to DNA, which supports the binding model presented 
in Figure 6.13A. 
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Figure 6.13. Acetylation Reduces DNA Binding of hsCohd. 
A) Atomic model for the binding of DNA to the head domain of cohesin. The colouring is 
as follows: Smc3 (orange), Smc1 (blue), N-Scc1 (pink), C-Scc1 (red) and dsDNA 
(orange). The tandem lysine motif is indicated in stick representation. B) SDS-PAGE 
analysis of the three head domain complexes. C) The EMSA experiment conducted with 
the three human head domain complexes. DNA was kept at a constant concentration 
and the protein was titrated at the concentration indicated above the gel. 
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Chapter 7. Discussion 
Directly after DNA replication sister-chromatids are held together until the onset of 
anaphase by a protein complex known as cohesin. The early loss of cohesion 
between chromatids causes chromosome mis-segregation. Therefore, cells have 
developed complex regulatory systems to help control cohesion throughout the cell 
cycle. This ‘cohesion cycle’ can broadly be split into four stages: loading, anti-
establishment, establishment and release. 
 
During G1, cohesin is loaded onto chromatin by a protein complex formed of two 
proteins called Scc2/4 (Ciosk et al., 2000). At this point, cohesion between sister-
chromatids is not established due to the anti-establishment activity of Pds5 and Wapl 
(Kueng et al., 2006). After S-phase, sister-chromatid cohesion becomes established 
with the passage of the replication fork due to the acetyltransferase called Eco1 
(Ben-Shahar et al., 2008). This protein acetylates Smc3 at K112 and K113, of the 
cohesin complex, which antagonises the releasing activity of Pds5 and Wapl. Apart 
from Eco1, numerous other non-essential establishment factors exist; such as Chl1, 
RFCCtf18, Tof1, Ctf4 and Mrc1. All of these factors, apart from Chl1 and Ctf4, aid in 
establishment of sister-chromatid cohesion by Eco1. Chl1 and Ctf4 function in a 
poorly understood Eco1 independent establishment pathway (Borges et al., 2013). 
After the establishment of sister-chromatid cohesion, cohesin topologically holds 
sister-chromatids together until the onset of anaphase; at which point, a protein 
called separase becomes active (Uhlmann et al., 2000). Separase cleaves the Scc1 
subunit of cohesin; breaking the ring structure and allowing the release of chromatin 
from cohesin’s embrace. 
 
In this thesis the aim was to improve our understanding of the establishment factors 
involved in sister-chromatid cohesion. I focused on two proteins, the key 
establishment factor Eco1 and the non-essential RFCCtf18 complex. In addition to its 
role in sister-chromatid cohesion, RFCCtf18 also functions in the DNA damage 
response checkpoint (DRC). RFCCtf18 is also the only RFC like complex which is 
formed of seven subunits as it contains the two non-Rfc subunits called Dcc1 and 
Ctf8. This stable sub-complex takes no part in the loading or unloading of PCNA. 
Therefore, I hypothesised that Dcc1 and Ctf8 must have a regulatory role. I was able 
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to solve the structure of the Dcc1-Ctf8 sub-complex with the C-terminus of Ctf18, 
which gave novel insights into the role of Dcc1. Furthermore, I was able to solve the 
structure of the C-terminal acetyltransferase domain (ACT) of xEco2 bound to its two 
conical substrate peptides. This revealed structural insights into how Eco1 is able to 
target and acetylate both tandem lysine residues of Smc3. In addition, biochemical 
experiments were conducted to determine the effect acetylation had on the head 
domain of cohesin. In this chapter the discussion will firstly focus on the results 
relating to RFCCtf18. 
 
7.1 Structure of the Ctf18c-Dcc1-Ctf8 Heterotrimer 
The RFCCtf18 complex is formed of seven subunits and has roles in both sister-
chromatid cohesion and the DRC (Mayer et al., 2001; Pan et al., 2006). The core 
RFC like complex is formed from Ctf18 and Rfc2-5 (Mayer et al., 2001). Unique to 
this complex is the additional requirement for two non-Rfc subunits called Dcc1 and 
Ctf8. These proteins form a stable sub-complex in vitro and cause the same genetic 
effect as a Ctf18 deletion. Previous research has revealed that Dcc1 and Ctf8 take 
no part in the loading or unloading of PCNA from chromatin, which suggests this sub-
complex has a regulatory role (Bylund and Burgers, 2005). To further understand the 
function of the Dcc1-Ctf8 sub-complex I crystallised the C-terminal region of Dcc1 
alone; and Dcc1 and Ctf8 bound to the C-terminal region of Ctf18 (Ctf18C). 
 
The results, unexpectedly, revealed that the C-terminal region of Dcc1 is formed of 
three tandem winged helix (WH) domains, which I have called WH1, WH2 and WH3 
in this thesis. The organisation of these three WH domains in a tandem conformation 
is novel and to my knowledge not observed in any previously solved structures. 
Usually, WH domains are involved in protein-protein interaction or DNA-protein 
interactions (Harami et al., 2013), which suggests a possible function for these 
domains. To test whether Dcc1 could interact with DNA an EMSA experiment was 
conducted, which indicated that Dcc1 was able to bind to both ssDNA and dsDNA. 
Mutating conserved basic residues in the C-terminal region of Dcc1 revealed that the 
binding site for ssDNA and dsDNA overlapped as mutations blocked both ssDNA 
and dsDNA binding to the same extent. The majority of the affinity for Dcc1 to both 
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ssDNA and dsDNA was given by WH3. However, further analysis showed that both 
WH1 and WH2 aided the binding of ssDNA but not dsDNA. 
 
The structure of the Ctf18c-Dcc1-Ctf8 heterotrimer revealed that Dcc1 and Ctf8 
interact to produce a large dimer interface, which forms a fold resembling the triple 
b-barrel structures previously identified in the three transcription factors Rap30/74 
(Gaiser et al., 2000), Sfc1/7 (Taylor et al., 2013) and A39/A34.5 (Geiger et al., 2010); 
and the heterotrimer RNase H2 formed of RNaseH2A, RNase H2B and RNase H2C 
(Figiel et al., 2011). Much like Ctf18c, the C-terminal region of RNase H2A binds 
across the dimer formed from RNase H2B and C. The structural similarities of Ctf18c-
Dcc1-Ctf8 with the transcription factors also extends to them sharing a similar 
modular organisation. These transcription factors also use this dimerisation domain 
to link a larger complex to DNA binding motifs; most of which are able to bind to both 
ssDNA and dsDNA. This raises the interesting possibility that Dcc1 and Ctf8 evolved 
from a distant relative of one of these transcription factors. Previous work supports 
the model for Ctf18 binding to the Dcc1-Ctf8 heterodimer like an extended peptide 
as mutating both W736 and W740 causes a disruption in the formation of the 
heterotrimer (García-Rodríguez et al., 2015). These key tryptophan residues bind as 
a partially buried a-helix in the first b-barrel of the heterodimer interface. 
 
RFC like complexes usually interact with a range of DNA substrates through a variety 
of Rfc subunits (Gomes et al., 2001). The addition of an extra DNA binding domain 
at the C-terminal region of Dcc1 in the RFCCtf18 complex raises the intriguing 
possibility that Dcc1 plays a vital role in the regulation of this complex. This 
hypothesis was confirmed with the discovery that deleting WH3 of Dcc1 drastically 
reduced the amount of Ctf18 at stalled replication forks. However, the results did not 
fully replicate a dcc1D as in this strain less Ctf18 was present at stalled replication 
forks compared to the WH3 deletion. This results suggests that RFCCtf18 could be 
recruited by multiple mechanisms. It is interesting that WH3 also supports the 
interaction with Pol2, a subunit of polymerase-e. This makes it difficult to conclude 
whether the recruitment of RFCCtf18 by Dcc1 is through direct interaction with DNA or 
through binding Pol2. Furthermore, the in vivo data indicated that deleting WH3 
caused a delay in Rad53 phosphorylation and a reduced cell survival in HU 
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supporting the hypothesis that the WH domains of Dcc1 play a regulatory role on the 
RFCCtf18 complex. 
 
The availability of a structure of PCNA bound to RFCRfc1 (Bowman et al., 2004) 
permitted the docking of Ctf18C-Dcc1-Ctf8 to Rfc1, which created a speculative 
model for the full RFCCtf18 complex (Figure 7.1). The model was made based on the 
bacteria g clamp loader complex, which is also formed of seven subunits (Simonetta 
et al., 2009). The core complex is formed from three g subunits, one d subunit and 
one d’ subunit. It also has a stable sub-complex associated with it, which is formed 
from the two subunits, y and c. This stable sub-complex does not show any structural 
similarities to the Dcc1-Ctf8 heterodimer. However, like RFCCtf18 the core g complex 
is able to load the bacterial clamp onto DNA without the accessory subunits. The y-
c sub-complex is involved in recruiting the g complex to DNA through its interaction 
with single-stranded binding protein (SSB), which is a homologue to eukaryotic RPA 
(Gulbis et al., 2004). It is therefore likely that the Dcc1-Ctf8 sub-complex plays a 
similar role in recruiting RFCCtf18 to chromatin through its interaction with Pol2 and 
DNA. 
 
In the g complex the accessory subunits are believed to be positioned behind the 
collar region of the core complex (Simonetta et al., 2009). Therefore, it is likely that 
the Dcc1-Ctf8 sub-complex will be in the same orientation. This places the WH 
domains of Dcc1 close to the ssDNA leaving the collar region of the core RFC 
complex (Figure 7.1A and B). If the Dcc1-Ctf8 sub-complex was flipped 180 ° it would 
interfere with the loading or unloading of PCNA making this geometry unlikely. 
 
Pol2 binds to the surface of the Ctf18C-Dcc1-Ctf8 complex (Figure 7.1); however, it 
is difficult to predict how the full eight subunit complex will look as the analysis of the 
interaction by glycerol gradients indicates that Pol2 binds to the b-barrel region and 
to the WH domains. Placing the Dcc1-Ctf8 sub-complex behind the collar region will 
likely position the polymerase in close proximity to the primer-template junction. 
 
The position of RFCCtf18 at stalled replication forks along with the suggestion that the 
DRC is activated by a build-up of ssDNA indicates that the target for the WH domains 
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of Dcc1 is likely to be primed-ssDNA or ssDNA. However, the results presented in 
this thesis imply that primed-ssDNA or ssDNA did not have a higher affinity than 
dsDNA. It is possible that substrate specificity is given through its interaction with 
polymerase-e. 
 
In conclusion, I have solved the structure of the Ctf18c-Dcc1-Ctf8 heterotrimer, which 
has revealed that the C-terminal region of Dcc1 contains three WH domains. These 
WH domains function in binding both ssDNA and dsDNA and are involved in 
recruiting the complex to stalled replication forks. 
 
 
Figure 7.1. Predicted Structure of RFCCtf18. 
A) Model for the RFCCtf18 complex. The colouring is as follows; PCNA (blue), Ctf18 
(orange), Rfc2-5 (Red), Ctf18C (purple), Dcc1-Ctf8 (green) and DNA (black). The position 
of the WH domains of Dcc1 are labelled in the figure. The black dotted line indicates the 
Pol2 binding region. B) Model for the RFCCtf18 complex based on the RFCRfc1 crystal 
structure and the Ctf18C-Dcc1-Ctf8 crystal structure. Colouring is the same as in (A). 
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7.2 Structural and Biochemical Analysis of Eco1 
Eco1 is the key establishment factor in sister-chromatid cohesion. It was first 
discovered to be an essential gene which did not form part of the core cohesin 
complex (Toth et al., 1999). Later it was found to contain a C-terminal GCN5-related 
N-acetyltransferases (GNAT) domain and an N-terminal C2H2 zinc finger motif (ZnF) 
(Ivanov et al., 2002). The N-terminus of Eco1 is divergent in both length and 
composition and is thought to provide species specific roles. During S-phase, Eco1 
is recruited to the replication fork through its interaction with PCNA via a conserved 
PCNA interaction motif or PIP box (Moldovan et al., 2006). Eco1 is then able to 
acetylate cohesin on K112 and K113 (K105 and K106 in higher eukaryotes) of the 
Smc3 subunit, which antagonises the action of Pds5 and Wapl (Ben-Shahar et al., 
2008). In addition, Eco1 is able to acetylate Scc1 at K84 during a DSB and auto-
acetylate itself in vitro (Heidinger-Pauli et al., 2008; Ivanov and Nasmyth, 2005). 
 
To gain further insight into how Eco1 is able to target the tandem lysine motif I firstly 
designed a series of in vitro assays coupled to mass spectrometry (MS). The results 
from these experiments indicated that K112 acetylation is faster and, possibly, 
facilitates the slower acetylation of K113. In addition, I identified a bi-directional 
peptide motif, which showed the target lysine was flanked by an aliphatic and 
basic/polar residue. To further support the above MS analysis, I solved the structure 
xEco2 ACT domain bound with two conjugated substrate peptides. Finally, the role 
of acetylation was investigated with the in vitro reconstitution of the head domain of 
cohesin. 
 
The discovery that Eco1 acetylates K112 before K113 could suggests that the basic 
side chain of K112 needs to be neutralised by an acetyl group before Eco1 can bind 
and acetylate K113. However, previous genetics would disagree with this argument 
because of two observations (Zhang et al., 2008). Firstly, K113 is more important in 
vivo as the mutant strain K112R is completely viable but K113R has a reduced 
survival rate and an increase in chromosome mis-segregation. Therefore, if K112 
acetylation was a pre-requisite of K113 acetylation you would expect there to be a 
large phenotype in the K112R strain, as in these cells, K113 could not become 
acetylated. This is not the case and therefore it is likely that the kinetics of the two 
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acetylation steps are different. Potentially, the acetylation of K112 occurs at as a 
faster rate than K113 acetylation, which is supported by the two peptide structures. 
For instance, upon binding K113 (Ac-CoA-K106) the C-extension of Eco1 is 
displaced by almost 180 °, which could be kinetically unfavourable; however, when 
Eco1 is bound to K112 (Ac-CoA-K105) the C-extension adopts the same 
conformation as in the peptide free structure making this substrate more favourable. 
This is also supported by the observation that the peptide density for Ac-CoA-K106 
is much stronger, which could indicate that the peptide has a slow on/off rate. 
 
The results from the peptide motif MS experiments indicate that Eco1 was able to 
acetylate a consensus motif which had a lysine flanked by an aliphatic residue (B/Z) 
and an acidic/polar (ϕ) residue (B/Z-AcK-ϕ). This result was supported by the 
structure of Ac-CoA-K106, which showed that D107 at position +1 (P+1) interacted 
with the indole side chain of W623 and formed a salt bridge with R621. In addition, 
at P-1 from the unconjugated lysine (K105) interacted through its aliphatic moieties 
with L562 and F564 of xEco2. Previous evidence has suggested that for Scc1 to 
become acetylated at K84, Chk-1 is required to phosphorylate S83 (Heidinger-Pauli 
et al., 2008), which could provide an acidic mimic to support strong Eco1 binding. 
 
A proportion of the peptides identified could not be classed into the above bi-
directional motif and were grouped as having ‘no direction’. These peptides were 
generally flanked by a proline or arginine which supports the b-hairpin conformation 
of the peptide observed in the structure of Ac-CoA-K105 and Smc3-Scc1N. 
Furthermore, in the peptide Ac-CoA-K105 structure K106 at P+1 salt bridges with 
D677 showing the importance of having a lysine residue which is not acetylated at 
this position. This supports the analysis from MS data and could be the reasons K112 
acetylation occurs first. In addition, it provides support for having a basic residue at 
P+1 in the peptide motif with no direction. 
 
Eco1 was able to acetylate a range of cohesin targets, in vitro, albeit at a high 
concentration. It raises the intriguing possibility that apart from acetylating Smc3 
during S-phase and Scc1 in response to DSB, Eco1 may be able to acetylate other 
cohesin related targets. The peptide motif and structures presented in this thesis 
could provide a rationale for investigating this further. 
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The ACT domain of xEco2 looks similar to other GNAT family proteins. However, 
between the N- and C-lobe there is an Eco1 specific insertion which forms a b-hairpin 
structure. The two structures solved in this thesis revealed that xEco2 formed two 
different conformations when bound to different conjugated peptides. Multiple 
contacts were made by both peptides with large movements being observed in the 
C-extension in the Ac-CoA-K106 structure (Figure 7.2). 
 
The effect, in vivo, of acetylation on Smc3 at K112 and K113 causes the 
establishment of sister-chromatid cohesion through antagonising the action of Pds5 
and Wapl. However, the biochemical function of acetylation is still relatively unknown. 
It has been suggested in previous studies that K112 and K113 act as DNA sensors 
to trigger the loading or release of DNA through the entry and exit gate respectively 
(Murayama and Uhlmann, 2015). To test this directly, the head domain of cohesin 
was recombinantly purified with acetylation mimics. Using these complexes, the DNA 
binding to dsDNA was tested. The results indicated that acetylation reduced the 
affinity of the head domain to DNA. This suggested that acetylation of the tandem 
lysine motif would block DNA stimulated hydrolysis, which agrees with the 
conclusions drawn from previous studies.  
 
The greater importance of K113 acetylation over K112 acetylation most likely relates 
to K113 being more significant in contacting DNA. Acetylation of K112 and K113 did 
not completely abolish DNA binding, which is unsurprising as there are numerous 
other surface exposed basic residues present around the proposed DNA binding site. 
More recently other binding models of Rad50 have been suggested rather than the 
tilted model presented in Figure 6.13A (Rojowska et al., 2014). In these conformation 
DNA would not contact the tandem lysine motif. However, I propose that the tilted 
DNA binding is an intermediate step and the head domain can probably interact with 
DNA in multiple protein-DNA geometries. 
 
In conclusion, I have discovered that K112 acetylation occurs before the acetylation 
of K113. I have also solved the structure of xEco2 bound to two conjugated peptides 
which has shown the importance of both the conserved C-extension and the b-
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hairpin. Finally, I have shown that acetylation blocks DNA binding to the head domain 
in a tilted conformation, which inhibits the DNA induced hydrolysis of ATP. 
 
 
Figure 7.2. Conformational Changes in Eco1 Upon Substrate Binding. 
 
7.3 Future Work 
7.3.1 Further work on the RFCCtf18 complex 
In this thesis I have presented work which improves our understanding of the role 
the Ctf8-Dcc1 sub-complex plays in regulating RFCCtf18. However, to gain further 
insights, two structural approaches could be taken. In the first instance, it would be 
useful to obtain a complete structural model for RFCCtf18. This could be done with the 
use of insect cells to express the seven-subunit complex. Once the full complex is 
expressed, structural studies could be carried out using electron microscopy (EM) or 
by X-ray crystallography. Hopefully, this will provide further support to the pseudo-
atomic structure presented in Figure 7.1. Additionally, to gain further information 
about the binding mechanisms of Dcc1 one could attempt to obtain a crystal structure 
of the C-terminal region of Dcc1 bound to DNA. This would potentially give additional 
insights into the type of substrate Dcc1 interacts with. 
 
In the work presented in Chapter 5 it was clearly shown that WH3 of Dcc1 binds to 
DNA and is involved in recruiting the complex to chromatin. However, more work is 
needed to clarify the function of WH2 and WH1. It could be possible that they serve 
as additional DNA binding sites to support WH3 although it is also conceivable that 
WH1 and WH2 carry out other roles. 
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7.3.2 Further work on the role of Eco1 
To gain further insights into the role of Eco1 future studies could further investigate 
the role of K112 acetylation. It would be interesting to observe if in vitro it would be 
possible for K113 acetylation to occur with the mutation K112R, albeit at a reduced 
rate. This would link the results presented in this thesis with the previous observed 
genetic observations (Zhang et al., 2008). 
 
Further work could also be conducted into the role of the N-terminus of Eco1 as a 
conserved ZnF domain is present in all Eco1 homologs; it would be interesting to 
assign a biological function to this motif. Structural studies could be carried out on 
the N-terminus of Eco1 which may aid in our understanding of the function of this 
region. 
 
The model for the role of acetylation presented in Chapter 6 implies that K112 and 
K113 regulate ATP hydrolysis of the head domain by sensing DNA. To further clarify 
this the structure of Smc3-Scc1N could be solved with DNA to support the tilted 
binding model of the Rad50-DNA complex (Rojowska et al., 2014). 
 
7.4 Summary of Findings Presented in This Thesis 
In summary, I solved the structure of the C-terminus of Dcc1 along with the Ctf18-
Dcc1-Ctf8 heterotrimer, which forms part of the RFCCtf18 complex. I have shown that 
the C-terminus of Dcc1 contains three tandem WH domains which can bind to both 
ssDNA and dsDNA. Furthermore, I have revealed that WH3 of Dcc1 is important for 
recruiting the complex to stalled replication forks. I have also solved the structure of 
xEco2 ACT domain in two peptide bound structures, which has indicated that Eco1 
is able to bind the tandem lysine motif through different conformations. In addition, I 
have presented results which show that the acetylation of Smc3 reduces the affinity 
of DNA to the head domain of cohesin. This has provided evidence that the tandem 
lysines motif is important in sensing DNA. Finally, I have revealed that the kinetics of 
the acetylation K112 and K113 is different as K112 acetylation occurs first. 
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Appendix 1. List Restriction Free (RF) Primers Used in this Thesis. 
For the forward (Primer 1) and the reverse primers (Primer 2) the sequence 
corresponding to the vector sequence is in orange and the protein codding sequence is 
in blue. The primer sequence runs in the 5’ to 3’ direction. 
 
 
Construct Vector Primer 1 Primer 2
Dcc1 pETDuet
AATAATTTTGTTTAAC
TTTAAGAAGGAGATA
TACCATGTCCATCAA
CCTACATTCCG
CGACTTAAGCATTAT
GCGGCCGCCTACCT
GCTCGTGACCAC
Ctf8 pCDFDuet
AATAATTTTGTTTAAC
TTTAATAAGGAGATA
TACCATGCCTAGTGT
AGATATAGATGCTA
ACAATACGATTACTT
TCTGTTCGACTTAAG
CATTATTACATAATA
GGTAGAGGCCTATC
C
Dcc1 (90 - 380) pET28a
GCGAAAACCTGTATT
TTCAGAGCGGAGGA
CTGTCCAAGCCGTAC
TCAGCTTCCTTTCGG
GCTTTGTTACTACCT
GCTCGTGACCAC
Ctf18 (666 - 741) pET28a
CGAAAACCTGTATTT
TCAGAGCGGATCCAA
AGTCAAAACTGGGTT
AAATTCTT
TCAGCTTCCTTTCGG
GCTTTGTTATTATTCC
CACAGGTTATTCCAA
GT
xEco2 (523 - 702) pET28a
CACAGCGAAAACCT
GTATTTTCAGAGCAT
GAAGAAAGAGCGAG
TTATTACAGAGT
TCAGCTTCCTTTCGG
GCTTTGTTACTAACT
GACAAAATTATACAC
CAGG
Eco1 pET28a
CGAAAACCTGTATTT
TCAGAGCGGATCCAT
GAAAGCTAGGAAATC
GCAGA
TCAGCTTCCTTTCGG
GCTTTGTTATCATAT
GTATACCGGCAATAG
TAAC
Dcc1 pET28a
GCGAAAACCTGTATT
TTCAGAGCGGAATGT
CCATCAACCTACATT
CCG
TCAGCTTCCTTTCGG
GCTTTGTTACTACCT
GCTCGTGACCAC
Pol2 (1 - 533) pET28a
CGAAAACCTGTATTT
TCAGAGCGGATCCAT
GATGTTTGGCAAGAA
AAAAAACA
TCAGCTTCCTTTCGG
GCTTTGTTAATTTGG
TAGAAGAATATTATG
TTGA
Dcc1ΔWH2-3 pETDuet
AATAATTTTGTTTAAC
TTTAAGAAGGAGATA
TACCATGTCCATCAA
CCTACATTCCG
ACAATACGATTACTT
TCTGTTCGACTTAAG
CATTACAAGCGCCAC
GTATTGTTT
Dcc1ΔWH3 pETDuet
CGAAAACCTGTATTT
TCAGAGCGGATCCAT
GTCCATCAACCTACA
TTCCG
TCAGCTTCCTTTCGG
GCTTTGTTATTTCGC
TATATACTGGACAGT
CTTA
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Appendix 2. List Primers Used for Mutagenic Cloning in This Thesis. 
 
 
Appendix 3. List of Acetylated Peptides From in vitro Acetylation Assay. 
Forward   
Gene names Sequence window 
PDS5 TSDQLISTNELLDRLKALHEELASLDQDNTD 
PDS5 TESIPQIIATREDISKELNQALAKTFIDSDP 
PDS5 ATREDISKELNQALAKTFIDSDPRVRRTSVM 
PDS5 TSVMIFNKVPVTEIWKNITNKAIYTSLLHLA 
PDS5 GLSDSTKAIDALETIKQFNDERIFYLLNACV 
PDS5 RRILDDISKVNPTLFKDQIRTLKTIIKDLDD 
PDS5 PTLFKDQIRTLKTIIKDLDDPDAEKNDNLSL 
PDS5 TLKKIKIRILPLDLQKDKYFTSHIIVLMEIF 
PDS5 LIKEVLLSNQVVGDSKKEIDWVEDSLLSDTK 
PDS5 QVLKLARISNLNNFIKPSDIIKLINLVEDES 
PDS5 DKLVEDEIDEEEGPQKEEAPKKHRPYGQKMY 
RAD61 NVKIITSSDTSMAFMKDEKLSAFNFLDGSKA 
RAD61 SKDKKYGKFRTILINKNKENEIMGEEVDQKA 
RAD61 AEKEGLTSTNHYNELKNMGDTIKYQDDIEFL 
RAD61 SKSNDNTTVPINEYFKKLLNLSLMIINDEEF 
RAD61 SDFPPSFDNFSIELSKDDGKIRTKKNKHIKK 
RAD61 LSLDIIKRISILASNKDLFSRHVKTFIPLLE 
RAD61 ISILASNKDLFSRHVKTFIPLLEKLITASEF 
SCC1 GNIDTITDAMTESQPKQTGTRRNSKLLNTKS 
SCC1 LPDPILKNFLSYESLKKRKIHNGREGSIEEP 
SCC2 CNQMKDIAPENIDLLKNEYKKQEEFLFNIVE 
SCC2 TKDAKEQIITVDNELKKILEQIKDGGLGPEL 
Protein Mutation Primer	1 Primer	2
Dcc1 K326A
CCAATGGACCCCGCAGA
ACGGTTTAAAGTCC
GGACTTTAAACCGTTCT
GCGGGGTCCATTGG
Dcc1 K357A
CAAGAGGTATGGCAAT
AGACAGTTTCATCATG
CATGATGAAACTGTCTA
TTGCCATACCTCTTG
Dcc1 K364A
GACAGTTTCATCATGGC
GTATGCCCGCCG
CGGCGGGCATACGCCA
TGATGAAACTGTC
Dcc1 R367A
CATGAAGTATGCCGCCC
GTAAAAGACTGGGC
GCCCAGTCTTTTACGGG
CGGCATACTTCATG
Dcc1 R380A
AAAGACCGTGGTCACG
AGCGCGTAGAGCTTGC
GCAAGCTCTACGCGCTC
GTGACCACGGTCTTT
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SCC2 SLLAKDKIKLRSTAIKCLSMLASKDKVILSN 
SCC2 RNTGVNSTLSSNSILKKKLLKTNRVEFANDG 
SCC2 RFLDNILQLCLLRDLKNSLVAIRLLKLILKF 
SCC3 SIIDNIVKLCFVHRYKDVSDLIRSESMLHLS 
SCC3 REIIEKVRDYENSISKDLRSVWKPIAAIIGR 
SCC4 RKFLPKVYSTTQKLIKNIAAGGVSMNELDSR 
SCC4 GKDVALTNAKLEALVKQITSVKQ________ 
SMC1 ___MGRLVGLELSNFKSYRGVTKVGFGESNF 
SMC1 FVLGVRSNHLRSNILKDLIYRGVLNDENSDD 
SMC1 SIKNRRRIHGELKTYKEGINKNEEYRKQLDK 
SMC1 LTDKLSALNSEISSLKGKINNEMKSLQRSKS 
SMC1 TDRLSTTQRRYEKAQKDLENAQVEMKSLEEQ 
SMC3 SRGDDEVTIRRTVGLKKDDYQLNDRNVTKGD 
SMC3 RGDDEVTIRRTVGLKKDDYQLNDRNVTKGDI 
Reverse 		
ECO1 RIWVCRTARKLGIATKLIDVARENIVYGEVI 
ECO1 PRYQVAWSQPTDSGGKLASKYNGIMHKSGKL 
PDS5 ________MAKGAVTKLKFNSPIISTSDQLI 
PDS5 LASLDQDNTDLTGLDKYRDALVSRKLLKHKD 
PDS5 DKRVHRLLTVLSHFDKKAFTSFFAFNARQIK 
PDS5 IPFLTFKNCYNELVSKLQTPGLFKKYNISTG 
PDS5 AKQLDLKRRILDDISKVNPTLFKDQIRTLKT 
PDS5 TKLYDFAVESKPEITKYATKLIALSPKAEET 
PDS5 DFAVESKPEITKYATKLIALSPKAEETLKKI 
PDS5 KKEIDWVEDSLLSDTKYSAIGNKVFTLKLFT 
PDS5 EDSLLSDTKYSAIGNKVFTLKLFTNKLRSIA 
PDS5 SAIGNKVFTLKLFTNKLRSIAPDVPRDELAE 
PDS5 APDVPRDELAESFTEKTMKLFFYLIASGGEL 
PDS5 EFNKEFYPTPSNYQTKLRCVAGIQVLKLARI 
PDS5 SLLYYLSERVKNYQDKLVEDEIDEEEGPQKE 
PDS5 AQLSFKTYIPESLTEKIQNNIKAKIGRILHT 
RAD61 IITSSDTSMAFMKDEKLSAFNFLDGSKASKR 
RAD61 DGSKASKRKRRRTYQKHDANITSSIEPDVQD 
RAD61 EFILKLPRADDDILNKMLENEMKMDDSIENN 
RAD61 NKNKENEIMGEEVDQKANTLSLNNADNSNAE 
RAD61 PSFDNFSIELSKDDGKIRTKKNKHIKKLSHL 
RAD61 KDDGKIRTKKNKHIKKLSHLNFEDFLRKTQF 
RAD61 LNICSRENSRLKLDGKLWYDMKTIFVKMIRD 
SCC1 KDTLTKISMLFKTSQKMTSTVNRLNTVTRVH 
SCC1 TIPVGLMAQENSMERKVQGAAPWDTSLEVGR 
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SCC1 MTESQPKQTGTRRNSKLLNTKSIQIDEETEN 
SCC1 IDAKTRNEQTTIQTEKVRPTPGEVASKAIVQ 
SCC1 PTPGEVASKAIVQMAKILRKELSEEKEVIFT 
SCC2 IEKKSEIVSRPEAKHKLESVTSNAGNLSFND 
SCC2 DDSIMVRKHVLRINEKMYDETNDIVTKVYVI 
SCC2 LVQKIVELNSDDTNEKNSIVDKQNFLNLLAK 
SCC2 INKANNEEAAIVVDGKLQRLIYLSTGFARFC 
SCC2 LYEHITKCLLVLSKDKITHVIRRVAVKNLTK 
SCC4 CEFLLLHDLPLMRDSKFHYKIALRNCNELVQ 
SCC4 NCYDEKGNFSRKFLPKVYSTTQKLIKNIAAG 
SCC4 NFSRKFLPKVYSTTQKLIKNIAAGGVSMNEL 
SCC4 EQTLLKGAVVTTESPKLGPSPGYVRLLQAMK 
SCC4 CYTVQAARVSRCSGDKQGELVEQCNKVWLQV 
SCC4 CTVAMRGKDVALTNAKLEALVKQITSVKQ__ 
SMC1 SSFVKESAVISKQKSKLDYIFKDKEKLVSDL 
SMC1 KLNENDLKTYNCLHEKYLTEGGSILEEKIAV 
SMC1 NEKNALHTERLHELKKLQSDIESANNQEYDL 
No direction 		
ECO1 AVGIIIIENLYGGNGKTSSRGRWMVYDSRRL 
ECO1 VYDSRRLVQNVYPDFKIGISRIWVCRTARKL 
ECO1 DSGGKLASKYNGIMHKSGKLLLPVYI_____ 
PDS5 KRVHRLLTVLSHFDKKAFTSFFAFNARQIKI 
PDS5 DTFFFTKLYDFAVESKPEITKYATKLIALSP 
PDS5 PEITKYATKLIALSPKAEETLKKIKIRILPL 
PDS5 NYQTKLRCVAGIQVLKLARISNLNNFIKPSD 
PDS5 DEIDEEEGPQKEEAPKKHRPYGQKMYIIGEL 
PDS5 TYIPESLTEKIQNNIKAKIGRILHTSQTQRQ 
PDS5 RLQKRLLAHENNESQKKKKKVHHARSQADDE 
PDS5 SDDDSYSPSNKNETKKGHENIVMKKLRVRKE 
RAD61 SFDGANEKPSSQLDSKRNDQNVKIITSSDTS 
RAD61 KPSSQLDSKRNDQNVKIITSSDTSMAFMKDE 
RAD61 EKLSAFNFLDGSKASKRKRRRTYQKHDANIT 
RAD61 ANTLSLNNADNSNAEKEGLTSTNHYNELKNM 
RAD61 STNHYNELKNMGDTIKYQDDIEFLLSNSKSN 
RAD61 TIKYQDDIEFLLSNSKSNDNTTVPINEYFKK 
RAD61 EFFQYAKRYFKKEIIKLSFAQFRSDFPELIL 
SCC1 RSNNLLTPQPTNFTTKRLWSEITESMSYLPD 
SCC1 DVLKSQANTEPENITKREASRGFFDILSLAT 
SCC1 GLSQTEAFGNIKIDAKPALFERFINA_____ 
SCC2 TSNAGNLSFNDNSSNKKTKTSTGVTMTQANL 
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SCC2 AGNLSFNDNSSNKKTKTSTGVTMTQANLAEQ 
SCC2 RLIYLSTGFARFCFPKPSNDKIAFLQEGETL 
SCC2 IVEESELKNKQLPAKKPDISKFSAQLENIEQ 
SCC3 ___MTAVRRSTRIRTKSQVIEEDYDDEQNTS 
SCC4 NFFDTNKQSLVTNEGKGCVIKIMPRIALKVE 
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